rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCTAGGAGAGGCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	10	1.7462368595676318E-4		38	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	7	10	2	2	2	3	23	32	38	34	41			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01*02	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCAGGCCTAGCGTCGAGCACAGATACGCAGTATTTTGGCCCA	CASSPGLASSTDTQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	6	0	6	3	23	35	47	41	50			01,02			01,02							Vb 1	CASSPGLASSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTACCCTGACAAGCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPTLTSANTGELFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	51	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	4	2	6	0	8	4	23	35	47	43	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSPTLTSANTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTGCCCCTAGCGCGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSPAPSASYNEQFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	4	6	3	7	4	23	35	48	42	52			01,02			01,02							Vb 1	CASSPAPSASYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCGGGCACCTCAGGGGGTTTGGTCGAGCAGTACTTCGGGCCG	CASSAGTSGGLVEQYF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	1	6	9	6	23	36	52	45	58			01,02										Vb 1	CASSAGTSGGLVEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTAGAACACCGATGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	15	2.6193552893514474E-4		46	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	5	2	7	4	16	0	23	34	-1	50	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCGGGCGGATCTAGCACAGATACGCAGTATTTTGGCCCA	CASSAGGSSTDTQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	3	8	0	0	1	6	23	36	41	37	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSAGGSSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAAGCAAGCGGGAGGCCAGATGAGCAGTTCTTCGGGCCA	CASSEASGRPDEQFF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	1	8	7	4	23	34	50	41	54			01,02										Vb 1	CASSEASGRPDEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGCTAGCGGGGGCCGGGAGCAGTACTTCGGGCCG	CASSVGASGGREQYF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	7	3	4	23	39	52	42	56			01,02										Vb 1	CASSVGASGGREQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGATTATCGACAGGGGGCGCGAGTGGCAATGAGCAGTTCTTCGGGCCA	CASRLSTGGASGNEQFF	In	VDJ	1	43	7.508818496140817E-4	9.114224549057843E-4	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	0	6	6	8	23	34	50	40	58			01,02										Vb 1	CASRLSTGGASGNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCGAGAAGGCCGGGGTCAGCTCAGCCCCAGCATTTTGGTGAT	CASSPRRPGSAQPQHF	In	VDJ	1	43	7.508818496140817E-4	9.114224549057843E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	8	3	6	10	5	23	35	50	45	55			01,02										Vb 1	CASSPRRPGSAQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD02-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCACACCCTTAGCGGGAGGGAGGGCAGATACGCAGTATTTTGGCCCA	CASSATPLAGGRADTQYF	In	VDJ	2	51	8.905807983794922E-4	0.001080989423260349	54	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	0	4	9	4	23	36	56	45	60			01,02										Vb 1	CASSATPLAGGRADTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCACGGGGCGGGAGGAGGCCGGGGAGCTGTTTTTTGGAGAA	CASSTGREEAGELFF	In	VDJ	2	80	0.0013969894876541054	0.0016956696835456453	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	7	1	6	5	3	23	35	48	40	51			01,02										Vb 1	CASSTGREEAGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGCCGGGAGGGAGGGGAGCTGTTTTTTGGAGAA	CASSVGREGGELFF	In	VDJ	5	175	0.0030559145042433557	0.003709277432756099	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	8	0	8	2	1	23	39	49	41	50			01,02										Vb 1	CASSVGREGGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTACCTAGCGGGAGTACCACCGGGGAGCTGTTTTTTGGAGAA	CASSLPSGSTTGELFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	48	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	4	2	4	1	3	19	34	45	35	48														CASSLPSGSTTGELFF+TCRBV11-01+TCRBJ02-02	TCRBV11-01*01	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCAGAATCCTCTCGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSRILSGSYNEQFF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	48	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	4	0	10	0	19	31	-1	41	45						01,02								CASSRILSGSYNEQFF+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACTCACAGGGGTGTCCAATGAGCAGTTCTTCGGGCCA	CASSQLTGVSNEQFF	In	VDJ	1	31	5.413334264659658E-4	6.570720023739376E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	2	6	3	4	29	44	54	47	58													Vb 16	CASSQLTGVSNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGAATACGGGCCAGGGGGCCCAGAGACCCAGTACTTCGGGCCA	CASSQDEYGPGGPETQYF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	54	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	0	4	11	2	27	44	63	55	65													Vb 16	CASSQDEYGPGGPETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAGGGGGCGGGGAGCTGTTTTTTGGAGAA	CASSQEGGGELFF	In	VDJ	1	42	7.334194810184054E-4	8.902265838614638E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	5	1	7	0	0	29	-1	-1	46	52													Vb 16	CASSQEGGGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGATCGACAGGGAGCAGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	42	7.334194810184054E-4		49	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	3	4	5	5	29	45	57	50	62													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCTTTACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLYTGELFF	In	VDJ	1	48	8.381936925924632E-4	0.0010174018101273873	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	4	10	3	2	2	29	42	46	44	48						01,02							Vb 16	CASSPLYTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCACCATCAGGGGGGGCACTGAAGCTTTCTTTGGACAA	CASTIRGGTEAFF	In	VDJ	2	50	8.731184297838158E-4	0.0010597935522160284	39	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	7	4	1	4	4	2	29	39	50	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASTIRGGTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTTTTGGATACGCAGTATTTTGGCCCA	CASSLLDTQYF	In	VJ	2	51	8.905807983794922E-4	0.001080989423260349	33	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	4	0	0	6	0	5	29	-1	42	-1	47													Vb 16	CASSLLDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGGGGGAGCGACCCAGTACTTCGGGCCA	CASSGGATQYF	In	VDJ	2	73	0.0012747529074843712	0.0015472985862354013	33	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	5	6	1	7	0	3	29	-1	46	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSGGATQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATAAGGATGAGGACAGGGGGCCCCGGGGGCAGTACTTCGGGCCG	CASSQDKDEDRGPRGQYF	In	VDJ	2	81	0.0014144518562497817	0.001716865554589966	54	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	0	9	9	7	27	44	64	53	71													Vb 16	CASSQDKDEDRGPRGQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCAAGGCCAGAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	87	0.0015192260678238397		43	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	4	4	5	2	6	2	29	42	51	48	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCTTTTGGGCTTTGGTGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	3	103	0.0017986239653546606		50	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	8	0	3	5	8	29	45	54	50	62													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGGGGCCTCCGAGGGGCCCAGTACTTCGGGCCA	CASSRGLRGAQYF	In	VDJ	4	135	0.0023574197604163028	0.0028614425909832763	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	4	5	2	9	10	0	29	42	-1	52	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSRGLRGAQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGAGGTCCGAGGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	5	160	0.002793978975308211		46	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	0	5	2	5	9	0	29	46	-1	55	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSGGANTEAFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	1	0	1	24	-1	43	36	44														CASSGGANTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGAGCGGGAGGGACCTTAGTGGAGACCCAGTACTTCGGGCCA	CASSVGAGGTLVETQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	6	0	5	5	9	24	36	51	41	60														CASSVGAGGTLVETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCGCGGGACTGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPRDWNTGELFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	10	1	4	1	24	36	46	40	47						01,02								CASSPRDWNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTTACCGGCTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	15	2.6193552893514474E-4		47	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-03	01	5	9	0	0	9	1	24	36	48	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01		TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGTCCTACACTGAAGCTTTCTTTGGACAA	CASSASYTEAFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	6	3	0	4	24	-1	39	36	43						01,02								CASSASYTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCCTGGGATCTCCTACGAGCAGTACTTCGGGCCG	CASSPGISYEQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	6	0	8	0	4	1	24	35	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGISYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTGCCTAGAGACACCGGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	20	3.4924737191352636E-4		46	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-04	01	5	2	6	5	8	4	24	36	48	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01		TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCGAGGGGATTATGCATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	3.4924737191352636E-4		55	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	5	2	4	3	20	24	35	43	38	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGCGGCTCCGGGATAGGGATGTACGAGCAGTACTTCGGGCCG	CASSGGSGIGMYEQYF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	3	4	8	8	24	36	49	44	57														CASSGGSGIGMYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGGACAGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSGTGGTGELFF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	1	4	0	0	24	-1	-1	36	47														CASSGTGGTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTACGTCTAGCGGGAGGCGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	28	4.889463206789369E-4		50	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	4	1	1	6	1	24	36	53	42	54														X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCTGTACTCACGTCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	4.889463206789369E-4		53	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	2	7	4	23	0	24	35	-1	58	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCCGACATGACAGGGGAGGGAGCGAGCAGTACTTCGGGCCG	CASSPRHDRGGSEQYF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	2	6	9	6	24	36	53	45	59														CASSPRHDRGGSEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTTTCCGGGACACTTTATACGAGCAGTACTTCGGGCCG	CASSPFRDTLYEQYF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	4	7	5	24	36	49	43	54														CASSPFRDTLYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCAGGAAGGGTTCAACACTGAAGCTTTCTTTGGACAA	CASSQEGFNTEAFF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	5	4	4	2	0	8	24	-1	40	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGFNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGTGAAGGGAATGAGCAGTTCTTCGGGCCA	CASSGEGNEQFF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	5	5	3	7	5	0	24	36	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGEGNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGCCGACTAGCGGGTAGCCTGAAGTTCTTCGGGCCA	CASSGRLAGSLKFF	In	VDJ	1	41	7.15957112422729E-4	8.690307128171432E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	4	14	4	8	24	36	50	40	58						01,02								CASSGRLAGSLKFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGAACCACAAGCGGGAGGTCCCTACGAGCAGTACTTCGGGCCG	CASSEPQAGGPYEQYF	In	VDJ	2	74	0.0012922152760800475	0.0015684944572797218	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	1	2	8	2	24	36	53	44	55														CASSEPQAGGPYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGTTACACGTAGGGGAGAGCGCAGATACGCAGTATTTTGGCCCA	CASRLHVGESADTQYF	In	VDJ	5	175	0.0030559145042433557	0.003709277432756099	48	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	6	5	2	4	9	6	24	35	49	44	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLHVGESADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAAGACTCGGCCCTGTATCTCTGTGCCAGCGGTTTGGAGAGGGGCACTGAAGCTTTCTTTGGACAA	CASGLERGTEAFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	39	TCRBV04	TCRBV04-02	01				TCRBJ01	TCRBJ01-01	01	8	5	2	4	9	0	21	30	-1	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLERGTEAFF+TCRBV04-02+TCRBJ01-01	TCRBV04-02*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTGACAGGGGGCCTAATGAAAAACTGTTTTTTGGCAGT	CASSFDRGPNEKLFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	0	3	1	0	18	32	-1	33	43														CASSFDRGPNEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGAACCAGGGGACACTCCAGGGCCCCAGCATTTTGGTGAT	CASSLEPGDTPGPQHF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	6	9	6	7	18	34	46	40	53														CASSLEPGDTPGPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCATGTATCGCTGTGCTAGCAGCTTAGGTTACGGACCCACAGATACGCAGTATTTTGGCCCA	CASSLGYGPTDTQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-03	01	1	1	7	2	5	1	18	34	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGYGPTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGCCGGGACAACCACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGTTTGELFF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	6	4	4	2	18	32	42	36	44														CASSLAGTTTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGTGCCAGGGGCGGATGAAAAACTGTTTTTTGGCAGT	CASSLVPGADEKLFF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	2	6	5	3	18	32	43	37	46														CASSLVPGADEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCATGTATCGCTGTGCCAGACTCGGCGTGAGCGGGACTTGAGATACGCAGTATTTTGGCCCA	CARLGVSGT*DTQYF	Stop	VDJ	1	15	2.6193552893514474E-4		45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	6	3	5	10	4	18	26	43	36	47														CARLGVSGT*DTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCAAAGCCTAAGGGTTACACTGAAGCTTTCTTTGGACAA	CASSPKPKGYTEAFF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	45	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-01	01	5	5	3	3	10	2	18	30	44	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPKPKGYTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCCCGACAGGGCAACTACGAGCAGTACTTCGGGCCG	CASSSRQGNYEQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	3	3	3	3	18	31	41	34	44														CASSSRQGNYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGACCCGGGACACCTTCTTTACGAGCAGTACTTCGGGCCG	CASSLDPGHLLYEQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	6	4	6	7	18	32	44	38	51														CASSLDPGHLLYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCGGGAGGAGGTTTAAATGAGCAGTTCTTCGGGCCA	CASSSGGGLNEQFF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	1	7	0	7	18	-1	38	31	45														CASSSGGGLNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCATGTATCGCTGTGCCAGAAGCTTAGGGTTGAGAGCCTAACGCCATCGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	21	3.667097405092027E-4		61	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	4	9	0	10	9	18	34	47	44	56						01,02								X+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCCTGGGGGTCCACAGATACGCAGTATTTTGGCCCA	CASSSWGSTDTQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	42	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-03	01	3	6	1	2	3	2	19	32	40	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSWGSTDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCGTAAGGACAGGGACGGACATTCAATACTTCGGCGCC	CASSVRTGTDIQYF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	1	3	16	4	12	19	31	43	35	55														CASSVRTGTDIQYF+TCRBV07-05+TCRBJ02-04	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGTCAGAAGCTCCTGGGGTGACCCTCAGACCGGGCAGGTGACGCAGTATTTTGGCCCA	CVRSSWGDPQTGQVTQYF	In	VDJ	20	666	0.011629937484720427	0.014116450115517497	54	TCRBV07	TCRBV07-05	02				TCRBJ02	TCRBJ02-03	01	4	4	4	9	23	2	18	31	58	54	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CVRSSWGDPQTGQVTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*02		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCTTAGGCCCAGGGGAGGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	1.920860545524395E-4		49	TCRBV07	TCRBV07-04	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	9	0	1	6	1	22	38	51	44	52														X+TCRBV07-04+TCRBJ01-01	TCRBV07-04*01	TCRBD02-01*02	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCCTGACAGGGGGGTCACTGAAGCTTTCTTTGGACAA	CASSPDRGVTEAFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	42	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	4	3	2	22	34	46	37	48														CASSPDRGVTEAFF+TCRBV07-04+TCRBJ01-01	TCRBV07-04*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGGATTTCGACAGGGGTAGAGGTGTAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	5	171	0.0029860650298606504		53	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	2	6	10	22	33	47	39	57														X+TCRBV07-04+TCRBJ01-01	TCRBV07-04*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGCCGAAAAAAAGAGACCCAGTACTTCGGGCCA	CAGRKKETQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	9	0	3	0	7	26	-1	35	32	42													Vb 20	CAGRKKETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGACCGGGACAGGGGCAAGTCAAGAGACCCAGTACTTCGGGCCA	CAWRTGTGASQETQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	2	2	4	5	26	37	51	41	56													Vb 20	CAWRTGTGASQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTGGGGGAAACACTGAAGCTTTCTTTGGACAA	CAWSVGGNTEAFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	0	6	1	2	1	1	26	40	46	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGGNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGAATGAGACCGGGAAGGTCCTACAATGAGCAGTTCTTCGGGCCA	CA*MRPGRSYNEQFF	Stop	VDJ	1	12	2.095484231481158E-4		45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	3	1	8	3	26	34	47	42	50													Vb 20	CA*MRPGRSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGGGACAACACCCAAGCTTTCTTTGGACAA	CAWSRDNTQAFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	9	1	6	26	38	45	39	51			unresolved										Vb 20	CAWSRDNTQAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCAGGGGGCCTCTACCAAGAGACCCAGTACTTCGGGCCA	CAWSVPGGLYQETQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	0	0	2	4	26	40	50	42	54			unresolved										Vb 20	CAWSVPGGLYQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCAGGGACTACGCGATGTCGGGGAGCTGTTTTTTGGAGAA	CAWSQGLRDVGELFF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	0	9	7	3	8	26	37	47	40	55						01,02							Vb 20	CAWSQGLRDVGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAACCGGGACAGGGGGCGCGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	13	2.2701079174379212E-4		47	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	0	2	5	3	26	35	52	40	55													Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAGCGGGAGGGCCGGAATGAGCAGTTCTTCGGGCCA	CAWEREGRNEQFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	0	7	1	4	26	35	46	36	50													Vb 20	CAWEREGRNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAGTCCGGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWESGAGANVLTF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	5	8	3	2	5	0	26	35	-1	40	45			unresolved										Vb 20	CAWESGAGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTCTCCGATATCTCCTACAATGAGCAGTTCTTCGGGCCA	CAFSDISYNEQFF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	7	2	8	0	5	3	26	33	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAFSDISYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCCGGGACAGGGGGCTATGGCTACACCTTCGGTTCG	CAWSAGTGGYGYTF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	1	4	2	0	26	39	-1	41	52			unresolved										Vb 20	CAWSAGTGGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACTTGGGGGCCTCCTACGAGCAGTACTTCGGGCCG	CAWNLGASYEQYF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	6	0	0	4	0	26	36	-1	40	46													Vb 20	CAWNLGASYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATGGGCCTTGGGACAGTCTATGCTTTCTTTGGACAA	CAWSMGLGTVYAFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	5	11	9	5	26	38	54	47	59													Vb 20	CAWSMGLGTVYAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCGCAGGACACGGGGAGCTACACCTTCGGTTCG	CAWAQDTGSYTF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	5	1	6	9	5	6	26	35	45	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWAQDTGSYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCCGGGACAGGGGGCACTCAGCCCCAGCATTTTGGTGAT	CAWAGTGGTQPQHF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	0	6	3	2	26	35	50	38	52													Vb 20	CAWAGTGGTQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAACCGGGCGAACACTGAAGCTTTCTTTGGACAA	CAWSVNRANTEAFF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	42	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	0	8	0	1	5	0	26	40	-1	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVNRANTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACATACCAGGGGATTGAACACTGAAGCTTTCTTTGGACAA	CAWSVHTRGLNTEAFF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	48	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	2	0	6	2	26	40	52	46	54													Vb 20	CAWSVHTRGLNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAAGATCACTACGAGCAGTACTTCGGGCCG	CAWKDHYEQYF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	4	2	8	3	2	3	26	36	40	38	43			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKDHYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCACTAGCGACTACGAGCAGTACTTCGGGCCG	CACTSDYEQYF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	6	3	1	1	26	34	42	35	43						01,02							Vb 20	CACTSDYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCGATGACAGAGGCGGGGAGAGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	27	4.7148395208326056E-4		46	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	3	5	11	5	26	35	52	46	57													Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGGAGAACACTGAAGCTTTCTTTGGACAA	CAWTENTEAFF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	4	1	8	1	1	0	26	36	-1	37	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTENTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCCGGGGGCGCTTACGAGCAGTACTTCGGGCCG	CAWSVPGGAYEQYF	In	VDJ	1	30	5.238710578702895E-4	6.35876131329617E-4	42	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-07	01	0	6	0	4	4	3	26	40	50	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVPGGAYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCGACGGAGAGACCCAGTACTTCGGGCCA	CAWSLDGETQYF	In	VDJ	1	31	5.413334264659658E-4	6.570720023739376E-4	36	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-05	01	2	2	7	4	3	2	26	38	44	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSLDGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCACCCCGACACTGAAGCTTTCTTTGGACAA	CAWSHPDTEAFF	In	VDJ	1	31	5.413334264659658E-4	6.570720023739376E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	3	3	7	3	2	4	26	37	41	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSHPDTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCTCAGGATACGAGCAGTACTTCGGGCCG	CAWSLSGYEQYF	In	VDJ	1	34	5.937205322529948E-4	7.206596155068993E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	4	4	4	1	26	38	46	42	47													Vb 20	CAWSLSGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCAAACAGGGGGTAGCTAATGAAAAACTGTTTTTTGGCAGT	CACKQGVANEKLFF	In	VDJ	1	34	5.937205322529948E-4	7.206596155068993E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	1	3	3	3	26	34	45	37	48													Vb 20	CACKQGVANEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGATCCTGGCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWDPGSSYNEQFF	In	VDJ	1	36	6.286452694443474E-4	7.630513575955404E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	5	0	8	0	26	35	-1	43	46													Vb 20	CAWDPGSSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGGATGGGGGACTGGGCTAAACTATGGCTACACCTTCGGTTCG	CAWSGWGTGLNYGYTF	In	VDJ	1	39	6.810323752313764E-4	8.266389707285021E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	0	10	2	7	6	26	37	50	44	56						01,02							Vb 20	CAWSGWGTGLNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGTCAGAGATTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	40	6.984947438270527E-4		41	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	1	4	5	1	2	5	26	39	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTTCTTATCAAGAGACCCAGTACTTCGGGCCA	CAWSVSYQETQYF	In	VDJ	1	40	6.984947438270527E-4	8.478348417728227E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	10	2	2	3	26	40	44	42	47						01,02							Vb 20	CAWSVSYQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCGCAACAAAACGATTTTAACTATGGCTACACCTTCGGTTCG	CAQQNDFNYGYTF	In	VDJ	1	41	7.15957112422729E-4	8.690307128171432E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	3	6	1	3	9	26	31	37	34	46													Vb 20	CAQQNDFNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACCGGGACTCATCCTACGAGCAGTACTTCGGGCCG	CAWNRDSSYEQYF	In	VDJ	1	43	7.508818496140817E-4	9.114224549057843E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	10	1	3	2	26	36	45	39	47			unresolved			01,02							Vb 20	CAWNRDSSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGACATCTCCCAAGAGATCCAGTACTTCGGGCCA	CAWSGDISQEIQYF	In	VDJ	2	51	8.905807983794922E-4	0.001080989423260349	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	6	10	0	13	26	-1	45	39	58			unresolved										Vb 20	CAWSGDISQEIQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGTCTGTAGGACTAGCGGGAGCGGTGACCCAGTACTTCGGGCCA	CAWSVGLAGAVTQYF	In	VDJ	2	53	9.255055355708448E-4	0.00112338116534899	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	1	2	7	6	4	26	35	54	41	58													Vb 20	CAWSVGLAGAVTQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGATTACGATCAGTCCCAGCATTTTGGTGAT	CAWSVDYDQSQHF	In	VDJ	2	64	0.0011175915901232843	0.0013565357468365163	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-05	01	0	1	8	11	0	11	26	-1	43	40	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVDYDQSQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCTTAAGGAGAGCAGGGGGATTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	78	0.0013620647504627528		43	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	1	4	11	2	26	34	52	45	54													Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAAGATTAGTTATAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CAWKD*L*QSRANVLTF	Stop	VDJ	2	80	0.0013969894876541054		51	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-06	01	4	3	6	5	13	5	26	36	52	49	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKD*L*QSRANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*02		TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGACGGACTAGCGGGAGCGATGAGCAGTTCTTCGGGCCA	CAWGRTSGSDEQFF	In	VDJ	3	88	0.001536688436419516	0.0018652366519002097	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	2	8	4	2	26	35	52	39	54													Vb 20	CAWGRTSGSDEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGTCTTGGGAATCAGCCCCAGCATTTTGGTGAT	CAWSGLGNQPQHF	In	VDJ	3	89	0.0015541508050151923	0.0018864325229445305	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-05	01	1	0	9	4	5	0	26	39	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGLGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTAGCGGGAGCGCCGGCCCAGATACGCAGTATTTTGGCCCA	CAWTSGSAGPDTQYF	In	VDJ	3	108	0.0018859358083330423	0.002289154072786621	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	4	2	4	0	8	26	-1	46	36	54			unresolved										Vb 20	CAWTSGSAGPDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGTGGCGGGGCCGGCTACAATGAGCAGTTCTTCGGGCCA	CAWGGGAGYNEQFF	In	VDJ	4	131	0.0022875702860335975	0.002776659106805994	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	7	3	3	0	4	26	-1	45	39	49			unresolved										Vb 20	CAWGGGAGYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGAACAGGGGCTGGAAACACCATATATTTTGGAGAG	CAWSGTGAGNTIYF	In	VDJ	5	148	0.002584430552160095	0.0031369889145594436	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	3	2	2	2	0	26	39	-1	41	48													Vb 20	CAWSGTGAGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGCGTATCTCTGCGCCAGCAGCCAAGAGTCCGCTAGCGGGAGGGCCTGATTTATGGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	11	1.920860545524395E-4		64	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	4	0	4	5	13	10	27	44	32	57														X+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGATTATGGCCTAGCGGGAACAGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	14	2.4447316033946847E-4		55	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	3	5	7	5	23	40	56	47	61														X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAGTACGTAGACGGGGTAGACTATGGCTACACCTTCGGTTCG	CASSQEYVDGVDYGYTF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	3	3	9	3	23	40	54	49	57														CASSQEYVDGVDYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCGCGGACAGGCAGGGTTGGCGGCTACACCTTCGGTTCG	CASSPRTGRVGGYTF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	4	8	3	10	23	36	46	39	56														CASSPRTGRVGGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAAGCATAGCGCTGGAGTTCCCAGATACGCAGTATTTTGGCCCA	CASSQSIALEFPDTQYF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	5	6	4	4	10	23	38	47	42	57						01,02								CASSQSIALEFPDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGACCAAACAGGCTACTATGGCTACACCTTCGGTTCG	CASSQDQTGYYGYTF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	4	3	4	2	23	40	49	44	51														CASSQDQTGYYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATACCCTAGCGGGAGGGCCCTACGAGCAGTACTTCGGGCCG	CASSQDTLAGGPYEQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	4	0	2	4	1	23	40	56	44	57														CASSQDTLAGGPYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGGGATAGGTGAAGCTTTCTTTGGACAA	CASSQGIGEAFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	36	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	3	0	8	7	1	4	23	37	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGIGEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGATGAGATCCCCGGGAGTTCTTCGGGCCA		Out	VDJ	1	23	4.016344777005553E-4		38	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	8	4	14	9	0	23	40	-1	49	53						01,02								X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACCCGGACGGCCTTCGGCTGAAGCTTTCTTTGGACAA	CASSQPGRPSAEAFF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	45	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	2	1	7	6	3	9	23	38	45	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQPGRPSAEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCGGGACAGCATAGAATGAACACTGAAGCTTTCTTTGGACAA	CASSPGQHRMNTEAFF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	0	1	7	23	36	44	37	51														CASSPGQHRMNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGTACGACTAGCGGGAGTAAAGAGACCCAGTACTTCGGGCCA	CASSTTSGSKETQYF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	2	2	3	3	2	23	34	49	37	51														CASSTTSGSKETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCCGGGGCGGGGTATGGCTACACCTTCGGTTCG	CASSQAGAGYGYTF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	7	3	5	5	0	23	39	-1	44	50														CASSQAGAGYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGTAGCTCTAGCGGGAGGAATATAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	32	5.587957950616421E-4		58	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	1	0	5	7	23	39	55	44	62														X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGCGGGACCAACAATGAGCAGTTCTTCGGGCCA	CASSRGTNNEQFF	In	VDJ	4	120	0.002095484231481158	0.002543504525318468	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	3	5	0	3	23	-1	42	36	45														CASSRGTNNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAACCCCCTAACACTGAAGCTTTCTTTGGACAA	CASSQEPPNTEAFF	In	VDJ	5	174	0.0030384521356476794	0.0036880815617117784	42	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	0	3	7	2	0	5	23	-1	42	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEPPNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGCAGGAGATCATGAAAAACTGTTTTTTGGCAGT	CASSLGAGDHEKLFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	0	4	4	6	3	5	19	35	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGAGDHEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGAATCCCCGGGAGGTGGGACAGATACGCAGTATTTTGGCCCA	CASSESPGGGTDTQYF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	8	1	3	7	4	19	31	45	38	49													Vb 5.1	CASSESPGGGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGGGGGCGCCTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	2.4447316033946847E-4		43	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-02	01	0	6	0	4	1	4	19	35	42	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGGAACAGGGAGTAGCCGGGGAGCTGTTTTTTGGAGAA	CASREQGVAGELFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	6	3	5	19	30	39	33	44													Vb 5.1	CASREQGVAGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGACGGGAGGGGTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRREGSTNEKLFF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	8	0	0	1	2	19	30	39	31	41													Vb 5.1	CASRREGSTNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGACTAGCGCCAATAAAACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	4.190968462962316E-4		50	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	6	3	0	9	19	-1	41	34	50						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGATCTAGGGACAGGGGGCGGCAATGAGCAGTTCTTCGGGCCA	CASSQDLGTGGGNEQFF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	0	6	9	2	19	31	52	40	54													Vb 5.1	CASSQDLGTGGGNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGATCAGACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSDQTTNEKLFF	In	VDJ	1	30	5.238710578702895E-4	6.35876131329617E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	5	0	3	1	19	31	37	34	38													Vb 5.1	CASSDQTTNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAGTAGCTGGACTAGTTACAATGAGCAGTTCTTCGGGCCA	CASSLSSWTSYNEQFF	In	VDJ	1	31	5.413334264659658E-4	6.570720023739376E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	8	4	7	1	19	34	48	41	49						01,02							Vb 5.1	CASSLSSWTSYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGACTAGCGGGCTACGAGCAGTACTTCGGGCCG	CASSLGLAGYEQYF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	4	3	0	0	19	-1	-1	35	45						01,02							Vb 5.1	CASSLGLAGYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCGAAGGTCACCGACAGGGAACTACTCTGGAAACACCATATATTTTGGAGAG	CASSRRSPTGNYSGNTIYF	In	VDJ	1	34	5.937205322529948E-4	7.206596155068993E-4	57	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	3	0	11	5	19	31	49	42	54													Vb 5.1	CASSRRSPTGNYSGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCGGGGAGGGGATCGGACGAGCAGTACTTCGGGCCG	CASSLAGRGSDEQYF	In	VDJ	1	44	7.68344218209758E-4	9.326183259501049E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	0	5	2	6	19	35	44	37	50													Vb 5.1	CASSLAGRGSDEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGGGGGGACAGGCGGGACACTGAAGCTTTCTTTGGACAA	CASSGGDRRDTEAFF	In	VDJ	3	102	0.0017811615967589843	0.002161978846520698	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	4	3	4	4	19	31	43	35	47													Vb 5.1	CASSGGDRRDTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGTACCATCTACGAGCAGTACTTCGGGCCG	CASSLGTIYEQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	2	0	10	3	0	6	25	-1	42	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGTIYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCTCCCGGCAGGGGATCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLSRQGISYNEQFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	0	9	2	25	37	52	46	54													Vb 3	CASSLSRQGISYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCCCGGCCGGGACAGGGGAGGACGAACTGAAGCTTTCTTTGGACAA	CASPGRDRGGRTEAFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	0	2	5	7	7	25	34	51	41	58													Vb 3	CASPGRDRGGRTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCGTTGGGACTAGCGGGAGGGCGGCGGTTCTTCGGGCCA	CASSPLGLAGGRRFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	0	15	6	5	25	36	58	42	63													Vb 3	CASSPLGLAGGRRFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGCGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGGANTGELFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	7	3	0	2	0	25	39	-1	41	47													Vb 3	CASSLGGANTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCAGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSFQGQETQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	3	1	1	0	25	39	-1	40	45													Vb 3	CASSFQGQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGCGCCCTTCCGAACACTGAAGCTTTCTTTGGACAA	CASSSALPNTEAFF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	6	6	1	0	7	25	-1	41	37	48						01,02							Vb 3	CASSSALPNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCCAGCGCGGCAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSPSAASSYEQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	6	6	0	5	7	25	38	47	43	54						01,02							Vb 3	CASSSPSAASSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCTTAGCGGAGCCCTCTACGAGCAGTACTTCGGGCCG	CASSSLSGALYEQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	5	3	4	6	25	38	48	42	54						01,02							Vb 3	CASSSLSGALYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCCCCAGGAGGGTCTGGAAACACCATATATTTTGGAGAG	CASSLPPGGSGNTIYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	2	10	0	1	6	0	25	40	-1	46	52													Vb 3	CASSLPPGGSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCGGGAGACTATGGCTACACCTTCGGTTCG	CASSLPGDYGYTF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	8	2	3	1	0	25	40	-1	41	47													Vb 3	CASSLPGDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGTCTAGCGGGGGCAAGACCCAGTACTTCGGGCCA	CASSLGSSGGKTQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	6	4	2	25	40	54	44	56													Vb 3	CASSLGSSGGKTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTCCACAACCTACGAGCAGTACTTCGGGCCG	CASSFSTTYEQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	6	2	4	1	25	39	46	43	47													Vb 3	CASSFSTTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTCCCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	2.7939789753082106E-4		34	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	4	10	2	1	4	25	35	38	36	42						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAGTCGGCGGGACACCTAATCAGCCCCAGCATTTTGGTGAT	CASRVGGTPNQPQHF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	6	0	6	4	7	3	25	36	49	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRVGGTPNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGTAGGTAGCGGGAGGGCCGTCGACGAGCAGTACTTCGGGCCG	CASSLVGSGRAVDEQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	5	0	5	5	6	25	40	56	45	62													Vb 3	CASSLVGSGRAVDEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCTTTCCGGCTAGCGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSFRLAGGETQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	4	1	4	9	0	25	34	-1	43	54													Vb 3	CASSFRLAGGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTTGTGGCGGGATGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASCGGMSSYNEQFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	7	3	0	5	4	25	33	44	38	48													Vb 3	CASCGGMSSYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGGGACAGGGGAGGAATACGCAGTATTTTGGCCCA	CASSRGQGRNTQYF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	2	7	3	4	25	36	49	39	53													Vb 3	CASSRGQGRNTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGACTCAGGGCCGAGAGCCCCAGCATTTTGGTGAT	CASRTQGREPQHF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	8	4	5	25	36	45	40	50													Vb 3	CASRTQGREPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGATCAAACCTATGGCTACACCTTCGGTTCG	CASSSDQTYGYTF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	4	2	8	4	2	6	25	38	42	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSDQTYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGAACAGGGAGTATCGGGACAATGAGCAGTTCTTCGGGCCA	CASSSNREYRDNEQFF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	5	3	9	25	38	47	41	56													Vb 3	CASSSNREYRDNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCGCCGGGACTAGCGGATTCTACGAGCAGTACTTCGGGCCG	CASSLAGTSGFYEQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	5	3	6	3	25	37	54	43	57						01,02							Vb 3	CASSLAGTSGFYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGAGCGGAGGGGCTACGAGCAGTACTTCGGGCCG	CASSLERRGYEQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	0	3	4	1	25	40	50	44	51													Vb 3	CASSLERRGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGAGAGCCGACCCCAAGAGACCCAGTACTTCGGGCCA	CASSFESRPQETQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	3	2	7	1	8	1	25	39	50	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFESRPQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGGTGGATAGCGGGAGTCGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	18	3.143226347221737E-4		46	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	9	5	2	4	5	5	25	33	47	38	52													Vb 3	X+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCTCCTCCCGTGGTAGCGGGAGTCCGGATACGCAGTATTTTGGCCCA	CASSFSSRGSGSPDTQYF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	2	6	12	4	25	39	60	51	64													Vb 3	CASSFSSRGSGSPDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCTAGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSFLAGTDTQYF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	5	1	1	0	25	39	-1	40	47						01,02							Vb 3	CASSFLAGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTAGCGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSLAGGETQYF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	4	1	4	0	0	25	-1	-1	37	48													Vb 3	CASSLAGGETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACTCCCTCAGGGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSTPSGGSGANVLTF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	1	0	7	0	25	37	-1	44	51													Vb 3	CASSTPSGGSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTTCCCGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLPGSGANVLTF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	8	4	1	5	0	25	37	-1	42	46						01,02							Vb 3	CASSLPGSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCCCCCGGGACAGTATCCTACGAGCAGTACTTCGGGCCG	CASSAPGTVSYEQYF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	1	6	2	25	37	50	43	52													Vb 3	CASSAPGTVSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGCCGGATCGAACACTGAAGCTTTCTTTGGACAA	CASSLAGSNTEAFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	2	1	8	1	3	2	25	40	46	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLAGSNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGCCCCCTCGGGAGGCTATGGCTACACCTTCGGTTCG	CASSAPSGGYGYTF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	8	1	4	8	0	25	36	-1	44	51													Vb 3	CASSAPSGGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCACGCAACTCTGGAAACACCATATATTTTGGAGAG	CASSPRNSGNTIYF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	6	3	7	0	3	4	25	36	41	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPRNSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAACCAGACATCTATGTACCTCTGTGCCAGCACCCTCCCTCGGCCTTGGGGGGGACAGGGACGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	25	4.365592148919079E-4		59	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	3	5	19	4	22	32	60	51	64													Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCGTCGGCGGGGGACTATGGCTACACCTTCGGTTCG	CASSSAGDYGYTF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	8	7	2	3	6	0	25	34	-1	40	47													Vb 3	CASSSAGDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCGGGCCCGCCGAGGGAGTTCTTCGGGCCA	CASSSPGPPREFF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	11	0	14	13	0	25	38	-1	51	56													Vb 3	CASSSPGPPREFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCCTGGGACAGGGGCGACAATGAGCAGTTCTTCGGGCCA	CASSWDRGDNEQFF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	2	5	4	2	25	34	48	38	50													Vb 3	CASSWDRGDNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGGGACAGGGGACGCAGATACGCAGTATTTTGGCCCA	CASSFGTGDADTQYF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	2	4	1	3	25	39	50	40	53													Vb 3	CASSFGTGDADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTATGGACTAGCGGGAACAATGAGCAGTTCTTCGGGCCA	CASSLWTSGNNEQFF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	2	3	5	0	0	25	-1	-1	42	53													Vb 3	CASSLWTSGNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCATCGGGGGATACGAGCAGTACTTCGGGCCG	CASSLIGGYEQYF	In	VDJ	1	30	5.238710578702895E-4	6.35876131329617E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	4	5	1	25	37	48	42	49													Vb 3	CASSLIGGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCACCGGACAGATATCAGCCCCAGCATTTTGGTGAT	CASSPPDRYQPQHF	In	VDJ	1	31	5.413334264659658E-4	6.570720023739376E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	5	5	5	2	25	37	48	42	50													Vb 3	CASSPPDRYQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGGCCGGGTACTTGACACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	31	5.413334264659658E-4		56	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-06	01	5	2	6	5	13	7	25	37	54	50	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01		TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCCCCCGCGGGTTATCCGGAGACCCAGTACTTCGGGCCA	CASSLPPAGYPETQYF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	7	4	5	6	7	25	40	51	46	58						01,02							Vb 3	CASSLPPAGYPETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGGTCACCCCAACTCCCGTTTTCCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	32	5.587957950616421E-4		44	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	11	3	10	5	10	11	25	31	44	41	55						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGTGGGCTGGGGTTGATCCCTCCTACGAGCAGTACTTCGGGCCG	CASSLWAGVDPSYEQYF	In	VDJ	1	33	5.762581636573184E-4	6.994637444625787E-4	51	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	6	2	0	7	7	25	39	50	46	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLWAGVDPSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTATTCACTGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSYSLGQETQYF	In	VDJ	1	34	5.937205322529948E-4	7.206596155068993E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	4	6	2	2	7	0	25	38	-1	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSYSLGQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCACGACAGGGGGACACGAGCAGTACTTCGGGCCG	CASSTTGGHEQYF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	1	5	3	2	25	36	48	39	50													Vb 3	CASSTTGGHEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAATCCCCAGGGTTACAATCAGCCCCAGCATTTTGGTGAT	CASSNPQGYNQPQHF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	3	6	3	25	37	48	43	51													Vb 3	CASSNPQGYNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACCGAATCCGGGACAGGGGCCGCACATGGCTACACCTTCGGTTCG	CASSTESGTGAAHGYTF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	6	9	6	25	37	56	46	62													Vb 3	CASSTESGTGAAHGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCCAAATTGAGCGGACCAATGAGCAGTTCTTCGGGCCA	CATQIERTNEQFF	In	VDJ	1	38	6.635700066357001E-4	8.054430996841816E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	6	5	6	9	2	25	32	46	41	48						01,02							Vb 3	CATQIERTNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCCCGTCGCAGGGCCCCCGTCAGCCCCAGCATTTTGGTGAT	CASSSPSQGPRQPQHF	In	VDJ	1	38	6.635700066357001E-4	8.054430996841816E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	6	10	6	25	36	51	46	57													Vb 3	CASSSPSQGPRQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCAACAGGGTCAGCCCCAGCATTTTGGTGAT	CASSPQQGQPQHF	In	VDJ	1	42	7.334194810184054E-4	8.902265838614638E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	6	6	0	25	36	-1	42	48													Vb 3	CASSPQQGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTGACAAGAGGGCACTACGAGCAGTACTTCGGGCCG	CASSLTRGHYEQYF	In	VDJ	1	43	7.508818496140817E-4	9.114224549057843E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	0	3	8	2	25	36	49	44	51													Vb 3	CASSLTRGHYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGCCATCGGACAGGGGCGGATATTTGCTGGAAACACCATATATTTTGGAGAG	CASSAIGQGRIFAGNTIYF	In	VDJ	2	53	9.255055355708448E-4	0.00112338116534899	57	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	2	2	7	10	24	35	51	42	61													Vb 3	CASSAIGQGRIFAGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCGCCTGRGGGCTCTTCGCTACGAGCAGTACTTCGGGCCG	CASSFRLXALRYEQYF	In	VDJ	2	53	9.255055355708448E-4	0.00112338116534899	48	TCRBV28	TCRBV28-01	01	unresolved			TCRBJ02	TCRBJ02-07	01	3	6	0	3	6	6	25	39	51	45	57				TCRBD01,TCRBD02									Vb 3	CASSFRLXALRYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	unresolved	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGAGGGCCAGGGGGGGAAGGCTGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	74	0.0012922152760800475		59	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	6	4	1	0	9	9	22	33	49	42	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGGATCGGCGGGTGAAAAACTGTTTTTTGGCAGT	CASSSGSAGEKLFF	In	VDJ	3	95	0.0016589250165892503	0.002013607749210454	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	7	4	7	8	0	25	38	-1	46	51						01,02							Vb 3	CASSSGSAGEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGAGGGACAGCTCTATGGCTACACCTTCGGTTCG	CASSLEGQLYGYTF	In	VDJ	3	109	0.0019033981769287186	0.0023103499438309415	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	5	4	3	2	25	39	49	42	51													Vb 3	CASSLEGQLYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCCCTTTGGGCGTCGAATGAGCAGTTCTTCGGGCCA	CASSLPLWASNEQFF	In	VDJ	5	148	0.002584430552160095	0.0031369889145594436	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	8	0	7	7	4	25	40	51	47	55													Vb 3	CASSLPLWASNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGACAGGGGAGACGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	6	212	0.003702022142283379		40	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	2	7	0	3	25	-1	46	37	49													Vb 3	X+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATACAGCGGGGGCGATACGCAGTATTTTGGCCCA	CASSLYSGGDTQYF	In	VDJ	7	223	0.0038941081968358188	0.004726679242883486	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	6	2	6	2	1	25	41	51	43	52													Vb 3	CASSLYSGGDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGTAGGGGCCCGAAATCAGCCCCAGCATTTTGGTGAT	CASSFVGARNQPQHF	In	VDJ	7	223	0.0038941081968358188	0.004726679242883486	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	5	2	4	3	5	25	39	47	42	52													Vb 3	CASSFVGARNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATSTCTGTGCAAGTCGCCCACAGGGGAGAAGGGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	10	1.7462368595676318E-4		49	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	2	2	2	8	18	30	39	32	47														X+TCRBV12-02+TCRBJ01-05	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATCTCTGTGCAAGTCGCCGCGGACAGCTTGATTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	11	1.920860545524395E-4		49	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	5	3	3	6	18	30	39	33	45														X+TCRBV12-02+TCRBJ02-06	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGGACTAGCGGGAGGGTCACTCTACGAGCAGTACTTCGGGCCG	CASRLGLAGGSLYEQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	51	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	2	0	3	0	5	18	-1	48	34	53														CASRLGLAGGSLYEQYF+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCATCCTGAGATCGGTAAAGACAGGCACCTCTGGGGTCAACGTCCTGACTTTCGGGGCC	CAILRSVKTGTSGVNVLTF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	57	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	12	2	4	9	18	12	18	23	47	41	59														CAILRSVKTGTSGVNVLTF+TCRBV12-02+TCRBJ02-06	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCATGTATCTCTGTGCAAGTCGCTTAGTATATTTATGAGACCGCCTAGCTTTCTTTGGACAA	CASRLVYL*DRLAFF	Stop	VDJ	1	32	5.587957950616421E-4		45	TCRBV12	TCRBV12-02	01				TCRBJ01	TCRBJ01-01	01	1	2	7	10	11	5	19	35	49	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLVYL*DRLAFF+TCRBV12-02+TCRBJ01-01	TCRBV12-02*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCACCCTGACTAGCGGGGCATCCTACAATGAGCAGTTCTTCGGGCCA	CATLTSGASYNEQFF	In	VDJ	1	33	5.762581636573184E-4	6.994637444625787E-4	45	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	2	3	1	6	2	18	23	40	29	42														CATLTSGASYNEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTAGTGGAGGGATTACCAATGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	18	3.143226347221737E-4		53	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	2	10	0	3	2	8	23	38	46	40	54													Vb 14	X+TCRBV27-01+TCRBJ02-06	TCRBV27-01*01	TCRBD02-01*02	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGACCGGGGTAGAAGCACTGAAGCTTTCTTTGGACAA	CSADRGRSTEAFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	3	4	5	6	25	32	42	37	48													Vb 4	CSADRGRSTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGGGACAGTCTAAGTCAGCCCCAGCATTTTGGTGAT	CSVGDSLSQPQHF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	6	2	6	25	33	42	35	48													Vb 4	CSVGDSLSQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCCTCTAACGGCTGGGACAGGGGGGAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	1.920860545524395E-4		49	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	1	5	12	2	25	34	57	46	59													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGGACTACCGACAATGAGCAGTTCTTCGGGCCA	CSVEGTTDNEQFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	9	5	1	3	25	36	44	37	47						01,02							Vb 4	CSVEGTTDNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCGTTGGGGCAGGACACGAGCAGTACTTCGGGCCG	CSVAVGAGHEQYF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	7	0	5	5	5	25	35	45	40	50													Vb 4	CSVAVGAGHEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCCACGTTTGGTGGCCCTGAAGACAGCAGCATWATCTCTGCAGCGTCAATTCCGGCAGTGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	2.095484231481158E-4		41	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	21	6	6	2	9	15	40	33	46	42	61						01,02							Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD02-01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGAAGGGGAAAGGGGAGATGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	12	2.095484231481158E-4		50	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-06	01	3	5	2	3	2	10	25	36	43	38	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01		TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGACTACCCTACAATGAGCAGTTCTTCGGGCCA	CSVGLPYNEQFF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	9	2	0	1	25	-1	40	33	41						01,02							Vb 4	CSVGLPYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCAGACAGGGGCCGGAATTACTGAAGCTTTCTTTGGACAA	CSVQTGAGITEAFF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	5	3	8	25	33	44	36	52													Vb 4	CSVQTGAGITEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGGGAGGGTCAGCCCCAGCATTTTGGTGAT	CSVEGEGQPQHF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	9	0	6	2	0	25	36	-1	38	45													Vb 4	CSVEGEGQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGCTAGCTTCTCCTCTACAGATACGCAGTATTTTGGCCCA	CSVASFSSTDTQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	4	7	3	2	9	25	33	40	35	49						01,02							Vb 4	CSVASFSSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAAGGGTTAGCGGGATATATTACGAGCAGTACTTCGGGCCG	CSVERVSGIYYEQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	5	3	4	5	5	25	37	50	42	55													Vb 4	CSVERVSGIYYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCGGGATGGGACTAGCCCCGAGACCCAGTACTTCGGGCCA	CSVEDRDGTSPETQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	7	5	7	3	25	39	55	46	58						01,02							Vb 4	CSVEDRDGTSPETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTCCGAGGCAGGGAACTGAAGCTTTCTTTGGACAA	CSAPRQGTEAFF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	3	5	8	1	25	32	45	40	46													Vb 4	CSAPRQGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATTGGGTGACAGGGAACTATGGCTACACCTTCGGTTCG	CSVEDWVTGNYGYTF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	2	6	0	25	39	-1	45	52													Vb 4	CSVEDWVTGNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATATTACGCCGGGGGGAAGCTATGGCTACACCTTCGGTTCG	CSVDITPGGSYGYTF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	1	4	8	3	25	36	51	44	54													Vb 4	CSVDITPGGSYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATGTTGGGACTAGCGGACCTATCAATGAGCAGTTCTTCGGGCCA	CSVEDVGTSGPINEQFF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	5	6	4	6	25	39	54	43	60						01,02							Vb 4	CSVEDVGTSGPINEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCAAAGGACCGGGGACCTTACAGATACGCAGTATTTTGGCCCA	CSVQRTGDLTDTQYF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	6	0	7	3	11	3	25	33	49	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVQRTGDLTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAAACAAGTAGTCGGATCTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	3.3178500331785003E-4		47	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	2	1	8	1	11	3	25	37	51	48	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTCCCGGTCGAGAGACCCAGTACTTCGGGCCA	CSVGPGRETQYF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	8	5	4	4	3	25	35	42	39	45						01,02							Vb 4	CSVGPGRETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTACGGGGTCCCTCTCCTACGAGCAGTACTTCGGGCCG	CSATGSLSYEQYF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	8	3	0	3	5	25	32	40	35	45													Vb 4	CSATGSLSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGAGGAATCGGAAACAATGAGCAGTTCTTCGGGCCA	CSVGGIGNNEQFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	10	1	5	1	8	25	33	39	34	47													Vb 4	CSVGGIGNNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGGGCTTCTTATGGCAAATCGGCGAACACTGAAGCTTTCTTTGGACAA	CSVEGASYGKSANTEAFF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	54	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	6	0	1	0	18	25	-1	42	36	60													Vb 4	CSVEGASYGKSANTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGGGCGGACAGGGGTCTTTGACCTTCGGTTCG	CSVVGGQGSLTF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	2	14	5	6	25	35	49	40	55													Vb 4	CSVVGGQGSLTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACTCCAGGCTCTATGGCTACACCTTCGGTTCG	CSVDSRLYGYTF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	4	4	3	2	25	36	43	39	45													Vb 4	CSVDSRLYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGTCAGGCGATTACTATGGCTACACCTTCGGTTCG	CSVGSGDYYGYTF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	4	3	3	5	25	35	42	38	47													Vb 4	CSVGSGDYYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTCGCTACAGGGGCGGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	24	4.190968462962316E-4		43	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	2	5	6	3	25	34	47	40	50													Vb 4	X+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTACTAGCGGGAAGGGGCTACAATGAGCAGTTCTTCGGGCCA	CSVLAGRGYNEQFF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	3	3	0	5	25	-1	43	33	48													Vb 4	CSVLAGRGYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGGACAGGGACATCGGATACGCAGTATTTTGGCCCA	CSVGGTGTSDTQYF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	6	2	6	25	35	46	37	52													Vb 4	CSVGGTGTSDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGACAGGGCGCAGATACGCAGTATTTTGGCCCA	CSVGQGADTQYF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	3	4	1	2	25	33	42	34	44													Vb 4	CSVGQGADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAGGATGAGCACTACGAGCAGTACTTCGGGCCG	CSVEEDEHYEQYF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	0	1	8	3	0	6	25	-1	42	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEEDEHYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGACGGACTACAATGAGCAGTTCTTCGGGCCA	CSVEGTDYNEQFF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	1	1	7	3	0	3	25	-1	42	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGTDYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGACAGGGGGCACTAATGAAAAACTGTTTTTTGGCAGT	CSVGTGGTNEKLFF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	0	2	0	0	25	-1	-1	35	46													Vb 4	CSVGTGGTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAATTGGATTCGTCCGCCTATGGCTACACCTTCGGTTCG	CSVEELDSSAYGYTF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	0	1	8	4	3	9	25	39	45	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEELDSSAYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCCTTTGAGGACAGATACGCAGTATTTTGGCCCA	CSVVPLRTDTQYF	In	VDJ	1	30	5.238710578702895E-4	6.35876131329617E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	11	1	3	7	0	25	35	-1	42	46													Vb 4	CSVVPLRTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCGACTAGCGGGAGGTTTTACAATGAGCAGTTCTTCGGGCCA	CSVSTSGRFYNEQFF	In	VDJ	1	30	5.238710578702895E-4	6.35876131329617E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	1	4	2	3	25	34	49	36	52													Vb 4	CSVSTSGRFYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCTCGCGAGCCCCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	32	5.587957950616421E-4		40	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	6	7	0	6	2	25	31	40	37	42						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGGATTCGGGGGCAGCCCCAGCATTTTGGTGAT	CSVEGIRGQPQHF	In	VDJ	1	45	7.858065868054343E-4	9.538141969944255E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	2	7	7	0	25	36	-1	43	49													Vb 4	CSVEGIRGQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTAGGAATAGGGGGCATTTGGGCTGAAGCTTTCTTTGGACAA	CSVVGIGGIWAEAFF	In	VDJ	1	48	8.381936925924632E-4	0.0010174018101273873	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	5	0	6	7	7	25	35	49	42	56													Vb 4	CSVVGIGGIWAEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTGTGAGCTCCTACGAGCAGTACTTCGGGCCG	CSVGVSSYEQYF	In	VDJ	2	58	0.0010128173785492263	0.0012293605205705928	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	2	0	4	0	25	35	-1	39	42													Vb 4	CSVGVSSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTACTAGGGACATACCTTTCTGAGCAGTACTTCGGGCCG	CSVLGTYLSEQYF	In	VDJ	2	79	0.001379527119058429	0.0016744738125013248	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	7	4	9	25	33	43	37	52													Vb 4	CSVLGTYLSEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTGGTCGACAGGGAACTCTGGAAACACCATATATTTTGGAGAG	CSVWSTGNSGNTIYF	In	VDJ	2	81	0.0014144518562497817	0.001716865554589966	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	3	0	5	2	25	34	46	39	48													Vb 4	CSVWSTGNSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATACCGGCAAACCTTCCTAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	82	0.001431914224845458		46	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	8	5	15	0	25	37	-1	52	56						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGCACAGGGGGCTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVGGTGGFSGANVLTF	In	VDJ	4	121	0.0021129466000768342	0.0025647003963627886	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	3	0	0	5	2	25	35	49	40	51													Vb 4	CSVGGTGGFSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTTTACAGGGGGCCCATGGAAACACCATATATTTTGGAGAG	CSALQGAHGNTIYF	In	VDJ	4	129	0.002252645548842245	0.002734267364717353	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	3	0	3	4	3	25	32	45	36	48													Vb 4	CSALQGAHGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAATTCCGGCAGTGGCAATCAGCCCCAGCATTTTGGTGAT	CSVNSGSGNQPQHF	In	VDJ	24	793	0.01384765829637132	0.01680832573814621	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	6	4	5	2	9	2	25	33	45	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVNSGSGNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGACGAATCCGGGGCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRRIRGPNTGELFF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	48	TCRBV07	TCRBV07-08					TCRBJ02	TCRBJ02-02	01	6	7	0	0	8	1	20	31	44	39	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRIRGPNTGELFF+TCRBV07-08+TCRBJ02-02	TCRBV07-08		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCCAGACTAGCGGCCACGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	27	4.7148395208326056E-4		49	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	5	0	2	3	20	32	43	34	46			01,02			01,02								X+TCRBV07-08+TCRBJ02-02	TCRBV07-08	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCTAGCGGGAGGGGATCTAGTGGCCCAGTACTTCGGGCCA	CASSLAGGDLVAQYF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	4	0	9	0	10	23	-1	47	35	57													Vb 12	CASSLAGGDLVAQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAAGTACAGGGGGACCTACGAGCAGTACTTCGGGCCG	CASKYRGTYEQYF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	3	1	2	3	1	23	33	44	36	45													Vb 12	CASKYRGTYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCTCGGTCGGGCGGGAGTTTAGCCACAATGAGCAGTTCTTCGGGCCA	CASSVGREFSHNEQFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	7	2	5	8	7	23	32	47	40	54													Vb 12	CASSVGREFSHNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGGCGACAGGAGGAAATGAAAAACTGTTTTTTGGCAGT	CASSESATGGNEKLFF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	48	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	4	5	3	4	23	40	49	43	53													Vb 12	CASSESATGGNEKLFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGAGGACCCTTGGGCCGGGGAGCTGTTTTTTGGAGAA	CASREDPWAGELFF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-02	01	2	0	9	6	7	0	23	38	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASREDPWAGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGCGTTTTGGGCGAACTACGAGCAGTACTTCGGGCCG	CASSAFWANYEQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	8	0	3	6	3	23	36	46	42	49													Vb 12	CASSAFWANYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAGTCCCCAGGGGCCCACTCGAGCAGTACTTCGGGCCG	CASSEVPRGPLEQYF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	6	6	6	23	37	49	43	55													Vb 12	CASSEVPRGPLEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGACAAAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSEGQSTGELFF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	6	4	0	3	23	-1	43	38	46													Vb 12	CASSEGQSTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGACAGCCACTGGAAACACCATATATTTTGGAGAG	CASSETATGNTIYF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	3	5	2	0	3	23	-1	42	38	45													Vb 12	CASSETATGNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAACACCCAGGGGACTAGTGGGTCCAATGAGCAGTTCTTCGGGCCA	CANTQGTSGSNEQFF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	0	8	6	8	6	23	30	46	38	52						01,02							Vb 12	CANTQGTSGSNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGGGTGGATGGCTACACCTTCGGTTCG	CASSEGVDGYTF	In	VDJ	1	31	5.413334264659658E-4	6.570720023739376E-4	36	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	2	6	2	6	0	3	23	-1	42	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEGVDGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGTATGTACAATGAGCAGTTCTTCGGGCCA	CASSEGMYNEQFF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-01	01	2	0	10	4	0	4	23	-1	40	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEGMYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCTGAACAGGGGGTAAGCCAGCCCCAGCATTTTGGTGAT	CASSESEQGVSQPQHF	In	VDJ	2	54	9.429679041665211E-4	0.0011445770363933106	48	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	1	7	3	5	23	40	51	43	56													Vb 12	CASSESEQGVSQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGACGAGAACCGGGGAGCTGTTTTTTGGAGAA	CASRTRTGELFF	In	VDJ	4	121	0.0021129466000768342	0.0025647003963627886	36	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-02	01	6	2	7	5	0	4	23	-1	37	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASRTRTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGGGGACAGGGGGGAACAATGAGCAGTTCTTCGGGCCA	CASSESGTGGNNEQFF	In	VDJ	32	1033	0.018038626759333636	0.021895334788783145	48	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	1	5	1	2	23	40	52	41	54													Vb 12	CASSESGTGGNNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGCGGCGGTTAGCACAGATACGCAGTATTTTGGCCCA	CAISEAAVSTDTQYF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	7	5	0	0	5	23	-1	42	38	47						01,02							Vb 12	CAISEAAVSTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGCAGTTACCTATGGCTACACCTTCGGTTCG	CAISESAVTYGYTF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	5	4	2	4	23	40	45	42	49													Vb 12	CAISESAVTYGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCCAGACATCTGTGTACTTGTGTGCCATCAGTGATCGGGGACTAGCGGAGGGACCTCGAAACACCGGGGAGCTGTTTTTTGGAGAA	CAISDRGLAEGPRNTGELFF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	60	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	0	5	2	3	11	21	35	49	38	60						01,02							Vb 12	CAISDRGLAEGPRNTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGACCCGATCGGCTACACCTTCGGTTCG	CAISEDPIGYTF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	36	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-02	01	2	2	7	8	0	6	23	-1	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISEDPIGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGAATAACGGGGAGCTGTTTTTTGGAGAA	CASKNNGELFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	7	2	8	7	1	4	27	37	40	38	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASKNNGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATGGAGGGGGCAGGAACTGAAGCTTTCTTTGGACAA	CASMEGAGTEAFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	5	0	5	3	4	27	37	47	40	51			01,02										Vb 17	CASMEGAGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATGGGCAGGCCTCAGTCTGGCTACACCTTCGGTTCG	CASMGRPQSGYTF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	4	7	4	8	27	37	45	41	53			01,02										Vb 17	CASMGRPQSGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACCCTCTAGGGACAGGGAACAATCAGCCCCAGCATTTTGGTGAT	CASSNPLGTGNNQPQHF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	3	3	8	2	27	40	57	48	59			01,02										Vb 17	CASSNPLGTGNNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCTAGAGGGGCGAAAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	2.095484231481158E-4		44	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	10	5	2	0	6	5	27	34	45	40	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCCAGCAGACCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	2.095484231481158E-4		40	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	6	2	7	4	9	0	27	38	-1	47	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGGGCCGGTGTTTCGAACGAGCAGTACTTCGGGCCG	CASSTRAGVSNEQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	4	8	0	5	3	11	27	40	47	43	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTRAGVSNEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGCAGGGGGAGCTCTCTATGAGCAGTTCTTCGGGCCA	CASSIAGGALYEQFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	1	8	2	8	27	41	50	43	58			01,02										Vb 17	CASSIAGGALYEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCCCCTTCGGGGACTGCTCAGCCCCAGCATTTTGGTGAT	CASTPPSGTAQPQHF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	0	10	6	11	2	27	37	54	48	56			01,02			01,02							Vb 17	CASTPPSGTAQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGATACGGGACAGGGGGAAACACCATATATTTTGGAGAG	CASRYGTGGNTIYF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	3	4	4	0	27	38	-1	42	51			01,02										Vb 17	CASRYGTGGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGAGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIGGSYNEQFF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	1	1	1	1	27	41	47	42	48			01,02										Vb 17	CASSIGGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGCCACGTTTGGTGCCAAAAGAACCCGACAGCTTCTATCTCTGTGCCAGTAGTGGCGGAGTAAACACTGAAGCTTTCTTTGGACAA	CASSGGVNTEAFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	5	2	1	4	42	54	59	55	63			01,02			01,02							Vb 17	CASSGGVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGGGGCCGAAGCTTTCTTTGGACAA	CASSIEGAEAFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	6	0	8	0	1	27	-1	50	44	51			01,02										Vb 17	CASSIEGAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTACGGGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSIYGGTGELFF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	8	1	5	3	0	27	41	-1	44	51			01,02										Vb 17	CASSIYGGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACAGGGATCCATGAGTAGTTCTTCGGGCCA	CASRTGIHE*FF	Stop	VDJ	1	16	2.7939789753082106E-4		36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	14	0	10	27	-1	45	38	55			01,02										Vb 17	CASRTGIHE*FF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCACAGATGAACACTGAAGCTTTCTTTGGACAA	CASSIPQMNTEAFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	5	0	3	1	27	41	48	44	49			01,02										Vb 17	CASSIPQMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAACGGGACAGAGATTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	17	2.968602661264974E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	5	1	4	5	27	38	49	42	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGTTCTCGAGCGGGAGGGCCGTCGAAGAGCAGTACTTCGGGCCG	CASKFSSGRAVEEQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	6	0	7	8	8	27	37	55	45	63			01,02										Vb 17	CASKFSSGRAVEEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCGACAGGGACCAGAGACCCAGTACTTCGGGCCA	CASSARQGPETQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	3	4	4	3	27	39	50	43	53			01,02										Vb 17	CASSARQGPETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAATAGTAGTTGGACAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CANSSWTGNTGELFF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	4	1	3	0	27	40	-1	43	50			01,02										Vb 17	CANSSWTGNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTGCAGGGTCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTAGSSYNEQFF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	3	0	3	2	27	37	45	40	47			01,02										Vb 17	CASTAGSSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCAGCTCTCTATGGCTACACCTTCGGTTCG	CASSIAALYGYTF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	1	4	5	4	0	4	27	-1	46	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAALYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCGCCAATGAGCAGTTCTTCGGGCCA	CASSIAANEQFF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	1	10	0	6	2	0	27	43	-1	45	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAANEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATGGGCAGGGTGGCCCCAGCATTTTGGTGAT	CASSIWAGWPQHF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	3	9	4	2	27	42	51	46	53			01,02										Vb 17	CASSIWAGWPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGGGACACGTTAATCAGCCCCAGCATTTTGGTGAT	CASSPGHVNQPQHF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	6	4	2	4	27	39	47	41	51			01,02										Vb 17	CASSPGHVNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGTTATGTAATCGGGGGCCTTAACACTGAAGCTTTCTTTGGACAA	CASSTRYVIGGLNTEAFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	54	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	4	6	0	2	14	3	27	40	60	54	63			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTRYVIGGLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCTAGCGGGAGGCTCCTTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSILAGGSFSYNEQFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	1	0	1	6	27	41	53	42	59			01,02										Vb 17	CASSILAGGSFSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCGGATTCCAAGAGACCCAGTACTTCGGGCCA	CASSGGFQETQYF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	7	5	1	1	3	27	39	44	40	47			01,02			01,02							Vb 17	CASSGGFQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCTTGGAAGGGGAGTAGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	3.84172109104879E-4		47	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	5	2	2	8	5	27	39	52	47	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACAAGTAGGGCGGTTGGCTGACGGCTACACCTTCGGTTCG	CASSIQVGRLADGYTF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	2	5	3	8	5	12	27	42	51	47	63			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIQVGRLADGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACAGGGGAAGGACAATCAGCCCCAGCATTTTGGTGAT	CASSIQGKDNQPQHF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	2	3	0	5	27	-1	48	42	53			01,02										Vb 17	CASSIQGKDNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCGACAGGGGTACTCCTACGAGCAGTACTTCGGGCCG	CASSIRQGYSYEQYF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	2	0	2	2	27	41	51	43	53			01,02										Vb 17	CASSIRQGYSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGGAAAGGACTAGCGGGAGTCGTGCCGAGCAGTACTTCGGGCCG	CASGERTSGSRAEQYF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	1	2	6	7	6	27	36	56	43	62			01,02										Vb 17	CASGERTSGSRAEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCGGACCTCGCGGGGGATGGGTCCCCCTACAATGAGCAGTTCTTCGGGCCA	CASADLAGDGSPYNEQFF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	7	2	2	9	9	27	36	52	45	61			01,02										Vb 17	CASADLAGDGSPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGACAGCGACAGATACGCAGTATTTTGGCCCA	CASSSTATDTQYF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	5	3	2	2	27	39	46	41	48			01,02										Vb 17	CASSSTATDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACCTACAGGGGTCCTAATGAAAAACTGTTTTTTGGCAGT	CASSTYRGPNEKLFF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	2	3	5	2	27	38	50	43	52			01,02										Vb 17	CASSTYRGPNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCATAAGGGACAGTGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CAIRDSENTGELFF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	5	1	3	3	27	34	44	37	47			01,02										Vb 17	CAIRDSENTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGTGACCGGGACAGGGGGCAACGAGCAGTACTTCGGGCCG	CASSVTGTGGNEQYF	In	VDJ	1	30	5.238710578702895E-4	6.35876131329617E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	0	5	7	1	27	38	57	45	58			01,02										Vb 17	CASSVTGTGGNEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCGGGACAGTCTACAATGAGCAGTTCTTCGGGCCA	CATGTVYNEQFF	In	VDJ	1	31	5.413334264659658E-4	6.570720023739376E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	0	5	3	2	1	27	34	43	36	44			01,02										Vb 17	CATGTVYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGACAAACCCTCTCGCCGCTGAAGCTTTCTTTGGACAA	CASSMGTNPLAAEAFF	In	VDJ	1	31	5.413334264659658E-4	6.570720023739376E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	6	1	13	27	41	48	42	61			01,02										Vb 17	CASSMGTNPLAAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACAGCTTTCTATCTCTGTGCCAGTAGTATTTCTCCGGGACTAGCGGGAGGAGTGGACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	31	5.413334264659658E-4		59	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	0	1	2	6	6	16	30	51	36	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGGGGATAGACAGGGATTAAGGTCAAATACGCAGTATTTTGGCCCA		Out	VDJ	1	33	5.762581636573184E-4		55	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	3	7	8	11	26	41	56	49	67			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTACCGAGGCGAGACAGGGTGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	34	5.937205322529948E-4		53	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	3	2	12	2	27	39	58	51	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCTGTGCCAGTAGTGCCCGGGGACAGGGGGCCTCCTTCGCGGGAGGCACCTACAATGAGCAGTTCTTCGGGCCA	CASSARGQGASFAGGTYNEQFF	In	VDJ	1	34	5.937205322529948E-4	7.206596155068993E-4	66	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	0	2	5	17	2	14	31	19	48			01,02										Vb 17	CASSARGQGASFAGGTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCCCGGGAGCCCACAGATACGCAATATTTTGGCCCA	CASSISREPTDTQYF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	8	2	15	3	15	27	42	51	45	66			01,02										Vb 17	CASSISREPTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGATGATCACAGATACGCAGTATTTTGGCCCA	CASSMMITDTQYF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	2	8	2	0	4	27	-1	43	41	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMMITDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTTTCGATTCTACGAGAGCAGTACTTCGGGCCG	CASSLSILREQYF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	9	7	9	3	27	39	51	48	54			01,02			01,02							Vb 17	CASSLSILREQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTGAACGGAACTATGGCTACACCTTCGGTTCG	CASSSERNYGYTF	In	VDJ	1	36	6.286452694443474E-4	7.630513575955404E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	8	5	2	5	0	27	40	-1	45	48			01,02			01,02							Vb 17	CASSSERNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCCGGAGGACTGAAGCTTTCTTTGGACAA	CASSIARRTEAFF	In	VDJ	1	36	6.286452694443474E-4	7.630513575955404E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	10	1	5	3	0	27	43	-1	46	51			01,02										Vb 17	CASSIARRTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGAGGGTTATCCTATGGCTACACCTTCGGTTCG	CASSPGGLSYGYTF	In	VDJ	1	36	6.286452694443474E-4	7.630513575955404E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	10	0	4	3	5	27	39	48	42	53			01,02										Vb 17	CASSPGGLSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCACACTCCAACTAGCGGGCATCACCGGGGAGCTGTTTTTTGGAGAA	CATTLQLAGITGELFF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	3	4	4	10	3	27	34	53	44	56			01,02			01,02							Vb 17	CATTLQLAGITGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCAGGGGGCTGACCGGGGAGCTGTTTTTTGGAGAA	CASSTRGLTGELFF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	0	5	1	2	27	40	49	41	51			01,02										Vb 17	CASSTRGLTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAGACCCCGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSRDPGSNQPQHF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	8	5	0	3	0	27	44	-1	47	50			01,02			01,02							Vb 17	CASSRDPGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTATCTTGGGGGCTTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	37	6.461076380400237E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	6	0	4	7	1	27	41	54	48	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTTTCTATCTCTGTGCCAGTCCCACCGGCGCCTCGACAGGGGGCGCATCTTACCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	37	6.461076380400237E-4		61	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	2	0	4	14	9	12	21	45	35	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCTGGTTAGATCAGCCCCAGCATTTTGGTGAT	CASSPWLDQPQHF	In	VDJ	1	40	6.984947438270527E-4	8.478348417728227E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	5	8	5	8	0	27	38	-1	46	49			01,02			01,02							Vb 17	CASSPWLDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAAACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASRKQGNTEAFF	In	VDJ	1	42	7.334194810184054E-4	8.902265838614638E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	1	3	0	27	38	-1	41	47			01,02										Vb 17	CASRKQGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTAGTGGGGAGGCCGGGGAGCTGTTTTTTGGAGAA	CASSIVSGEAGELFF	In	VDJ	1	42	7.334194810184054E-4	8.902265838614638E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	9	1	6	6	0	27	43	-1	49	55			01,02										Vb 17	CASSIVSGEAGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGCAGTTACGGCTACACCTTCGGTTCG	CASSIGSYGYTF	In	VDJ	1	42	7.334194810184054E-4	8.902265838614638E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	5	8	3	4	27	41	47	44	51			01,02										Vb 17	CASSIGSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGGCAGTGGGGGAGGGAATCAGCCCCAGCATTTTGGTGAT	CAGSGGGNQPQHF	In	VDJ	1	42	7.334194810184054E-4	8.902265838614638E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	11	9	0	4	8	0	27	33	-1	41	48			01,02										Vb 17	CAGSGGGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGGTGACAGCAACTTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	42	7.334194810184054E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	2	5	0	3	5	27	33	41	36	46			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATGACAGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSMTGTNEKLFF	In	VDJ	1	43	7.508818496140817E-4	9.114224549057843E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	3	2	3	0	27	38	-1	41	48			01,02										Vb 17	CASSMTGTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCGTTCGGGCAGGGGATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASTRSGRGYSNQPQHF	In	VDJ	1	44	7.68344218209758E-4	9.326183259501049E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	2	0	10	3	27	37	53	47	56			01,02										Vb 17	CASTRSGRGYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAAGGGGGGACTAGCGGAGGAGCAGTTCTTCGGGCCA	CASSKGGLAEEQFF	In	VDJ	1	44	7.68344218209758E-4	9.326183259501049E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	5	10	6	2	27	38	55	44	57			01,02			01,02							Vb 17	CASSKGGLAEEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATATGGGTCGAACACTGAAGCTTTCTTTGGACAA	CASSIYGSNTEAFF	In	VDJ	1	44	7.68344218209758E-4	9.326183259501049E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	2	0	9	1	3	2	27	42	48	45	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIYGSNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTACCAGTAGTATAAGCGCGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CTSSISAAGANVLTF	In	VDJ	1	46	8.032689554011106E-4	9.750100680387461E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	6	6	2	0	3	27	-1	46	42	49			01,02			01,02							Vb 17	CTSSISAAGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD02-01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCTAGGTCGAGCCTGCAGTTCTTCGGGCCA		Out	VDJ	1	48	8.381936925924632E-4		35	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	4	8	12	2	9	27	37	43	39	52			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCCGGGCGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSRAANTGELFF	In	VDJ	1	48	8.381936925924632E-4	0.0010174018101273873	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	4	8	0	0	3	2	27	40	47	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSRAANTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGGACTAGCAGATACGCAGTATTTTGGCCCA	CASSRGLADTQYF	In	VDJ	1	49	8.556560611881395E-4	0.0010385976811717078	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	8	4	1	0	27	40	-1	41	49			01,02			01,02							Vb 17	CASSRGLADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGCCAGGATGGGGCTACACCTTCGGTTCG	CASSLPGWGYTF	In	VDJ	1	49	8.556560611881395E-4	0.0010385976811717078	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	4	8	4	4	27	39	47	43	51			01,02										Vb 17	CASSLPGWGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACCAGGGCTGGGATACGCAGTATTTTGGCCCA	CASNQGWDTQYF	In	VDJ	2	50	8.731184297838158E-4	0.0010597935522160284	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	3	6	2	4	27	37	44	39	48			01,02										Vb 17	CASNQGWDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCAGCGATCCCACAGATACGCAGTATTTTGGCCCA	CASSIVSDPTDTQYF	In	VDJ	2	52	9.080431669751685E-4	0.0011021852943046695	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	6	6	2	2	4	27	43	49	45	53			01,02			01,02							Vb 17	CASSIVSDPTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTAGGGGCTGCCTACGAGCAGTACTTCGGGCCG	CASSVGAAYEQYF	In	VDJ	2	53	9.255055355708448E-4	0.00112338116534899	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	8	0	2	0	2	27	-1	47	43	49			01,02										Vb 17	CASSVGAAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCTATTCGGCAGGTCAGCCCCAGCATTTTGGTGAT	CASSFYSAGQPQHF	In	VDJ	2	55	9.604302727621974E-4	0.0011657729074376311	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	4	6	10	0	27	39	-1	49	53			01,02										Vb 17	CASSFYSAGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGACAGGGTGGCTACACCTTCGGTTCG	CASSTRQGGYTF	In	VDJ	2	56	9.778926413578739E-4	0.0011869687784819517	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	7	3	0	27	40	-1	43	50			01,02										Vb 17	CASSTRQGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGACAGGGGGCCGGGACTGAAGCTTTCTTTGGACAA	CASSRQGAGTEAFF	In	VDJ	2	59	0.0010302797471449026	0.0012505563916149133	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	0	5	0	4	27	-1	50	40	54			01,02										Vb 17	CASSRQGAGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCACAGGGACTATCCAAGAGACCCAGTACTTCGGGCCA	CASSSTGTIQETQYF	In	VDJ	2	59	0.0010302797471449026	0.0012505563916149133	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	9	1	5	1	27	40	52	45	53			01,02			01,02							Vb 17	CASSSTGTIQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGCTATTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSIRYSSTDTQYF	In	VDJ	2	59	0.0010302797471449026	0.0012505563916149133	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	9	0	2	4	27	42	47	44	51			01,02			01,02							Vb 17	CASSIRYSSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIGGSYNEQFF	In	VDJ	2	59	0.0010302797471449026	0.0012505563916149133	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	1	6	2	1	0	1	27	-1	47	43	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTGGAGCGGAGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSIWSGGSTDTQYF	In	VDJ	2	61	0.0010652044843362553	0.0012929481337035544	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	6	5	0	4	4	27	41	50	45	54			01,02			01,02							Vb 17	CASSIWSGGSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACAGGGGGGACGGAGACCCAGTACTTCGGGCCA	CASSITGGTETQYF	In	VDJ	2	65	0.0011350539587189606	0.0013777316178808369	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	1	5	0	4	27	-1	50	42	54			01,02										Vb 17	CASSITGGTETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGATCAGGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASSDQGAKNIQYF	In	VDJ	2	65	0.0011350539587189606	0.0013777316178808369	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	3	0	3	0	27	39	-1	42	47			01,02										Vb 17	CASSDQGAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAATACAGGAGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSNTGASTDTQYF	In	VDJ	2	68	0.0011874410645059895	0.0014413192310137985	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	4	0	2	4	27	40	47	42	51			01,02										Vb 17	CASSNTGASTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCCGAAGTTTGGATGAGCAGTTCTTCGGGCCA	CASSGRSLDEQFF	In	VDJ	2	71	0.0012398281702930185	0.0015049068441467602	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	9	0	8	0	10	27	-1	42	39	52			01,02										Vb 17	CASSGRSLDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACAGCTTTCTATCTCTGTGCCAGTAGTATAAGGGGACTAGCGGGCCCAGCCCTTTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	76	0.0013271400132714001		59	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	4	3	2	11	16	31	45	33	56			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGACAGGGGGCCGGTTCCGAGCAGTACTTCGGGCCG	CASSGQGAGSEQYF	In	VDJ	2	78	0.0013620647504627528	0.0016532779414570042	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	0	6	0	6	27	-1	50	39	56			01,02										Vb 17	CASSGQGAGSEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGGTGGGGGGAGGATGGCTACACCTTCGGTTCG	CASRWGEDGYTF	In	VDJ	2	79	0.001379527119058429	0.0016744738125013248	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	9	9	1	6	5	3	27	35	46	40	49			01,02			01,02							Vb 17	CASRWGEDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATTGGGGGGCAAGGAACGAGCAGTACTTCGGGCCG	CASSIDWGARNEQYF	In	VDJ	2	80	0.0013969894876541054	0.0016956696835456453	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	0	6	0	5	3	5	27	44	53	47	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDWGARNEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGACAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGTGSYNEQFF	In	VDJ	2	80	0.0013969894876541054	0.0016956696835456453	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	1	0	0	27	-1	-1	39	48			01,02										Vb 17	CASSGTGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGTCTCTATGGCTACACCTTCGGTTCG	CASSIGLYGYTF	In	VDJ	2	81	0.0014144518562497817	0.001716865554589966	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	8	5	4	0	3	27	-1	44	41	47			01,02			01,02							Vb 17	CASSIGLYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACATCTGGACAGGGCTTTAACGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSTSGQGFNANTGELFF	In	VDJ	3	93	0.0016240002793978976	0.0019712160071218127	57	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	3	0	5	8	24	37	50	42	58			01,02										Vb 17	CASSTSGQGFNANTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTAACCCGGGACTAGCGGGAGGCAATGAGCAGTTCTTCGGGCCA	CASSTNPGLAGGNEQFF	In	VDJ	3	101	0.001763699228163308	0.002140782975476377	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	0	1	6	7	0	27	40	-1	47	62			01,02										Vb 17	CASSTNPGLAGGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTCCGACAGGGATAACGGGTAGACTATGGCTACACCTTCGGTTCG	CASSVRQG*RVDYGYTF	Stop	VDJ	4	129	0.002252645548842245		51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	3	4	11	27	39	50	43	61			01,02										Vb 17	CASSVRQG*RVDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGCTACTATGTACTACGAGCAGTACTTCGGGCCG	CASSATMYYEQYF	In	VDJ	5	149	0.0026018929207557713	0.0031581847856037644	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	3	9	3	4	4	27	38	46	42	50			01,02			01,02							Vb 17	CASSATMYYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTGTTGGGGGTGCCACCTACGAGCAGTACTTCGGGCCG	CASSSVGGATYEQYF	In	VDJ	5	150	0.0026193552893514476	0.0031793806566480847	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	4	6	1	2	5	5	27	40	50	45	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSVGGATYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGCCCATGAACACTGAAGCTTTCTTTGGACAA	CASSIGPMNTEAFF	In	VDJ	5	165	0.0028812908182865925	0.0034973187223128937	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	9	0	0	0	3	27	-1	46	43	49			01,02										Vb 17	CASSIGPMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCTCTGTTGACTAGCGGGACCACAGATACGCAGTATTTTGGCCCA	CASSSLLTSGTTDTQYF	In	VDJ	5	169	0.0029511402926692978	0.003582102206490176	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	2	3	2	8	1	27	39	58	47	59			01,02										Vb 17	CASSSLLTSGTTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGACGACAGGGGTTATGGCTACACCTTCGGTTCG	CASRDDRGYGYTF	In	VDJ	6	208	0.003632172667900674	0.004408741177218678	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	2	5	4	1	27	38	50	42	51			01,02										Vb 17	CASRDDRGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTCCTCCGTCCGGAAAACTGTTTTTTGGCAGT	CASTPPSGKLFF	In	VDJ	13	411	0.007177033492822967	0.008711502999215753	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	7	8	5	10	10	0	27	37	-1	47	50			01,02			01,02							Vb 17	CASTPPSGKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCGGAGTAAACACTGAAGCTTTCTTTGGACAA	CASSGGVNTEAFF	In	VDJ	48	1587	0.027712778961338315	0.03363784734733674	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	5	2	1	4	27	39	44	40	48			01,02			01,02							Vb 17	CASSGGVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCCCGGGACTAGCGGGAGCGGGAAACATTCAGTACTTCGGCGCC	CASSPGLAGAGNIQYF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	0	2	6	3	4	23	34	51	37	55													Vb 11	CASSPGLAGAGNIQYF+TCRBV25-01+TCRBJ02-04	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATGGTGGGGTAGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	14	2.4447316033946847E-4		43	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-05	01	1	6	2	6	3	4	23	39	46	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ01-05	TCRBV25-01*01		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATTCTCAGGACGGGGATTGAACACTGAAGCTTTCTTTGGACAA	CASSEFSGRGLNTEAFF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	51	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	3	0	8	2	23	39	52	47	54													Vb 11	CASSEFSGRGLNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTGGGTCGTACTAGCGGCCAGCAAGAGACCCAGTACTTCGGGCCA	CASSVGRTSGQQETQYF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	51	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	3	5	2	8	4	23	36	52	44	56						01,02							Vb 11	CASSVGRTSGQQETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCCCCCGGGGGGAGTCGCCGGGGAGCTGTTTTTTGGAGAA	CASSPPGGVAGELFF	In	VDJ	1	38	6.635700066357001E-4	8.054430996841816E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	1	6	4	5	23	35	46	39	51													Vb 11	CASSPPGGVAGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTGAGGGACGCTGACCTCACCGGGGAGCTGTTTTTTGGAGAA	CASSVRDADLTGELFF	In	VDJ	3	104	0.001816086333950337	0.002204370588609339	48	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-02	01	4	0	7	4	3	8	23	36	44	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSVRDADLTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCCGGGACAGGGTTTGGATGAGCAGTTCTTCGGGCCA	CASSPGQGLDEQFF	In	VDJ	4	133	0.00232249502322495	0.002819050848894635	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	8	2	5	23	35	46	37	51													Vb 11	CASSPGQGLDEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACGGGGTGGGACAGGGCTACGAGCAGTACTTCGGGCCG	CASSYGVGQGYEQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	3	5	0	23	38	-1	43	52		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYGVGQGYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTTTCAGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSFQGSYEQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	0	2	0	23	36	-1	38	43		TCRBV06-04,TCRBV06-08												CASSFQGSYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCGGAGCTGCGGACAGGGGTAGCACCGGGGAGCTGTTTTTTGGAGAA	CASGAADRGSTGELFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	48	TCRBV05	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	1	2	4	8	3	19	28	45	36	48		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASGAADRGSTGELFF+TCRBV05-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAGGGACTGGAGACAATGAGCAGTTCTTCGGGCCA	CASSLGTGDNEQFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	10	5	0	4	19	-1	40	35	44		TCRBV07-05,TCRBV07-07				01,02								CASSLGTGDNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCTTTGGGAATTCCCCCTACGAGCAGTACTTCGGGCCG	CASSFGNSPYEQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	42	TCRBV07	unresolved					TCRBJ02	TCRBJ02-07	01	3	0	8	2	1	6	19	33	38	34	44		TCRBV07-02,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGNSPYEQYF+TCRBV07-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGTWCCCTCYCARACATCTGTGTACTTCTGTGCCATCACCCATAGCGGGAGGGACAATGAGCAGTTCTTCGGGCCA	CAITHSGRDNEQFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	5	0	5	7	0	25	32	-1	39	50		TCRBV06-02,TCRBV06-03,TCRBV06-04												CAITHSGRDNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTCCGGGACTTGACTACACCTTCGGTTCG	CASSPGLDYTF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	33	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	0	10	10	2	3	28	40	48	42	51		TCRBV06-04,TCRBV06-07				01,02								CASSPGLDYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTGGAATGGCGGGGTGCCAGATACGCAGTATTTTGGCCCA	CASSWNGGVPDTQYF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	7	3	4	6	3	23	36	48	42	51		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSWNGGVPDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTTATCGCCCCGGGACAGGGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSLSPRDRGMNTEAFF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	54	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	1	0	7	1	19	34	52	41	53		TCRBV07-05,TCRBV07-06												CASSLSPRDRGMNTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTCCACGACCTGGGAAAAACTGTTTTTTGGCAGT	CASSSTTWEKLFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	39	TCRBV06	unresolved					TCRBJ01	TCRBJ01-04	01	4	2	7	8	4	4	23	36	43	40	47		TCRBV06-05,TCRBV06-06,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTTWEKLFF+TCRBV06-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAAGGTCCAGGGACCTATGGCTACACCTTCGGTTCG	CASSEGPGTYGYTF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	42	TCRBV10	unresolved					TCRBJ01	TCRBJ01-02	01	3	0	7	4	7	0	26	40	-1	47	52		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGPGTYGYTF+TCRBV10-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCCCCCGGGTAGAGTACAATGAGCAGTTCTTCGGGCCA	CASSPRVEYNEQFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	4	4	3	5	19	31	38	34	43		TCRBV07-05,TCRBV07-06				01,02								CASSPRVEYNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTCGACGGACCCTACACCGGGGAGCTGTTTTTTGGAGAA	CASSFDGPYTGELFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	45	TCRBV11	unresolved					TCRBJ02	TCRBJ02-02	01	3	1	7	3	4	3	18	32	40	36	43		TCRBV11-01,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFDGPYTGELFF+TCRBV11-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGCCAACAACCTGGGACCTACGAGCAGTACTTCGGGCCG	CASSQQPGTYEQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	42	TCRBV11	unresolved					TCRBJ02	TCRBJ02-07	01	5	0	8	2	9	0	19	31	-1	40	44		TCRBV11-01,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQQPGTYEQYF+TCRBV11-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAACTAGCGGGTGACACCGGGGAGCTGTTTTTTGGAGAA	CASSELAGDTGELFF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	3	4	3	2	2	26	38	49	40	51		TCRBV06-01,TCRBV06-07,TCRBV06-08				01,02								CASSELAGDTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTCGGGCAATGCCTACGAGCAGTACTTCGGGCCG	CASSSGNAYEQYF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-07	01	4	8	0	2	1	4	23	36	41	37	45		TCRBV06-08,TCRBV06-09		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGNAYEQYF+TCRBV06-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGYWCCCTCYCAGACATCTGTRTACTTCTGTGCCAGCAGTTCGTGGACTAGCGGAACGCACGTTACGCAGTATTTTGGCCCA	CASSSWTSGTHVTQYF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	5	8	3	9	26	39	52	42	61		TCRBV06-04,TCRBV06-09				01,02								CASSSWTSGTHVTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGCGCCTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	3.3178500331785003E-4		47	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	4	0	3	0	23	38	-1	41	49		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACAGGGGGCGACGGTTTTGTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	3.4924737191352636E-4		53	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	0	1	0	10	23	-1	45	35	55		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCCGGGACACTGAACACTGAAGCTTTCTTTGGACAA	CASSYSGTLNTEAFF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	6	0	1	1	28	45	52	46	53		TCRBV06-04,TCRBV06-08												CASSYSGTLNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGGATTACGGACTAGCGGGAGGTGTAGAGCAGTTCTTCGGGCCA	CASSEDYGLAGGVEQFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	51	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	1	1	10	6	4	26	41	61	47	65		TCRBV10-01,TCRBV10-02												CASSEDYGLAGGVEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAATCAGGGGATACGCAGTATTTTGGCCCA	CASSESGDTQYF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	36	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	3	6	1	0	23	38	-1	39	44		TCRBV06-01,TCRBV06-07,TCRBV06-08												CASSESGDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACGGACAGGGGTGGGGCACTGAAGCTTTCTTTGGACAA	CASSYGQGWGTEAFF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	2	4	0	5	23	-1	47	38	52		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYGQGWGTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGTCCTCAAGCGGGAGGGGCCTACGAGCAGTACTTCGGGCCG	CASSPQAGGAYEQYF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	6	0	2	9	1	19	27	46	36	47		TCRBV07-02,TCRBV07-05												CASSPQAGGAYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGACCACACAGATACGCAGTATTTTGGCCCA	CASSYDHTDTQYF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-03	01	2	2	7	2	0	2	23	-1	41	38	43		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYDHTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCATTAGACTAGCGGGAGAAGGAAATACGCAGTATTTTGGCCCA	CAIRLAGEGNTQYF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	10	2	2	7	3	6	26	33	48	36	54		TCRBV06-07,TCRBV06-08												CAIRLAGEGNTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTATTTAGGAGTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	28	4.889463206789369E-4		41	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	10	2	3	4	1	23	37	45	41	46		TCRBV06-05,TCRBV06-06,TCRBV06-08												X+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCTCCGAGGCGACAGCGAAGGGGGATACGCAGTATTTTGGCCCA	CASSEATAKGDTQYF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	2	5	6	8	8	28	37	50	45	58		TCRBV06-04,TCRBV06-08												CASSEATAKGDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGGGACAGGGGGCCTCCCCAAACTGTTTTTTGGCAGT	CASSGTGGLPKLFF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	0	11	0	6	26	-1	50	38	56		TCRBV06-07,TCRBV06-08												CASSGTGGLPKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCAAAGGAGTGACAGGGGTGAAAAACTGTTTTTTGGCAGT	CASSQRSDRGEKLFF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	2	7	9	0	18	30	-1	39	47		TCRBV11-01,TCRBV11-03												CASSQRSDRGEKLFF+TCRBV11-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGAGGGGGGACCTACGCAAGAGCAGTACTTCGGGCCG	CASSYEGGPTQEQYF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	45	TCRBV06	unresolved					TCRBJ02	TCRBJ02-07	01	2	5	1	7	1	11	26	41	48	42	59		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYEGGPTQEQYF+TCRBV06-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCCCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCCCAACCGCCGGGACAGGGGGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPQPPGQGVSGANVLTF	In	VDJ	1	34	5.937205322529948E-4	7.206596155068993E-4	60	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	0	1	0	12	1	13	24	47	36	48		TCRBV06-07,TCRBV06-08												CASSPQPPGQGVSGANVLTF+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCACTATGACAGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASTMTGGNTEAFF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	1	1	4	0	28	38	-1	42	51		TCRBV06-04,TCRBV06-08												CASTMTGGNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCACCTGACGAACTCGACTGGGAAGTCCCAACCTATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	40	6.984947438270527E-4		55	TCRBV10	unresolved					TCRBJ02	TCRBJ02-07	01	10	0	8	4	16	13	26	33	53	49	66		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGCATTTTACGACTAGCGGGCGAGCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	41	7.15957112422729E-4		56	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	2	4	7	9	4	23	40	59	49	63		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGAAACATGGACAGGGGGGCAGGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	43	7.508818496140817E-4		49	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	1	6	6	5	23	34	50	40	55		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTCCCCGGACGTACGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	49	8.556560611881395E-4		43	TCRBV07	unresolved					TCRBJ01	TCRBJ01-03	01	3	1	7	4	4	4	19	32	40	36	44		TCRBV07-05,TCRBV07-06		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ01-03	unresolved		TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCCGTCGTTAGGCCTAGCGGGGACCTTCTCCGAGCAGTACTTCGGGCCG	CASSPSLGLAGTFSEQYF	In	VDJ	2	50	8.731184297838158E-4	0.0010597935522160284	54	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	6	12	8	19	31	52	43	60		TCRBV11-01,TCRBV11-03												CASSPSLGLAGTFSEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGCAGGCCCGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	112	0.0019557852827157478		35	TCRBV06	unresolved					TCRBJ02	TCRBJ02-05	01	6	10	0	1	0	3	26	-1	39	37	42		TCRBV06-07,TCRBV06-09		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCGCGGCTCTAGCGGGAGGGTTAGATGAGCAGTTCTTCGGGCCA	CASAALAGGLDEQFF	In	VDJ	6	186	0.0032480005587957952	0.003942432014243625	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	4	0	8	6	4	23	32	50	38	54		TCRBV06-07,TCRBV06-08												CASAALAGGLDEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCGGAGACAGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	7	237	0.004138581357175287		40	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	0	3	0	19	31	-1	34	39		TCRBV07-05,TCRBV07-07												X+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGATTAGGGGGCCCTGGAGATACGCAGTATTTTGGCCCA	CASRLGGPGDTQYF	In	VDJ	8	251	0.004383054517514756	0.005320163632124462	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	0	5	3	5	23	34	44	37	49		TCRBV06-07,TCRBV06-08												CASRLGGPGDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGTAGGCCCTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGPNTGELFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-02	01	6	5	4	2	3	4	23	34	40	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSVGPNTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAGCGCAGGGGCAGCCCCAGCATTTTGGTGAT	CASSEAQGQPQHF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	39	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	7	4	0	28	42	-1	46	52			01,02											CASSEAQGQPQHF+TCRBV06-04+TCRBJ01-05	TCRBV06-04	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCGAGAAGCGGGAGGGCCTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	2.2701079174379212E-4		52	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	6	0	3	4	3	28	45	59	49	62			01,02											X+TCRBV06-04+TCRBJ02-03	TCRBV06-04	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACGAGGGTTCGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSYEGSGTGELFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	45	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	8	3	5	10	0	28	40	-1	50	55			01,02			01,02								CASSYEGSGTGELFF+TCRBV06-04+TCRBJ02-02	TCRBV06-04	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACTCGGCCCAAGGCCTAAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYSAQGLNSNQPQHF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	54	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-05	01	0	5	4	0	6	6	27	44	53	50	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSAQGLNSNQPQHF+TCRBV06-04+TCRBJ01-05	TCRBV06-04		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACGGCGGGAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSYGGSGTDTQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	7	2	1	1	2	26	41	49	42	51														CASSYGGSGTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGATGCCCCCCGTACGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	27	4.7148395208326056E-4		40	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	8	5	8	12	0	26	37	-1	49	52						01,02								X+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCGGTGGGGTCAGGTCCCCCCCTACGAGCAGTACTTCGGGCCG	CASSRWGQVPPYEQYF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	48	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	6	4	4	2	10	6	26	37	51	47	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRWGQVPPYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGCAGAATGGACTAGCGGAGACCCAGTACTTCGGGCCA	CASRQNGLAETQYF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	42	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	6	5	7	0	26	37	-1	44	53						01,02								CASRQNGLAETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCAGCAACGGGTAGTCGACCTACGAGCAGTACTTCGGGCCG	CASSSNG*STYEQYF	Stop	VDJ	2	50	8.731184297838158E-4		45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	8	4	2	6	7	26	37	47	43	54						01,02								CASSSNG*STYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGGTGGGGGCCAGTTTCGGTTCCCAGATACGCAGTATTTTGGCCCA	CASSLGGGQFRFPDTQYF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	54	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	6	0	4	2	13	19	35	43	37	56														CASSLGGGQFRFPDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGGCTACAGGGACTAGCGGGAGGAGCAGATACGCAGTATTTTGGCCCA	CASRLQGLAGGADTQYF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	51	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	0	1	4	6	2	19	30	51	36	53														CASRLQGLAGGADTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGCCGGGACAGGGGTTGCAGATACGCAGTATTTTGGCCCA	CASSLAGTGVADTQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	48	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	2	4	1	3	19	36	47	37	50														CASSLAGTGVADTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGGGGGAGAACTAATGGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	14	2.4447316033946847E-4		53	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	9	2	1	1	10	19	35	41	36	51														X+TCRBV07-07+TCRBJ02-04	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCTAGACAGGGGGGAGACGGATGAGCAGTTCTTCGGGCCA	CASSLDRGETDEQFF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	3	1	8	0	7	19	-1	43	35	50														CASSLDRGETDEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCAGCCATGTATCGCTGTGTCAGAAGCTTCTTTTAGCGGGAGGGCCGTGAGCAGTTCTTCGGGCCA	CVRSFF*REGREQFF	Stop	VDJ	1	17	2.968602661264974E-4		45	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	5	0	9	4	3	19	33	48	37	51														CVRSFF*REGREQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCCGGAGGGCGGCAGGGGTTCCCGATCATCACTATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	34	5.937205322529948E-4		61	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-07	01	5	4	2	4	12	16	19	31	49	43	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-07+TCRBJ02-07	TCRBV07-07*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCTTCTTTCGGGGCTCTCGGAAACACCATATATTTTGGAGAG	CASSQSSFGALGNTIYF	In	VDJ	2	56	9.778926413578739E-4	0.0011869687784819517	51	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-03	01	0	7	0	4	7	4	29	46	58	53	62			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSSFGALGNTIYF+TCRBV16-01+TCRBJ01-03	TCRBV16-01		TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAAGGGGGGCCGTCTGGCTACACCTTCGGTTCG	CASSQGGPSGYTF	In	VDJ	4	122	0.0021304089686725106	0.002585896267407109	39	TCRBV16	TCRBV16-01					TCRBJ01	TCRBJ01-02	01	2	6	0	7	1	4	29	44	51	45	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGPSGYTF+TCRBV16-01+TCRBJ01-02	TCRBV16-01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACGTTTGGTGGTCAGGAGACACAGCACTGTATTTCTGTGCCAGCAGCGGTAACAGGGGTAAAAATGAAAAACTGTTTTTTGGCAGT	CASSGNRGKNEKLFF	In	VDJ	1	33	5.762581636573184E-4	6.994637444625787E-4	45	TCRBV21	TCRBV21-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	2	5	4	4	36	48	59	52	63														CASSGNRGKNEKLFF+TCRBV21-01+TCRBJ01-04	TCRBV21-01*01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGGTGGGCGTGAAGCGAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CPGRWA*SEQSRANVLTF	Stop	VDJ	1	38	6.635700066357001E-4		54	TCRBV22	TCRBV22-01	01				TCRBJ02	TCRBJ02-06	01	5	8	0	5	2	17	25	36	42	38	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CPGRWA*SEQSRANVLTF+TCRBV22-01+TCRBJ02-06	TCRBV22-01*01		TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAACCCCTCGCTAGACAGGAGCGGAGCTTTCTTTGGACAA	CASNPSLDRSGAFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	4	10	11	5	23	33	50	44	55													Vb 7.1	CASNPSLDRSGAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGAGAATGTCGGGGAGCTGTTTTTTGGAGAA	YASSQENVGELFF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-02	01	0	2	8	7	0	4	22	-1	41	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	YASSQENVGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAACAGACAGGCGTGAACACTGAAGCTTTCTTTGGACAA	CASSQQTGVNTEAFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	4	0	2	2	23	38	46	40	48													Vb 7.1	CASSQQTGVNTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCCCCTGGGACAGGTAAGGGGGTAGTGGAGATACGCAGTATTTTGGCCCA	CASPWDR*GGSGDTQYF	Stop	VDJ	1	14	2.4447316033946847E-4		51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	4	5	4	14	23	32	44	36	58													Vb 7.1	CASPWDR*GGSGDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTCATACCGGGACCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLIPGPSGANVLTF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	51	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-06	01	4	0	7	0	7	1	23	36	48	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSLIPGPSGANVLTF+TCRBV04-01+TCRBJ02-06	TCRBV04-01*01		TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAAGGGGGGGGTCAGCTGAAAAACTGTTTTTTGGCAGT	XASSQRGGSAEKLFF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	9	0	7	1	6	22	37	45	38	51													Vb 7.1	XASSQRGGSAEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD02-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGTCTACAGTTTCAACTATGGCTACACCTTCGGTTCG	XASSQVYSFNYGYTF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	5	2	3	4	22	38	45	41	49													Vb 7.1	XASSQVYSFNYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGTTTCGGGACTACCTATAGCACAGATACGCAGTATTTTGGCCCA	CASSQGFGTTYSTDTQYF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	54	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	0	9	0	5	5	23	39	51	44	56						01,02							Vb 7.1	CASSQGFGTTYSTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAATTACGGGGAGCGCCCTACGAGCAGTACTTCGGGCCG	YASSQLRGAPYEQYF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	8	3	2	3	5	22	37	45	40	50						01,02							Vb 7.1	YASSQLRGAPYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAAGACTCAGCCCTGTATCTCTGCGTCAGCAGCCTCCTTCCTCCCCCGGGACTTACGACAGATACGCAGTATTTTGGCCCA	CVSSLLPPPGLTTDTQYF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	54	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	10	3	13	4	23	36	55	49	59						01,02							Vb 7.1	CVSSLLPPPGLTTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGGTCCCGGAGCGAGGTGAAAAACTGTTTTTTGGCAGT	CASSQEVPERGEKLFF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	6	6	7	8	3	23	40	52	48	55						01,02							Vb 7.1	CASSQEVPERGEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD02-01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGATTTGGGGACTAGTCAACGCGAGCAGTACTTCGGGCCG	XASSQDLGTSQREQYF	In	VDJ	1	31	5.413334264659658E-4	6.570720023739376E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	8	6	4	6	23	40	52	44	58						01,02							Vb 7.1	XASSQDLGTSQREQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGTTGGACAGGGGGAGACACAGATACGCAGTATTTTGGCCCA	CASSQGWTGGDTDTQYF	In	VDJ	1	31	5.413334264659658E-4	6.570720023739376E-4	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	1	2	3	3	23	39	52	42	55													Vb 7.1	CASSQGWTGGDTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATTAGTCCCGGACTAAGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	33	5.762581636573184E-4		53	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	1	9	1	8	2	22	39	53	47	55						01,02							Vb 7.1	X+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCCAATTCTAGGGCATCCTACGAGCAGTACTTCGGGCCG	CASSPNSRASYEQYF	In	VDJ	1	38	6.635700066357001E-4	8.054430996841816E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-07	01	4	5	3	1	8	2	23	36	48	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSPNSRASYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCGCCTAGCCGACCACAATGAGCAGTTCTTCGGGCCA	CASSQDRLADHNEQFF	In	VDJ	1	46	8.032689554011106E-4	9.750100680387461E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	7	5	4	5	23	40	49	44	54						01,02							Vb 7.1	CASSQDRLADHNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGAGTAACTATGGCTACACCTTCGGTTCG	CASSQESNYGYTF	In	VDJ	2	54	9.429679041665211E-4	0.0011445770363933106	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	11	2	1	0	0	23	-1	-1	40	43													Vb 7.1	CASSQESNYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCGGGCAGGGTACTATGGCTACACCTTCGGTTCG	CASSQDRAGYYGYTF	In	VDJ	2	70	0.0012223658016973422	0.0014837109731024396	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	3	5	1	23	40	50	45	51													Vb 7.1	CASSQDRAGYYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCAGGAGACTCTGGAAACACCATATATTTTGGAGAG	CASSPGDSGNTIYF	In	VDJ	3	82	0.001431914224845458	0.0017380614256342864	42	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-03	01	4	4	4	0	0	3	23	-1	40	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSPGDSGNTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01		TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCCTCTAGCGGGTCCGTGAGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	2.095484231481158E-4		38	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	4	4	7	2	7	26	35	45	37	52			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ02-07	TCRBV10-01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAAGGGAACAGGGGGCGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	2.4447316033946847E-4		50	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	0	1	5	2	26	40	54	45	56			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGTGAGCGGGAGCTCAGATACGCAGTATTTTGGCCCA	CASSVSGSSDTQYF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	42	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	6	2	4	2	2	26	39	49	41	51			01,02										Vb 12	CASSVSGSSDTQYF+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCCCAGGGACAGAAGTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	18	3.143226347221737E-4		41	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	5	4	3	3	26	35	45	38	48			01,02										Vb 12	X+TCRBV10-01+TCRBJ01-04	TCRBV10-01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGTCAGCAGTGGGACTCCCACAGATACGCAGTATTTTGGCCCA	CVSSGTPTDTQYF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	39	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	1	10	2	0	2	26	-1	44	39	46			01,02			01,02							Vb 12	CVSSGTPTDTQYF+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGGGGGTAGTGGGTTAATTCTATGGCTACACCTTCGGTTCG	CASSWGVVG*FYGYTF	Stop	VDJ	1	10	1.7462368595676318E-4		48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	9	1	4	0	13	26	-1	45	39	58		TCRBV12-03,TCRBV12-04												CASSWGVVG*FYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGATTAGCGGGAGAAGTCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	10	1.7462368595676318E-4		46	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	5	2	4	3	4	26	39	51	42	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAACTAGCGGACAATGAGCAGTTCTTCGGGCCA	CSAQLADNEQFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	5	5	3	0	26	34	-1	37	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSAQLADNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGGGACTAGCGGGAGGAGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	1.7462368595676318E-4		44	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	1	7	3	3	26	34	52	37	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCAACAGGGGTGGATGGCTACACCTTCGGTTCG	CSARDPTGVDGYTF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	2	6	4	3	26	40	51	44	54		TCRBV20-01,TCRBV20-or09_02												CSARDPTGVDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCGGGAGGGCCTTGAGCGCAGATACGCAGTATTTTGGCCCA	CSARSGRALSADTQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	8	0	4	2	9	26	38	48	40	57		TCRBV20-01,TCRBV20-or09_02												CSARSGRALSADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGTCCGGGACTAGCGGGAGGGCCCCCCCCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	10	1.7462368595676318E-4		55	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	0	0	4	6	8	26	35	57	41	65		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACTAGCGTTGTACAATGAGCAGTTCTTCGGGCCA	CSAGLALYNEQFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	6	4	0	3	26	-1	44	35	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGLALYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CACCARCCARACAKCTWTGTACYTCTGTGCCAGCCTAACTAGCGGGATAGACAATGAGCAGTTCTTCGGGCCA	CASLTSGIDNEQFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	3	3	5	3	3	25	34	47	37	50	TCRBV22,TCRBV28													CASLTSGIDNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGCGCGGGACAGACTTTACAATGAGCAGTTCTTCGGGCCA	CASSARDRLYNEQFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	4	5	4	22	33	45	38	49		TCRBV12-03,TCRBV12-04												CASSARDRLYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTCRGCYGTGTAYKTCTGTGCCAGCAGCGTAGGTGGTGTAGAGGGCGGCGAGCAGTACTTCGGGCCG	CASSVGGVEGGEQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	0	6	13	3	22	33	51	46	54	TCRBV11,TCRBV12													CASSVGGVEGGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CARGGACTCRGCYSTGTAYYTCTGTGCCAGCAGGGTTCGAGGGGGCCAGAACACTGAAGCTTTCTTTGGACAA	CASRVRGGQNTEAFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	0	1	6	2	22	33	46	39	48	TCRBV05,TCRBV12													CASRVRGGQNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCATCACTCCGGGGGTACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	1.7462368595676318E-4		40	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	2	3	6	1	22	32	44	38	45		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACGGAGACTAGCGGGAGTGCAGATACGCAGTATTTTGGCCCA	CATETSGSADTQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	10	2	2	4	3	2	24	32	47	35	49		TCRBV24-01,TCRBV24-or09_02												CATETSGSADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCGTCGGCGACCGGGGGCGGCACAATGAGCAGTTCTTCGGGCCA	CAVGDRGRHNEQFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	42	unresolved						TCRBJ02	TCRBJ02-01	01	12	6	0	5	10	3	24	30	46	40	49	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAVGDRGRHNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGCTGGGGACCACGGGAGACCCAGTACTTCGGGCCA	CASSWGPRETQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	39	unresolved						TCRBJ02	TCRBJ02-05	01	6	0	7	5	3	5	23	34	42	37	47	TCRBV06,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGPRETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCMTGTATCKCTGTGCCAGCAACTTAGTTCCGTGCCGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	10	1.7462368595676318E-4		49	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	8	5	1	8	0	18	34	-1	42	45	TCRBV05,TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAAGACTCGGCCSTGTATCTCTGTGCCAGCAGCTTAGTTTCCCCCGGGGAGCTGTTTTTTGGAGAA	CASSLVSPGELFF	In	VJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-02	01	1	0	0	6	0	6	18	-1	34	-1	40	TCRBV04,TCRBV07			TCRBD02										CASSLVSPGELFF+X+TCRBJ02-02	unresolved	unresolved	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCAAGGAGGGCGCTAGCGGGATGGAGGGCAGATACGCAGTATTTTGGCCCA	CASSPRRALAGWRADTQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	4	3	4	12	7	18	30	51	42	58	TCRBV07,TCRBV11													CASSPRRALAGWRADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGCCACGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASSLPRTVNTEAFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	5	0	5	0	18	32	-1	37	43	TCRBV07,TCRBV11													CASSLPRTVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGGGACAGGGACTGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	10	1.7462368595676318E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	4	1	4	18	32	42	33	46	TCRBV07,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCCAAGAAGGGGCTTACACTGAAGCTTTCTTTGGACAA	CASSQEGAYTEAFF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	3	5	3	19	31	41	36	44	TCRBV03,TCRBV07													CASSQEGAYTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCCCCTAGCGGGAGGGCCCGAGCAGTACTTCGGGCCG	CASSPLAGGPEQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	4	0	6	3	2	19	31	46	34	48	TCRBV05,TCRBV11													CASSPLAGGPEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTGGCAAGCCACGTTTGGTGGGRMYYSRSCMTSTATCKCTGTGCCAGCAGCCCTACAGCGGAAAACTATGGCTACACCTTCGGTTCG	CASSPTAENYGYTF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	6	5	2	5	2	19	31	41	36	43	TCRBV05,TCRBV07					01,02								CASSPTAENYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGGACAGATCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASRTDLAKNIQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	5	0	0	4	19	-1	35	30	39	TCRBV05,TCRBV07													CASRTDLAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCCAGGGACAGCCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGQPSGANVLTF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	0	5	0	2	2	19	31	40	33	42	TCRBV05,TCRBV11													CASSQGQPSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
YRGRRGACTCAGCYYTGTATYTCTGYGCCAGCAGCCAACAGGGATTCTATGGCTACACCTTCGGTTCG	CASSQQGFYGYTF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	4	2	3	23	35	43	37	46	TCRBV04,TCRBV09													CASSQQGFYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTCACGGGAGGGAGGAATCAGCCCCAGCATTTTGGTGAT	CASSLTGGRNQPQHF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	8	0	4	5	3	26	37	50	42	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLTGGRNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*02	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCTTAGCGGGATCGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLSGIVSYNEQFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	48				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	3	0	2	4	24	36	46	38	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSLSGIVSYNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGACAGGGTTGGGCGGCTACACCTTCGGTTCG	CASSQTGLGGYTF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	8	0	6	26	-1	47	40	53		TCRBV03-01,TCRBV03-02												CASSQTGLGGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGAATTAAGGTGGGAACTGAAGCTTTCTTTGGACAA	CRIKVGTEAFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	9	0	8	5	9	0	26	31	-1	40	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CRIKVGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAAGGGCGTACCAAGAGACCCAGTACTTCGGGCCA	CSARERAYQETQYF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	5	3	0	1	3	26	40	45	41	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARERAYQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAAACGAGGGGAGGTTGAAAAACTGTTTTTTGGCAGT	CASKRGEVEKLFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	9	1	7	6	1	22	32	44	38	45		TCRBV12-03,TCRBV12-04												CASKRGEVEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*02	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAGGAGCGGGAGAAGGGGAACGAGCAGTACTTCGGGCCG	CASSEEREKGNEQYF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	2	5	4	7	22	34	46	38	53		TCRBV12-03,TCRBV12-04												CASSEEREKGNEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGACAGGGGAAGGATAGAAACACTGAAGCTTTCTTTGGACAA	CARQGKDRNTEAFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	2	2	2	0	9	24	-1	39	31	48		TCRBV24-01,TCRBV24-or09_02												CARQGKDRNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCAAGCATTGTAAACCAAGAGACCCAGTACTTCGGGCCA	CASSPSIVNQETQYF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	6	7	0	3	7	24	36	42	39	49		TCRBV24-01,TCRBV24-or09_02				01,02								CASSPSIVNQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTATTTCAAATAGGGGGCTTTGGCAAGAGACCCAGTACTTCGGGCCA	CASSISNRGLWQETQYF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	5	0	2	9	5	23	35	51	44	56	TCRBV06,TCRBV10													CASSISNRGLWQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTCGGGGACAGGGAACTCGATGAAAAACTGTTTTTTGGCAGT	CASSFGDRELDEKLFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	3	6	2	6	18	32	43	34	49	TCRBV07,TCRBV11													CASSFGDRELDEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCCGAACGGGGGGGTTACCTACGAGCAGTACTTCGGGCCG	YASSPNGGVTYEQYF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	0	2	5	3	22	34	47	39	50	TCRBV07,TCRBV17	TCRBV07-03,TCRBV17-01												YASSPNGGVTYEQYF+X+TCRBJ02-07		TCRBD02-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTGGGGGACTAGCGGTACAGATACGCAGTATTTTGGCCCA	CASSWGTSGTDTQYF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	45	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	5	3	2	1	19	32	45	34	46		TCRBV05-06,TCRBV05-07				01,02								CASSWGTSGTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAAAACAGGGGTCGGGAAGACCCAGTACTTCGGGCCA	CASKTGVGKTQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	3	2	6	2	6	24	34	43	36	49	TCRBV06,TCRBV10													CASKTGVGKTQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGATCCGGGCAGAACTATGGCTACACCTTCGGTTCG	CASRSGQNYGYTF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	39							TCRBJ01	TCRBJ01-02	01	6	8	0	2	4	2	24	35	43	39	45	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSGQNYGYTF+X+TCRBJ01-02			TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCCCCAGGGGCGGGGGCTACACCTTCGGTTCG	CASSPRGGGYTF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	8	1	4	26	39	46	40	50	TCRBV03,TCRBV09													CASSPRGGGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGGACTCGGCCSTGTATSTCTGTGCCAGCAGCCTACAGGGTATATGGACTGAAGCTTTCTTTGGACAA	CASSLQGIWTEAFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	5	2	7	20	32	40	34	47	TCRBV05,TCRBV11													CASSLQGIWTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGAGCGGGAGGGTCCTACGAGCAGTACTTCGGGCCG	CSARAGGSYEQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	8	0	1	0	0	26	-1	-1	39	47		TCRBV20-01,TCRBV20-or09_02												CSARAGGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCCCCCCCGGGGCGGGCACTGAAGCTTTCTTTGGACAA	CSAAPPGAGTEAFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	7	0	4	9	3	26	35	49	44	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAAPPGAGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGTCAGAGCGGGAGCTGGGGAACATTCAGTACTTCGGCGCC	CSAGSERELGNIQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	6	2	7	7	6	26	35	50	42	56		TCRBV20-01,TCRBV20-or09_02												CSAGSERELGNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGCGGGGCGATCAGCCCCAGCATTTTGGTGAT	CSASRGDQPQHF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	7	3	5	2	2	26	35	43	37	45		TCRBV20-01,TCRBV20-or09_02												CSASRGDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAAGCCACGTTTGGTGCATCCTGAAGACAGCAGYTCTACATCTGCAGTGCGGACAGGGGCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	2.095484231481158E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	24	1	2	0	17	2	43	33	59	50	61		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACGGGAGGGAGATGGTTGAGAGATACGCAGTATTTTGGCCCA	CASTGGRWLRDTQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	8	0	5	0	11	22	-1	40	32	51		TCRBV12-03,TCRBV12-04												CASTGGRWLRDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGACCGGGACAGGGTCTGTTTATACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CATRPGQGLFIPNTGELFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	57	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	3	0	3	11	24	35	47	38	58		TCRBV24-01,TCRBV24-or09_02												CATRPGQGLFIPNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACATAAGACAGAATTAGCCCCAGCATTTTGGTGAT	CATSDIRQN*PQHF	Stop	VDJ	1	12	2.095484231481158E-4		42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	5	8	5	4	24	38	48	43	52		TCRBV24-01,TCRBV24-or09_02												CATSDIRQN*PQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCCGGGACAGGGACCGGGGAGCTGTTTTTTGGAGAA	CATSDPGTGTGELFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	3	5	4	0	24	38	-1	42	51		TCRBV24-01,TCRBV24-or09_02												CATSDPGTGTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTCCGACAGGAGGAACTATGGCTACACCTTCGGTTCG	CASSSDRRNYGYTF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	4	2	3	3	24	36	45	39	48	TCRBV06,TCRBV24													CASSSDRRNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGACATGGTTACTATGGCTACACCTTCGGTTCG	CASSLRHGYYGYTF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	6	3	4	5	24	36	44	40	49		TCRBV24-01,TCRBV24-or09_02												CASSLRHGYYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAACCGTGCAGGCAGGGTTCAATGAGCAGTTCTTCGGGCCA	CASSETVQAGFNEQFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	48	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	6	10	2	23	38	53	48	55		TCRBV06-01,TCRBV06-08												CASSETVQAGFNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGTCGATCGTTCGAGGGCTACGATGAGCAGTTCTTCGGGCCA	CASSRSFEGYDEQFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	0	8	10	5	18	29	44	39	49	TCRBV05,TCRBV11													CASSRSFEGYDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCATCGGGACTAGCGGGAGCGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	2.095484231481158E-4		47	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	2	3	3	2	19	31	48	34	50	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCRGCYSTSTATYTYTGTGCCAGCAGCGAGACTAGCGGGAGGGGGATTCAGTACTTCGGCGCC	CASSETSGRGIQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	4	2	0	10	2	2	19	31	47	33	49	TCRBV05,TCRBV12													CASSETSGRGIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGGAGCGGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGAVSYNEQFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	6	5	0	3	1	24	35	43	38	44	TCRBV09,TCRBV21					01,02								CASSGAVSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCACCGGGCAGGGGGCTTTTTACACTGAAGCTTTCTTTGGACAA	CASTGQGAFYTEAFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	0	3	5	5	23	33	46	38	51	TCRBV09,TCRBV21													CASTGQGAFYTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGRAGACWCRGCWSYGTATCTCTGCACCAGCAGCCAAGATTCGGGGAATGAAGCTTTCTTTGGACAA	CTSSQDSGNEAFF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	3	7	2	2	23	40	47	42	49	TCRBV01,TCRBV23													CTSSQDSGNEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGCGAGGGGACTAGCGGGACTACTACCTACGAGCAGTACTTCGGGCCG	CAISEGTSGTTTYEQYF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	0	3	2	0	6	24	-1	52	39	58	TCRBV06,TCRBV10													CAISEGTSGTTTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGGACAGGGGGCCTGGGCTACACCTTCGGTTCG	CASSQDWTGGLGYTF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	0	8	2	3	26	43	56	45	59		TCRBV03-01,TCRBV03-02												CASSQDWTGGLGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGTCAGCAAAGAGACCCAGTACTTCGGGCCA	CSAREVSKETQYF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	4	5	3	3	2	26	40	46	43	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREVSKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGGGGAGCCCGTGGAACGAGCAGTACTTCGGGCCG	CSARDRGSPWNEQYF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	5	1	10	26	40	47	41	57		TCRBV20-01,TCRBV20-or09_02												CSARDRGSPWNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGACATGAACTATGGCTACACCTTCGGTTCG	CSASDMNYGYTF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	6	2	1	2	26	37	42	38	44		TCRBV20-01,TCRBV20-or09_02												CSASDMNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCGGGTGGGGCAAGCCAAGAGACCCAGTACTTCGGGCCA	CATSDAGGASQETQYF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	48	TCRBV24						TCRBJ02	TCRBJ02-05	01	3	7	0	1	6	3	24	39	50	45	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDAGGASQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTAACTCGGGCGGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	13	2.2701079174379212E-4		46	TCRBV24						TCRBJ01	TCRBJ01-03	01	1	8	0	4	6	1	24	41	51	47	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-03	TCRBV24		TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTGCGGGACATTGACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	13	2.2701079174379212E-4		49	TCRBV24						TCRBJ01	TCRBJ01-05	01	1	0	6	3	3	4	24	41	50	44	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTCTCGGACAGGGAAGAGAGTCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSRTGKRVGANVLTF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	1	3	4	4	9	24	36	48	40	57	TCRBV06,TCRBV24													CASSSRTGKRVGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCTCCCAGGACAGGGGGAATCGGGGAGCTGTTTTTTGGAGAA	CASSPPRTGGIGELFF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	1	7	7	3	19	31	48	38	51	TCRBV05,TCRBV11													CASSPPRTGGIGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGTCGGACCGTTAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	14	2.4447316033946847E-4		41	TCRBV12						TCRBJ02	TCRBJ02-01	01	3	1	7	7	4	4	26	40	48	44	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCAAGCGGCCTTGAAGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	14	2.4447316033946847E-4		47	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	6	5	6	3	8	26	40	48	43	56		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTTCAGAAGCGGGAGTTAAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	14	2.4447316033946847E-4		50	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	6	2	5	8	4	26	39	55	47	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGWGACWCKGCWSTGTATYTCTGYGCCAGCAGCTCGATGACTAGCGGGGGGAACAATGAGCAGTTCTTCGGGCCA	CASSSMTSGGNNEQFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	2	1	5	5	1	26	38	56	43	57	TCRBV03,TCRBV23													CASSSMTSGGNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTGGACTGGGGAGCACTGAAGCTTTCTTTGGACAA	CASSGLGSTEAFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	1	10	4	1	6	26	37	43	38	49		TCRBV03-01,TCRBV03-02				01,02								CASSGLGSTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGACAGCCCAAAGAGACCCAGTACTTCGGGCCA	CSAGQPKETQYF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	5	3	0	4	26	-1	41	34	45		TCRBV20-01,TCRBV20-or09_02												CSAGQPKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTTACGGACAGGGGGCAGCGGAATCGGGCGAGCAATACTTCGGGCCG	CSARGYGQGAAESGEQYF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	0	13	5	19	26	39	55	44	74		TCRBV20-01,TCRBV20-or09_02												CSARGYGQGAAESGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCGGGACAGGGGATGAAAAACTGTTTTTTGGCAGT	CSASPGTGDEKLFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	2	6	4	0	26	37	-1	41	51		TCRBV20-01,TCRBV20-or09_02												CSASPGTGDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGCACTAGCTCCGAGCAGTACTTCGGGCCG	CSASRTSSEQYF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	3	7	6	4	2	26	37	47	41	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSASRTSSEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGGTCGGGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRSGYSNQPQHF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	8	4	0	2	3	24	35	41	37	44	TCRBV06,TCRBV24					01,02								CASRSGYSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCTCTGGACAGGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSPLDRGPYEQYF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	0	2	5	0	18	30	-1	35	46	TCRBV05,TCRBV11													CASSPLDRGPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCCAACCGGGACTAGCGGGAACCCAAGAGACCCAGTACTTCGGGCCA	CASSQPGLAGTQETQYF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	0	3	1	2	2	20	35	50	37	52	TCRBV07,TCRBV23													CASSQPGLAGTQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCCCAGGGGGGAGTCGAGAGACCCAGTACTTCGGGCCA	CASSPGGSRETQYF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	1	4	1	6	19	31	39	32	45	TCRBV07,TCRBV11													CASSPGGSRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGKGACTCKGCYRTGTATYTCTGTGCCAGCAGTCCCGAGGGGGACCGACCAGGGCAGTTCTTCGGGCCA	CASSPEGDRPGQFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	5	1	12	5	10	19	30	41	35	51	TCRBV03,TCRBV11													CASSPEGDRPGQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTGGGGAGGGAGACAGATACGCAGTATTTTGGCCCA	CASSLGRETDTQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	0	3	3	2	26	38	48	41	50		TCRBV12-03,TCRBV12-04												CASSLGRETDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTACTGGACTAACAAAGAGACCCAGTACTTCGGGCCA	CASSYWTNKETQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	9	3	3	3	26	39	48	42	51		TCRBV12-03,TCRBV12-04				01,02								CASSYWTNKETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGAAGACTCRGCYSYGTATCTCTGCGCCAGCAGCCAAGCACTTGGGGAAAAACTGTTTTTTGGCAGT	CASSQALGEKLFF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	39	unresolved						TCRBJ01	TCRBJ01-04	01	1	0	9	8	5	0	23	39	-1	44	47	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQALGEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCCGAGGAGGGACAGGGGGCGCCGCAGATACGCAGTATTTTGGCCCA	CASSRGGTGGAADTQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	0	4	5	4	26	39	56	44	60	TCRBV03,TCRBV11													CASSRGGTGGAADTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGCCCCGGGACAGGGTCGGAGACCCAGTACTTCGGGCCA	CSARPGTGSETQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	3	5	7	3	26	34	50	41	53		TCRBV20-01,TCRBV20-or09_02												CSARPGTGSETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGACAGGGGGGCTAGTAAATCAGCCCCAGCATTTTGGTGAT	CSARGTGGLVNQPQHF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	1	4	1	7	26	37	49	38	56		TCRBV20-01,TCRBV20-or09_02												CSARGTGGLVNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGAACAGGGGCGCCTACGAGCAGTACTTCGGGCCG	CSASNRGAYEQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	2	4	2	26	35	46	39	48		TCRBV20-01,TCRBV20-or09_02												CSASNRGAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCARCCAGACMKMTCTKTACYWCTGTGCCAGCAATCCGACTAGCGGGATCAATGAGCAGTTCTTCGGGCCA	CASNPTSGINEQFF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	2	3	6	4	1	22	32	47	36	48	TCRBV08,TCRBV24													CASNPTSGINEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTAGCCACAGGCAGGGGGCAGCCCGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	2.6193552893514474E-4		53	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	0	3	12	6	22	33	53	45	59		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGCCCGACTAGCGGGAGTGGCACAGATACGCAGTATTTTGGCCCA	CATSGPTSGSGTDTQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	2	2	1	4	2	24	37	53	41	55		TCRBV24-01,TCRBV24-or09_02												CATSGPTSGSGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTTCGGGTAAGGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	15	2.6193552893514474E-4		46	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	8	4	0	2	5	24	37	43	39	48		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD02-01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACGATACAGGGACATTCAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	2.6193552893514474E-4		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	0	6	2	6	3	24	32	44	38	47		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGTTACCCCCCTACAGGGAGCAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	2.6193552893514474E-4		58	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	3	0	14	5	23	37	57	51	62		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAACCTCCGAATTAACTAGCGGGACAAGAAGACCCAGTACTTCGGGCCA	CASSQNLRIN*RDKKTQYF	Stop	VDJ	1	15	2.6193552893514474E-4		57	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	3	3	6	13	5	24	39	62	52	67		TCRBV03-01,TCRBV03-02												CASSQNLRIN*RDKKTQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTGTAACCGGGGGGGAGACCCAGTACTTCGGGCCA	CASSLAVTGGETQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	1	5	6	0	18	35	-1	41	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAVTGGETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCTACGAACGGCACTTGAGAAGATACGCAGTATTTTGGCCCA	CASSPTNGT*EDTQYF	Stop	VDJ	1	15	2.6193552893514474E-4		48	TCRBV05						TCRBJ02	TCRBJ02-03	01	4	9	0	5	9	8	19	31	43	40	51		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTNGT*EDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTCCTTGACCAGGGCTACGAGCAGTACTTCGGGCCG	CASSFLDQGYEQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	3	7	0	19	33	-1	40	45	TCRBV05,TCRBV11													CASSFLDQGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCCCCGCGGACAGGGCGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSPADRAGQETQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	3	1	6	4	26	37	51	43	55	TCRBV12,TCRBV21													CASSPADRAGQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGGGGGACTAGCGCCTACAATGAGCAGTTCTTCGGGCCA	CASRGTSAYNEQFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	6	2	1	0	24	35	-1	36	46	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03				01,02								CASRGTSAYNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGGACAGGGGGCCTAGAAAAACTGTTTTTTGGCAGT	CASSQRTGGLEKLFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	1	0	8	1	3	26	41	53	42	56		TCRBV03-01,TCRBV03-02												CASSQRTGGLEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGAGGGGCGCATCACCGGGGAGCTGTTTTCTGGAGAA	CASSQGEGRITGELFS	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	9	0	22	0	24	26	-1	49	42	73		TCRBV03-01,TCRBV03-02												CASSQGEGRITGELFS+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCACTAGCGGGATTAAACATTCAGTACTTCGGCGCC	CSAPLAGLNIQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	6	3	3	6	3	2	26	34	47	37	49		TCRBV20-01,TCRBV20-or09_02												CSAPLAGLNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAGGGACGAGAGCTCCTACGAGCAGTACTTCGGGCCG	CSARDRDESSYEQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	45	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	0	7	0	2	5	26	40	47	42	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDRDESSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGCGGAAATCCTACAATGAGCAGTTCTTCGGGCCA	CSARDRRKSYNEQFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	7	5	1	3	3	26	40	47	43	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRRKSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCCAGGACAGGGTCCTATGGCTACACCTTCGGTTCG	CATSDPRTGSYGYTF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	3	4	5	2	24	38	51	43	53		TCRBV24-01,TCRBV24-or09_02												CATSDPRTGSYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGACGGTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	16	2.7939789753082106E-4		43	TCRBV24						TCRBJ01	TCRBJ01-05	01	5	1	7	0	0	4	24	-1	41	37	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCAATACAGGGGCCGGGGTTACGCAGTATTTTGGCCCA	CASSNTGAGVTQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	2	8	3	7	19	31	41	34	48	TCRBV07,TCRBV11													CASSNTGAGVTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCAAGAAGGGGGCGTGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	16	2.7939789753082106E-4		44				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	4	0	4	19	-1	43	36	47	TCRBV03,TCRBV07	TCRBV03-01,TCRBV03-02,TCRBV07-05												X+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCRTGTATSKCTGTGCCAGAAGCCCATTCGGGACCCCTTCTGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	16	2.7939789753082106E-4		50	unresolved						TCRBJ02	TCRBJ02-02	01	4	0	7	4	6	8	18	30	41	36	49	TCRBV05,TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCCCAATCTTGAGGGGGAGGGCTGAAGCTTTCTTTGGACAA	CASSPILRGRAEAFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	6	12	0	18	30	-1	42	49	TCRBV05,TCRBV11													CASSPILRGRAEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGTCGGGCTAGCGGAGACCTACGAGCAGTACTTCGGGCCG	CASSLAVGLAETYEQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	51				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	5	2	7	3	18	35	49	42	52	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAVGLAETYEQYF+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTTCAGGGCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	2.7939789753082106E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	1	2	1	18	34	41	36	42	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGCGGGCCCCGGGACAGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLRAPGQGSYEQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	0	9	0	18	32	-1	41	50	TCRBV07,TCRBV11													CASSLRAPGQGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCAGGAGACWCRGCMSKGTATKTCTGTGCCAGCAGGAAGTAATCAGGAAGGCGTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASRK*SGRRE*KTYGYTF	Stop	VDJ	1	16	2.7939789753082106E-4		57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	4	4	8	18	18	29	41	37	59	TCRBV11,TCRBV21													CASRK*SGRRE*KTYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTGGGACAGGGGGCTCACTGAAGCTTTCTTTGGACAA	CASSWDRGLTEAFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	0	4	0	1	19	-1	44	32	45	TCRBV05,TCRBV11													CASSWDRGLTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTACTATCCACAACCGACGAGCAGTACTTCGGGCCG	CASSLLSTTDEQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	2	3	9	5	0	10	19	-1	37	33	47	TCRBV05,TCRBV11			TCRBD01,TCRBD02										CASSLLSTTDEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCAAACCCGGGACTAGCGGGAGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSANPGLAGVTGELFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	0	2	4	8	1	24	36	58	44	59	TCRBV09,TCRBV21													CASSANPGLAGVTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTTTAGCCTTTGGACAGGGGAACTATGGCTACACCTTCGGTTCG	CASSLAFGQGNYGYTF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	2	2	9	0	23	35	-1	44	53	TCRBV02,TCRBV12													CASSLAFGQGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTATCCGGGAGTGGTTACAATGAGCAGTTCTTCGGGCCA	CASSVSGSGYNEQFF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	2	4	6	4	26	37	49	43	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVSGSGYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGACGGCTAGTAAAGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	2.968602661264974E-4		43				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	8	6	3	6	24	38	45	41	51	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03				01,02								X+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGAAAGGGGTGATGGCTACACCTTCGGTTCG	CSAKERGDGYTF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	5	2	6	5	2	26	36	46	41	48		TCRBV20-01,TCRBV20-or09_02												CSAKERGDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCAGTGACCCCTACGAGCAGTACTTCGGGCCG	CSARVSDPYEQYF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	1	2	7	2	5	1	26	39	47	44	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVSDPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCAAGTTGGAAACACCATATATTTTGGAGAG	CSASQVGNTIYF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	36	TCRBV20						TCRBJ01	TCRBJ01-03	01	3	4	6	3	1	3	26	37	40	38	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASQVGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGTAGACTAGCGGGAGACTACGAGCAGTACTTCGGGCCG	CSARRLAGDYEQYF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	2	3	4	1	26	35	51	39	52		TCRBV20-01,TCRBV20-or09_02												CSARRLAGDYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAGAGGGGGTTGGGAGACCCAGTACTTCGGGCCA	CASSRGGWETQYF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	5	1	5	2	4	24	36	44	38	48		TCRBV24-01,TCRBV24-or09_02												CASSRGGWETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTGGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSWTSGSTDTQYF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	4	0	1	0	24	36	-1	37	48	TCRBV06,TCRBV24					01,02								CASSWTSGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCATGAGGGGCGATGTGACTGAAGCTTTCTTTGGACAA	CASMRGDVTEAFF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	7	5	2	5	2	7	23	33	40	35	47	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASMRGDVTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTACAGGACAGGGGGCAGGGGGCTGGAAACACCATATATTTTGGAGAG	CASSQVQDRGQGAGNTIYF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	57	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	1	0	2	4	6	24	40	55	44	61		TCRBV03-01,TCRBV03-02												CASSQVQDRGQGAGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGAAAACGGGAGGCACTGAAGCTTTCTTTGGACAA	CASSPKTGGTEAFF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	1	4	7	0	26	38	-1	45	52		TCRBV12-03,TCRBV12-04												CASSPKTGGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTTTTTTTACTAGCGGAAACAATGAGCAGTTCTTCGGGCCA	CASSFFTSGNNEQFF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	5	5	4	2	26	40	52	44	54	TCRBV02,TCRBV12					01,02								CASSFFTSGNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCACGCTTCGTCCGGCTACGAGCAGTACTTCGGGCCG	CASSHASSGYEQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	5	3	9	0	23	37	-1	46	49	TCRBV01,TCRBV04					01,02								CASSHASSGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TMSCTCCCARACATCTGTGTACTTCTGTGCCAGCAGTGCGACGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSATDTGELFF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	39	unresolved						TCRBJ02	TCRBJ02-02	01	4	2	7	3	1	2	24	37	41	38	43	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSATDTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAATAGCGTTCTACGAGCAGTACTTCGGGCCG	CSAREIAFYEQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	5	6	3	2	2	26	40	47	42	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAREIAFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGCGGGAGTGATCGAGCAGTACTTCGGGCCG	CSARDLAGVIEQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	4	2	6	1	4	26	40	51	41	55		TCRBV20-01,TCRBV20-or09_02												CSARDLAGVIEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCAACGGGGGGGGCACTGAAGCTTTCTTTGGACAA	CSARPNGGGTEAFF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	0	4	6	1	26	37	51	43	52		TCRBV20-01,TCRBV20-or09_02												CSARPNGGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGTCCCGGGTGGGGCACAGATACGCAGTATTTTGGCCCA	CSASSPGWGTDTQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	4	1	6	4	26	37	47	43	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSPGWGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGAGGCCAGAACAGCCCCAGCATTTTGGTGAT	CSAQRPEQPQHF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	11	1	7	2	6	26	35	41	37	47		TCRBV20-01,TCRBV20-or09_02												CSAQRPEQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTACAGGGGGGGAAGTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	3.143226347221737E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	1	6	2	6	26	35	45	37	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTATCCAGGGGGTTCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	3.143226347221737E-4		37	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	1	4	4	3	26	33	44	37	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTYGGSCSTRTATKTCTGTGCCAGCAGCCCAGACGGGGCTGTAGGGGGTGAGCAGTACTTCGGGCCG	CASSPDGAVGGEQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	1	7	14	1	22	34	54	48	55	TCRBV11,TCRBV12													CASSPDGAVGGEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGGAGGGAGGAGAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	18	3.143226347221737E-4		41	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	9	1	5	3	3	24	35	44	38	47		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01*02	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGCTCTTACAATGAGCAGTTCTTCGGGCCA	CATSDRSYNEQFF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	39	TCRBV24						TCRBJ02	TCRBJ02-01	01	4	10	0	4	2	3	24	38	42	40	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDRSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCGCGGAGGCGGGACGCTCCAAGAGACCCAGTACTTCGGGCCA	CASRGGGTLQETQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	11	7	3	1	9	4	24	31	46	40	50		TCRBV24-01,TCRBV24-or09_02												CASRGGGTLQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTCTTACTTAGTAGGAGTTTAGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	3.143226347221737E-4		44	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	10	2	4	13	5	24	31	48	44	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGGATCGGGGACTCTAAATGAGCAGTTCTTCGGGCCA	CASSQAGSGTLNEQFF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	0	10	7	8	3	26	42	56	50	59		TCRBV03-01,TCRBV03-02				01,02								CASSQAGSGTLNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGGCTAGCGGCACCTACGAGCAGTACTTCGGGCCG	CSARDLASGTYEQYF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	5	2	5	2	26	40	52	45	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLASGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCGGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CSASPGGNQPQHF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	8	2	2	2	0	26	37	-1	39	45		TCRBV20-01,TCRBV20-or09_02												CSASPGGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCGTGCCGGGACAGGGACCTACGAGCAGTACTTCGGGCCG	CASSRAGTGTYEQYF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	2	6	1	24	36	51	42	52		TCRBV24-01,TCRBV24-or09_02												CASSRAGTGTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAACCACCCACAGCCTGTGAGTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	3.3178500331785003E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	3	5	3	10	9	24	31	45	41	54	TCRBV12,TCRBV21													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCACCACCGCGGGGCCTAGCTCAGATACGCAGTATTTTGGCCCA	CATTAGPSSDTQYF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	9	7	3	4	5	7	23	30	41	35	48	TCRBV09,TCRBV21													CATTAGPSSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGACCCAGGGAATGAGCAGTTCTTCGGGCCA	CASSDPGNEQFF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	36				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	7	2	0	24	38	-1	40	45	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03												CASSDPGNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCCGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASTPTSGSTDTQYF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	2	4	0	4	0	26	36	-1	40	50		TCRBV03-01,TCRBV03-02				01,02								CASTPTSGSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACAGGTCCAGCGGAGAAACACCATATATTTTGGAGAG	CASSQGQVQRRNTIYF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	2	4	5	0	9	26	-1	48	42	57		TCRBV03-01,TCRBV03-02												CASSQGQVQRRNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAAGCCGACAGGCCTGGGGCTATGAAAAACTGTTTTTTGGCAGT	CASSPSRQAWGYEKLFF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	4	6	6	9	26	39	51	45	60		TCRBV03-01,TCRBV03-02												CASSPSRQAWGYEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGTTAACAGGGCAATCAGCCCCAGCATTTTGGTGAT	CSAG*QGNQPQHF	Stop	VDJ	1	20	3.4924737191352636E-4		39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	4	2	5	0	26	35	-1	40	45		TCRBV20-01,TCRBV20-or09_02												CSAG*QGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
SRGGGACTYRGCTGTGTAYYTCTGTGCCAGCAGCTTAGGGCCGGTGGCTGTCTATGGCTACACCTTCGGTTCG	CASSLGPVAVYGYTF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	1	9	0	4	0	10	22	-1	41	38	51	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPVAVYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGCTCCCGGGACCCAAATAGACATTCAGTACTTCGGCGCC	CASSAPGTQIDIQYF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	45	unresolved						TCRBJ02	TCRBJ02-04	01	5	0	7	8	6	8	22	34	45	40	53	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAPGTQIDIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGAAGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	20	3.4924737191352636E-4		41	TCRBV12						TCRBJ02	TCRBJ02-02	01	1	5	5	1	1	0	22	38	-1	39	41		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCCCCACAGGGGGCGCGATGTGAGGCTACACCTTCGGTTCG		Out	VDJ	1	20	3.4924737191352636E-4		50	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	0	8	6	9	24	38	53	44	62		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGAATCCTGAGGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	3.4924737191352636E-4		46	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	1	3	7	1	24	42	53	49	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCATCAGTGAAGGGGGACTAGCGTACGAGCAGTACTTCGGGCCG	CAISEGGLAYEQYF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	6	4	3	0	24	38	-1	41	51		TCRBV24-01,TCRBV24-or09_02				01,02								CAISEGGLAYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GARGACTCSGCCSTGTATCTCTGTGCCAGCAGCTTAGGGTTGGCGGGAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLAGANTGELFF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	7	2	0	9	0	21	33	-1	42	49	TCRBV04,TCRBV07													CASSLGLAGANTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCAATAACGCATGCCATCCTACAATGAGCAGTTCTTCGGGCCA	CASSQ*RMPSYNEQFF	Stop	VDJ	1	20	3.4924737191352636E-4		48	unresolved						TCRBJ02	TCRBJ02-01	01	5	3	7	1	5	8	18	30	37	35	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQ*RMPSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCACCCCCGGGCCCCACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	3.4924737191352636E-4		44	unresolved						TCRBJ02	TCRBJ02-07	01	4	8	0	3	7	4	18	31	42	38	46	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCCAAGACATTTCCAAAACCTACAATGAGCAGTTCTTCGGGCCA	CASSQDISKTYNEQFF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	6	2	3	9	19	31	38	34	47	TCRBV07,TCRBV11													CASSQDISKTYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGTCCGACAGGGCCTAACTATGGCTACACCTTCGGTTCG	CASSPTGPNYGYTF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	0	3	1	19	30	40	33	41	TCRBV07,TCRBV11													CASSPTGPNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCGGGCTAGCGGGCCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	3.4924737191352636E-4		47	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	4	2	4	2	19	32	44	36	46		TCRBV05-06,TCRBV05-07				01,02								X+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTCTTTGGGACAGCTGCGGGGGGAGACCCAGTACTTCGGGCCA	CASSSLGQLRGETQYF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	48	unresolved						TCRBJ02	TCRBJ02-05	01	3	0	5	5	4	9	19	32	43	36	52	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLGQLRGETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGGCACGGGGGCCGACGTCATGGATGAGCAGTTCTTCGGGCCA	CASGTGADVMDEQFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	10	6	0	8	7	11	24	31	44	38	55	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGTGADVMDEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAAGGCGGGAGGGCCAGTCCGGGCAGTTCTTCGGGCCA		Out	VDJ	1	21	3.667097405092027E-4		49	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	0	12	4	9	26	43	56	47	65		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCTAATGGGGGAGACCCAGTACTTCGGGCCA	CASSPLMGETQYF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	39	TCRBV03						TCRBJ02	TCRBJ02-05	01	4	6	2	5	7	0	26	39	-1	46	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLMGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGCCGGGGCGGGGGGTCTGAAAAACTGTTTTTTGGCAGT	CSARRGGGSEKLFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	7	1	7	8	2	26	34	50	42	52		TCRBV20-01,TCRBV20-or09_02												CSARRGGGSEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGGCTAGCGGGAGCTACGAGCAGTACTTCGGGCCG	CSASWASGSYEQYF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	2	3	5	0	26	37	-1	42	52		TCRBV20-01,TCRBV20-or09_02												CSASWASGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAATCCCCGCCCAGCGGGAGTTCCTACGAGCAGTACTTCGGGCCG	CASSQESPPSGSSYEQYF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	2	1	10	1	23	40	58	50	59	TCRBV01,TCRBV04													CASSQESPPSGSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACATGGGGACAGATACGCAGTATTTTGGCCCA	CATSDMGTDTQYF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	39	TCRBV24						TCRBJ02	TCRBJ02-03	01	4	6	2	3	3	0	24	38	-1	41	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDMGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGAACAGCACACTGAAGCTTTCTTTGGACAA	CASSLEQHTEAFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	5	3	5	1	24	36	45	41	46		TCRBV24-01,TCRBV24-or09_02												CASSLEQHTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCCCATACCAGCGGGAGGACAATGAGCAGTTCTTCGGGCCA	CASSPYQREDNEQFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	1	5	7	0	18	30	-1	37	46	TCRBV07,TCRBV11													CASSPYQREDNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAAGCGGGAGGGCCGTACGAGCAGTACTTCGGGCCG	CASS*AGGPYEQYF	Stop	VDJ	1	21	3.667097405092027E-4		42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	0	4	0	3	18	-1	42	35	45	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASS*AGGPYEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTACAACAGGGTGGCACTGAAGCTTTCTTTGGACAA	CASSLQQGGTEAFF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	4	4	3	26	39	49	43	52		TCRBV03-01,TCRBV03-02												CASSLQQGGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAACAGGGACTTTCCTACGAGCAGTACTTCGGGCCG	CSAQQGLSYEQYF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	3	3	1	3	4	26	34	43	37	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAQQGLSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGAGGATTGTACTATGGCTACACCTTCGGTTCG	CSAGGLYYGYTF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	1	3	0	5	26	-1	40	34	45		TCRBV20-01,TCRBV20-or09_02												CSAGGLYYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCGGACTAGCGGGTTCTAAGTGGCAGTTCTTCGGGCCA		Out	VDJ	1	22	3.84172109104879E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	1	4	12	3	9	26	40	54	43	63		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTTTCGGGACAGACTACAATGAGCAGTTCTTCGGGCCA	CSAPFGTDYNEQFF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	3	6	1	26	35	48	41	49		TCRBV20-01,TCRBV20-or09_02												CSAPFGTDYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTTGTCGGCACAGATACGCAGTATTTTGGCCCA	CASSLFVGTDTQYF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	9	1	1	7	24	36	39	37	46		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLFVGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCCCACTGGGGGGGGCAGGGGAGACCCAGTACTTCGGGCCA	CASSPLGGAGETQYF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	9	0	5	5	6	18	30	42	35	48	TCRBV03,TCRBV11													CASSPLGGAGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTAGGGGGGGTATACTCTGGAAACACCATATATTTTGGAGAG	CASSLVGGVYSGNTIYF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	1	9	0	0	2	4	18	34	43	36	47	TCRBV07,TCRBV11													CASSLVGGVYSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCAACACAGCGGGAAGAGACCCAGTACTTCGGGCCA	CASSPTQREETQYF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	6	4	3	7	0	19	31	-1	38	44	TCRBV05,TCRBV11					01,02								CASSPTQREETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTAGCGGGGGGGCAAGATGAGCAGTTCTTCGGGCCA	CASSLAGGQDEQFF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	9	0	8	0	4	19	-1	43	36	47	TCRBV05,TCRBV11													CASSLAGGQDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCCTACAGGGGGTCCCCTCCTACGAGCAGTACTTCGGGCCG	CASSLQGVPSYEQYF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	1	0	2	4	22	34	44	36	48	TCRBV07,TCRBV11													CASSLQGVPSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGCCCTCCGGGACTACCTCTACAATGAGCAGTTCTTCGGGCCA	CASSALRDYLYNEQFF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	9	3	7	3	24	36	50	43	53	TCRBV12,TCRBV21					01,02								CASSALRDYLYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACACAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQDTSSYEQYF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	6	0	1	2	26	43	47	44	49		TCRBV03-01,TCRBV03-02												CASSQDTSSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGGGCCGAAATCCTACGAGCAGTACTTCGGGCCG	CASSRGPKSYEQYF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	0	1	0	6	26	-1	44	39	50		TCRBV03-01,TCRBV03-02												CASSRGPKSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACACAGGGGCAATCAGCCCCAGCATTTTGGTGAT	CSAHRGNQPQHF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	2	2	0	26	34	-1	36	42		TCRBV20-01,TCRBV20-or09_02												CSAHRGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCCCACTAGCGGGACCTCATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	23	4.016344777005553E-4		46	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	3	3	1	5	5	26	34	49	39	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACAGGGGGCCCAGATACGCAGTATTTTGGCCCA	CSARTGGPDTQYF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	0	4	0	1	26	-1	47	37	48		TCRBV20-01,TCRBV20-or09_02												CSARTGGPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCAGAGGCAGTTGGACACTGAAGCTTTCTTTGGACAA	CSAPQRQLDTEAFF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	1	3	5	7	26	35	44	40	51		TCRBV20-01,TCRBV20-or09_02												CSAPQRQLDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCCGGACAGGCTCTGGAAACACCATATATTTTGGAGAG	CATSDPRTGSGNTIYF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	4	0	4	0	24	39	-1	43	50		TCRBV24-01,TCRBV24-or09_02												CATSDPRTGSGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTACGGGACAGACAATCACAGATACGCAGTATTTTGGCCCA	CASSTGQTITDTQYF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	5	2	2	5	24	36	45	38	50	TCRBV24,TCRBV27													CASSTGQTITDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCGTGTGGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSRVGGNQPQHF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	6	6	1	2	5	0	24	36	-1	41	46	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRVGGNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCSTSTATSTCTGTGCCACTATCCCAATTAGCGGGTTTGTCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	23	4.016344777005553E-4		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	9	5	4	5	10	7	19	26	43	36	50	TCRBV05,TCRBV12					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGTAGAAGCGAGCGTACAGTTCTACGAGCAGTACTTCGGGCCG	CASSVEASVQFYEQYF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	48	unresolved						TCRBJ02	TCRBJ02-07	01	0	3	5	3	10	2	23	39	53	49	55	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVEASVQFYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTGAAAAGGGTAGCGAGCAGTTCTTCGGGCCA	CASSEKGSEQFF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	36	unresolved						TCRBJ02	TCRBJ02-01	01	5	5	3	10	4	4	26	38	46	42	50	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEKGSEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGAGCCCGCTTTTTTCTGGCTACACCTTCGGTTCG	CASSRSPLFSGYTF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	10	2	7	0	12	26	-1	43	39	55		TCRBV03-01,TCRBV03-02												CASSRSPLFSGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGAGCGGGAGAGTACGAGCAGTACTTCGGGCCG	CSAREGAGEYEQYF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	6	2	4	3	2	26	40	51	43	53		TCRBV20-01,TCRBV20-or09_02												CSAREGAGEYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGCGGGAGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CSARDLAGGPYNEQFF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	0	2	1	1	26	40	53	41	54		TCRBV20-01,TCRBV20-or09_02												CSARDLAGGPYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCCCCGCGGGGACCGGAGGACCCTTAACTATGGCTACACCTTCGGTTCG	CASSPRGDRRTLNYGYTF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	54	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	7	3	1	4	13	22	34	44	38	57		TCRBV12-03,TCRBV12-04												CASSPRGDRRTLNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
SRGGGACTYRGCTGTGTAYYTCTGTGCCAGCAGTGAGGGACGTTTCAGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEGRFRSGANVLTF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	51	unresolved						TCRBJ02	TCRBJ02-06	01	5	0	7	1	2	8	22	34	41	36	49	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGRFRSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGTCCCGGACCAAATCAGCCCCAGCATTTTGGTGAT	CATSDCPGPNQPQHF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	45	TCRBV24						TCRBJ01	TCRBJ01-05	01	2	1	7	4	5	2	24	40	49	45	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDCPGPNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCGGGACAGGGGGGCTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	4.190968462962316E-4		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	1	6	4	3	24	36	51	40	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCCTCCCCCCCCTCGGGACGGTGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	24	4.190968462962316E-4		52	unresolved						TCRBJ01	TCRBJ01-01	01	8	0	7	0	13	5	23	32	50	45	55	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCACTAGCGTCCTCGGATGAGCAGTTCTTCGGGCCA	CASSLALASSDEQFF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	6	8	0	7	18	-1	42	35	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLALASSDEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCGAAATTGGATCAGCGAGCGGAACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	24	4.190968462962316E-4		49	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	6	5	2	15	2	18	27	47	42	49	TCRBV05,TCRBV11					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGGGGACTCRGCYSTSTATCTCTGTGCCAGCAGCCACTTCGGACAGTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	24	4.190968462962316E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	5	2	6	1	19	31	43	37	44	TCRBV05,TCRBV07													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGATCCCGGACTAGCAACCCAGTACTTCGGGCCA	CASSLDPGLATQYF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	1	7	8	7	1	19	33	48	40	49	TCRBV05,TCRBV11					01,02								CASSLDPGLATQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGRGGACTYGGCYSTGTATCTCTGTGCCAGTAGGGGGACCCTTGAGGCTGAAGCTTTCTTTGGACAA	CASRGTLEAEAFF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	5	1	6	1	10	22	30	37	31	47	TCRBV05,TCRBV07													CASRGTLEAEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTGGAGGACAGGGGAGACTACGAGCAGTACTTCGGGCCG	CASSLEDRGDYEQYF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	2	3	3	3	26	40	52	43	55	TCRBV12,TCRBV21													CASSLEDRGDYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTGACTCGGGGGAGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSDSGEGYNEQFF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	0	3	5	0	24	38	-1	43	50	TCRBV06,TCRBV10													CASSDSGEGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATACTAGCGGGAGAGACCTTAATGAGCAGTTCTTCGGGCCA	CASSHTSGRDLNEQFF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	3	2	7	1	7	26	40	52	41	59		TCRBV03-01,TCRBV03-02												CASSHTSGRDLNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATTGTCATCCCATGCAAGATACGCAGTATTTTGGCCCA	CASSHCHPMQDTQYF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	45	TCRBV03						TCRBJ02	TCRBJ02-03	01	3	4	6	5	4	9	26	40	46	44	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHCHPMQDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGACGGGGCAATCTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	4.365592148919079E-4		43	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	7	0	3	6	5	26	34	45	40	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTYRGKGACTCWGCTGTGTAYTTCTGTGCCAGCAGTGAAGCGAGAAGACAGTTCTATGGCTACACCTTCGGTTCG	CASSEARRQFYGYTF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	5	4	10	2	22	34	49	44	51	TCRBV03,TCRBV12													CASSEARRQFYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGCCCGGGCCATCAATGAAAAACTGTTTTTTGGCAGT	CASSARAINEKLFF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	42	TCRBV12						TCRBJ01	TCRBJ01-04	01	5	8	0	5	4	4	22	34	42	38	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSARAINEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTTGGGATTCGACCACAGATACGCAGTATTTTGGCCCA	CASSWDSTTDTQYF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	6	0	8	2	2	6	18	29	35	31	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWDSTTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGAGGACAGCATGAAGCTTTCTTTGGACAA	CSARDGGQHEAFF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	5	7	4	2	26	40	50	44	52		TCRBV20-01,TCRBV20-or09_02												CSARDGGQHEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGATCTCTAGCCAAAAACATTCAGTACTTCGGCGCC	CSARSLAKNIQYF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	39	TCRBV20						TCRBJ02	TCRBJ02-04	01	5	2	8	0	1	5	26	35	38	36	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARSLAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCAGGACAGGGGGAACCCTGAAGCTTTCTTTGGACAA	CSASQDRGNPEAFF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	1	6	5	4	26	35	50	40	54		TCRBV20-01,TCRBV20-or09_02												CSASQDRGNPEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGGACCATTCTAGCGGGGCAAGAGACCCAGTACTTCGGGCCA	CASRTILAGQETQYF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	4	3	2	7	0	23	34	-1	41	50	TCRBV06,TCRBV27													CASRTILAGQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTGGCTTACCGGGAAGCAGGGGATACGCAGTATTTTGGCCCA	CASSLAYREAGDTQYF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	48	unresolved						TCRBJ02	TCRBJ02-03	01	0	4	3	6	12	0	19	35	-1	47	52	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAYREAGDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGAGGCCCTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	4.7148395208326056E-4		44	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	9	1	0	1	4	26	40	47	41	51		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACAAGGCTCGGGGTTTGGCACTGAAGCTTTCTTTGGACAA	CSAREQGSGFGTEAFF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	3	4	8	5	26	40	53	48	58		TCRBV20-01,TCRBV20-or09_02												CSAREQGSGFGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGGCCAGTACTCTGGAGCAGTACTTCGGGCCG	CSAMASTLEQYF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	4	4	5	7	4	7	26	36	43	40	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAMASTLEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGACGGACAGGGCGAAAACACCATATATTTTGGAGAG	CATSDDGQGENTIYF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	3	6	3	3	24	39	50	42	53		TCRBV24-01,TCRBV24-or09_02												CATSDDGQGENTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACTCGTTCGAGAGATACAATGAGCAGTTCTTCGGGCCA	CASSDSFERYNEQFF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	2	4	4	3	23	40	47	44	50	TCRBV06,TCRBV10													CASSDSFERYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTATCGAGGGCGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLSRAGNQPQHF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	11	0	2	4	3	23	36	45	40	48	TCRBV06,TCRBV24,TCRBV27													CASSLSRAGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGAGACTAGCGGGAGGGCCAAGTAACACAGATACGCAGTATTTTGGCCCA	CASSLRLAGGPSNTDTQYF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	57	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	2	0	2	1	8	19	34	49	35	57		TCRBV05-06,TCRBV05-07												CASSLRLAGGPSNTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGCGGGTACCGAGGAGATACGCAGTATTTTGGCCCA	CASSVGGYRGDTQYF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	4	5	0	8	23	-1	44	39	52	TCRBV09,TCRBV21					01,02								CASSVGGYRGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGGACTAGCGGAGCGGGGGAGCAGTACTTCGGGCCG	CASSFGTSGAGEQYF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	0	5	7	1	7	26	40	52	41	59		TCRBV12-03,TCRBV12-04				01,02								CASSFGTSGAGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCCTATCCGGGACAGGGGGTAAGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	28	4.889463206789369E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	0	1	8	8	4	24	31	50	39	54	TCRBV06,TCRBV10													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGACAGGGTTATTGGCTACACCTTCGGTTCG	CASSQEDRVIGYTF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	7	1	4	26	43	51	44	55		TCRBV03-01,TCRBV03-02												CASSQEDRVIGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTGCAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSQGAGGTEAFF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	1	4	3	0	26	42	-1	45	52		TCRBV03-01,TCRBV03-02												CASSQGAGGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGAAGTGGTTTCGAAACACCATATATTTTGGAGAG		Out	VDJ	1	28	4.889463206789369E-4		43	TCRBV03						TCRBJ01	TCRBJ01-03	01	0	0	10	5	3	4	26	43	48	46	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTTGGCCCGGAATGAACACTGAAGCTTTCTTTGGACAA	CSARGWPGMNTEAFF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	1	1	8	0	8	1	26	39	50	47	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGWPGMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGTTGGAGGGGGATAGCGGGAGATACGCAGTATTTTGGCCCA	CASSWRGIAGDTQYF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	4	5	10	0	24	36	-1	46	53	TCRBV24,TCRBV28					01,02								CASSWRGIAGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCCCCGCGGGGAAACTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	28	4.889463206789369E-4		44	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	7	3	2	3	3	18	30	39	33	42	TCRBV07,TCRBV11													X+X+TCRBJ01-03	unresolved	TCRBD02-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GARGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTGGGGCCGGGGGGAATCCCCCAGCATTTTGGTGAT	CASSLGPGGIPQHF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	1	10	5	4	19	33	45	38	49	TCRBV04,TCRBV05,TCRBV11													CASSLGPGGIPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTGTGGGACTGAACACTGAAGCTTTCTTTGGACAA	CASSVGLNTEAFF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	5	0	7	0	2	0	26	38	-1	40	45	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGLNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACCGCCGGGACCGTATCGGGCTACACCTTCGGTTCG	CASSTAGTVSGYTF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	42	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	0	7	8	6	7	26	38	49	44	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTAGTVSGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAATTAACTACAATGAGCAGTTCTTCGGGCCA	CASSQINYNEQFF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	5	9	3	2	1	26	41	45	43	46		TCRBV03-01,TCRBV03-02				01,02								CASSQINYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACTAGCGGGAGAAGGAACAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	5.064086892746132E-4		53	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	2	2	3	0	8	26	-1	54	42	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCGGACAGGGGGCCCGTCAGATACGCAGTATTTTGGCCCA	CASSPRTGGPSDTQYF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	0	4	3	4	26	39	53	42	57		TCRBV03-01,TCRBV03-02												CASSPRTGGPSDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGGGCCTTTCAGGGGAGGGCGAGCAGTACTTCGGGCCG	CRGLSGEGEQYF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	9	9	0	6	11	0	26	31	-1	42	49		TCRBV20-01,TCRBV20-or09_02												CRGLSGEGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGAGGGCGGGACAGGTTATTCTACGAGCAGTACTTCGGGCCG	CSARGRDRLFYEQYF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	3	8	5	26	34	50	42	55		TCRBV20-01,TCRBV20-or09_02												CSARGRDRLFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGCTAGCGGGAGCCTTTACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	5.064086892746132E-4		44	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	4	2	2	3	6	26	34	47	37	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACAAGTTCTACGAGCAGTACTTCGGGCCG	CSARDKFYEQYF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	6	3	0	4	26	-1	42	37	46		TCRBV20-01,TCRBV20-or09_02												CSARDKFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGTCCGGGACTAGCGGGAGGGCCCCCCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	5.064086892746132E-4		53	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	0	0	4	6	6	26	35	57	41	63		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAAGTCAAGGGGACTGTCTGGAAACACCATATATTTTGGAGAG	CASKSRGLSGNTIYF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	7	0	10	1	7	1	23	33	46	40	47	TCRBV24,TCRBV27					01,02								CASKSRGLSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCAAACAAGTACCAAGAGACCCAGTACTTCGGGCCA	CATSDANKYQETQYF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	6	0	4	3	24	39	46	43	49		TCRBV24-01,TCRBV24-or09_02												CATSDANKYQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTGGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCTTCTCGGACAGGGGCAGCAGTACTTCGGGCCG	CASSLLGQGQQYF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	39				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	8	6	1	42	54	69	60	70	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASSLLGQGQQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCACTATATCGACAGATACGCAGTATTTTGGCCCA	CASSATISTDTQYF	In	VDJ	1	29	5.064086892746132E-4	6.146802602852964E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	9	3	3	5	24	36	43	39	48	TCRBV09,TCRBV21					01,02								CASSATISTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTTTCACATCCATTTACACGCACGAAACACCATATATTTTGGAGAG		Out	VDJ	1	30	5.238710578702895E-4		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	6	5	5	15	26	38	46	43	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTGGAGGACAGGGGGCCCAGGTCCGCAGTATTTTGGCCCA	CSAWRTGGPGPQYF	In	VDJ	1	30	5.238710578702895E-4	6.35876131329617E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	0	10	5	7	26	34	50	39	57		TCRBV20-01,TCRBV20-or09_02												CSAWRTGGPGPQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGCAGTTCTTACGAGCAGTACTTCGGGCCG	CSARSSSYEQYF	In	VDJ	1	30	5.238710578702895E-4	6.35876131329617E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	2	4	5	4	2	4	26	38	43	40	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARSSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGGGAGGAAGGACAGGTGAACACTGAAGCTTTCTTTGGACAA	CSARREEGQVNTEAFF	In	VDJ	1	30	5.238710578702895E-4	6.35876131329617E-4	48	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	1	4	0	9	0	26	38	-1	47	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARREEGQVNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGGCGGGAAAGCAGTTCTTCGGGCCA	CSARDLAGKQFF	In	VDJ	1	30	5.238710578702895E-4	6.35876131329617E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	7	3	11	4	1	26	40	50	44	51		TCRBV20-01,TCRBV20-or09_02												CSARDLAGKQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGTGAACTAGCGATGGGGCTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	5.238710578702895E-4		41	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	6	9	3	7	19	30	40	33	47	TCRBV05,TCRBV07					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGGGGTTGGAAACACCATATATTTTGGAGAG	CSARVGVGNTIYF	In	VDJ	1	31	5.413334264659658E-4	6.570720023739376E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	1	8	3	3	1	1	26	39	45	40	46		TCRBV20-01,TCRBV20-or09_02												CSARVGVGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCTGTGTACTTCTGTGCCAGCAGTAAAACCGGGACAGGGGATAGACTAGCGGGAGGACAATGAGCAGTTCTTCGGGCCA		Out	VDDJ	1	31	5.413334264659658E-4		61	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	2	1	5	3	0	12	40	-1	43	56		TCRBV06-02,TCRBV06-03												X+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCGACAGGGGCCCGGGGCTGAAGCTTTCTTTGGACAA	CSRQGPGAEAFF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	2	2	6	1	7	26	32	41	33	48		TCRBV20-01,TCRBV20-or09_02												CSRQGPGAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCGACAGGGGTTGGGAGAGCAGTACTTCGGGCCG	CSANRQGLGEQYF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	2	7	3	6	26	36	47	39	53		TCRBV20-01,TCRBV20-or09_02												CSANRQGLGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACGGACTAGCGGCAATCCCTGAGCAGTTCTTCGGGCCA	CSANGLAAIPEQFF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	5	9	2	7	26	36	48	38	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSANGLAAIPEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTGAAGGGAACTCCTACGAGCAGTACTTCGGGCCG	CSAIEGNSYEQYF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	4	0	8	0	5	1	26	36	45	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAIEGNSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCGTCTAGCGGCTACAATGAGCAGTTCTTCGGGCCA	CASSDSSSGYNEQFF	In	VDJ	1	33	5.762581636573184E-4	6.994637444625787E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	5	3	5	0	24	38	-1	43	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-04,TCRBV06-05,TCRBV06-06,TCRBV10-03				01,02								CASSDSSSGYNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCAAATCTAGGGGCACTGAAGCTTTCTTTGGACAA	CSARAKSRGTEAFF	In	VDJ	1	33	5.762581636573184E-4	6.994637444625787E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	4	8	0	26	39	-1	47	52		TCRBV20-01,TCRBV20-or09_02												CSARAKSRGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCAGGGGGCATGACACTGAAGCTTTCTTTGGACAA	CSARGRGHDTEAFF	In	VDJ	1	33	5.762581636573184E-4	6.994637444625787E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	0	3	1	3	26	39	48	40	51		TCRBV20-01,TCRBV20-or09_02												CSARGRGHDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAATCCGGACTAGCGGGACAGTCGAGCAGTACTTCGGGCCG	CASSLIRTSGTVEQYF	In	VDJ	1	33	5.762581636573184E-4	6.994637444625787E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	1	3	6	4	4	18	33	49	37	53	TCRBV07,TCRBV11													CASSLIRTSGTVEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAGARGACTCRGCYSYKTATCTYTGCGCCAGCAGCCAAGCAGGGGACAGGGGAAGAACCGGGGAGCTGTTTTTTGGAGAA	CASSQAGDRGRTGELFF	In	VDJ	1	34	5.937205322529948E-4	7.206596155068993E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	0	2	5	3	4	23	39	52	42	56	TCRBV01,TCRBV05													CASSQAGDRGRTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGGGGTTGGAAACACCATATATTTTGGAGAG	CSARVGVGNTIYF	In	VDJ	1	34	5.937205322529948E-4	7.206596155068993E-4	39	TCRBV20						TCRBJ01	TCRBJ01-03	01	1	6	1	3	1	1	26	39	45	40	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVGVGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCGGACAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAADSSYNEQFF	In	VDJ	1	34	5.937205322529948E-4	7.206596155068993E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	5	0	2	0	26	35	-1	37	43		TCRBV20-01,TCRBV20-or09_02												CSAADSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGGGACAGGGGAAAGGAAACACCATATATTTTGGAGAG	CASSPGQGKGNTIYF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	2	4	2	3	26	38	50	40	53		TCRBV12-03,TCRBV12-04												CASSPGQGKGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGATCACTATCCAGGACTAGGGTTATCAATGAGCAGTTCTTCGGGCCA	CASRSLSRTRVINEQFF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	8	6	11	6	26	37	55	48	61		TCRBV03-01,TCRBV03-02				01,02								CASRSLSRTRVINEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGGGGGGTCTCTGGCTACACCTTCGGTTCG	CASSQDWGVSGYTF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	9	1	7	2	4	26	43	51	45	55		TCRBV03-01,TCRBV03-02												CASSQDWGVSGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGTTAAGAGGCTAGCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQAVKRLAGTGELFF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	54	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	4	4	4	11	0	26	42	-1	53	61		TCRBV03-01,TCRBV03-02				01,02								CASSQAVKRLAGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACTCCCCGACAGGGGGAAGAACTGAAGCTTTCTTTGGACAA	CASSHSPTGGRTEAFF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	5	6	4	26	40	55	46	59		TCRBV03-01,TCRBV03-02												CASSHSPTGGRTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTCCCCGGGACGGACAAAATCAGCCCCAGCATTTTGGTGAT	CSAIPRDGQNQPQHF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	4	0	7	4	6	6	26	36	47	42	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAIPRDGQNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAGCCGGGACAGGGGGCTACACCTTCGGTTCG		Out	VDJ	1	35	6.111829008486711E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	8	4	0	24	39	-1	43	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAAATAGACCAAACATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	35	6.111829008486711E-4		50	unresolved						TCRBJ01	TCRBJ01-05	01	2	2	7	0	4	6	23	38	45	42	51	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTTACTTCTTGGGACAGGGTGAAGCTTTCTTTGGACAA	CSAPYFLGQGEAFF	In	VDJ	1	36	6.286452694443474E-4	7.630513575955404E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	7	12	0	26	34	-1	46	55		TCRBV20-01,TCRBV20-or09_02												CSAPYFLGQGEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCCGGAGGAATACTGAAGCTTTCTTTGGACAA	CSARGRRNTEAFF	In	VDJ	1	36	6.286452694443474E-4	7.630513575955404E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	1	5	5	3	26	37	47	42	50		TCRBV20-01,TCRBV20-or09_02												CSARGRRNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGGTTAGCGGGAAACTTACTCTCGAGCAGTACTTCGGGCCG	CSASGVSGKLTLEQYF	In	VDJ	1	36	6.286452694443474E-4	7.630513575955404E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	3	6	6	10	26	37	51	43	61		TCRBV20-01,TCRBV20-or09_02												CSASGVSGKLTLEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTAGCTTTCCGTCCTTTGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CSVSFPSFGSNQPQHF	In	VDJ	1	36	6.286452694443474E-4	7.630513575955404E-4	48	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	0	10	0	13	0	26	37	-1	50	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVSFPSFGSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCGTGGACAGATACAGATACGCAGTATTTTGGCCCA	CASSSWTDTDTQYF	In	VDJ	1	36	6.286452694443474E-4	7.630513575955404E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	5	3	4	2	24	36	46	40	48		TCRBV24-01,TCRBV24-or09_02												CASSSWTDTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGACGGGGTTCACCTATGGCTACACCTTCGGTTCG	CASSLSTGFTYGYTF	In	VDJ	1	36	6.286452694443474E-4	7.630513575955404E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	3	4	7	5	24	36	48	43	53	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSTGFTYGYTF+X+TCRBJ01-02		TCRBD02-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGCGGATACAAGAACCCCCAGTACTTCGGGCCA	CASSQEGGYKNPQYF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	7	5	9	2	11	26	43	49	45	60		TCRBV03-01,TCRBV03-02				01,02								CASSQEGGYKNPQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCAAATGCAGGGACAGTCAACAATGAGCAGTTCTTCGGGCCA	CSASNAGTVNNEQFF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	5	5	10	3	26	34	51	44	54		TCRBV20-01,TCRBV20-or09_02												CSASNAGTVNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACCCCCGTTGACAGATACGCAGTATTTTGGCCCA	CSAREPPLTDTQYF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	0	3	7	3	0	8	26	-1	42	40	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREPPLTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGCAATTGGGCGGGGGCGAGGCGGAGCGAGCAGTACTTCGGGCCG	CSARNWAGARRSEQYF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	2	6	9	10	26	35	51	44	61		TCRBV20-01,TCRBV20-or09_02												CSARNWAGARRSEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGGCGGGAGGGCGAGAGACCCAGTACTTCGGGCCA	CSARAGGRETQYF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	7	0	4	3	2	26	35	47	38	49		TCRBV20-01,TCRBV20-or09_02												CSARAGGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGTTATTAAGGGACTAGCGCATCGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	37	6.461076380400237E-4		49	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	6	5	8	5	22	34	52	42	57		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGCAAGGTCGGCAGGGGGGAGGAATGAGCAGTTCTTCGGGCCA	CASSSARSAGGRNEQFF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	51				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	1	7	8	4	18	35	50	43	54	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSSARSAGGRNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCGGAGGGTAAAGCTTTCTTTGGACAA	CSARDSEGKAFF	In	VDJ	1	38	6.635700066357001E-4	8.054430996841816E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	0	9	3	2	26	40	49	43	51		TCRBV20-01,TCRBV20-or09_02												CSARDSEGKAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGGCTAGCGGGATAGAAGAGTACTTCGGCGCC	CSASWASGIEEYF	In	VDJ	1	38	6.635700066357001E-4	8.054430996841816E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	4	3	14	5	6	26	37	51	42	57		TCRBV20-01,TCRBV20-or09_02												CSASWASGIEEYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATCCCCCAAGGGGGCGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	39	6.810323752313764E-4		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	0	1	8	1	26	38	53	46	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGGGTTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQEGVGTGELFF	In	VDJ	1	39	6.810323752313764E-4	8.266389707285021E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	5	2	4	0	4	26	-1	48	43	52		TCRBV03-01,TCRBV03-02												CASSQEGVGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGGCAGTATGCCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	39	6.810323752313764E-4		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	8	0	5	1	8	26	42	47	43	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTACAGGGGGGGGAAGTCAATGAGCAGTTCTTCGGGCCA	CSALQGGEVNEQFF	In	VDJ	1	39	6.810323752313764E-4	8.266389707285021E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	1	6	2	7	26	35	45	37	52		TCRBV20-01,TCRBV20-or09_02												CSALQGGEVNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGTACGCTCAAGAGACCCAGTACTTCGGGCCA	CASSLSYAQETQYF	In	VDJ	1	39	6.810323752313764E-4	8.266389707285021E-4	42							TCRBJ02	TCRBJ02-05	01	6	3	7	2	7	3	24	36	45	43	48	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSYAQETQYF+X+TCRBJ02-05			TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
SGACTCGGCYSTGTATCTCTGTGCCAGCAGCTCCCGGGGGGGATCAATGGACCCAGATACGCAGTATTTTGGCCCA	CASSSRGGSMDPDTQYF	In	VDJ	1	39	6.810323752313764E-4	8.266389707285021E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	0	4	2	11	19	32	42	34	53	TCRBV05,TCRBV07													CASSSRGGSMDPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAATTCGACAGTCGCTACGAGCAGTACTTCGGGCCG	CASSEFDSRYEQYF	In	VDJ	1	39	6.810323752313764E-4	8.266389707285021E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	3	7	3	23	34	46	41	49	TCRBV09,TCRBV12													CASSEFDSRYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGATCTTGGGCCCCAGCATTTTGGTGAT	CASSFDLGPQHF	In	VDJ	1	40	6.984947438270527E-4	8.478348417728227E-4	36	TCRBV12						TCRBJ01	TCRBJ01-05	01	3	0	10	9	7	0	26	40	-1	47	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFDLGPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTAGGACGGGAGGGAGCAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	40	6.984947438270527E-4		47	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	8	0	3	7	4	26	37	52	44	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGAGCCATGAACAGGGTCCTCTTTCCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	41	7.15957112422729E-4		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	3	3	0	8	9	26	31	45	39	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGTTACCGGGACTAGCGGGAGAAATACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	41	7.15957112422729E-4		52	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	0	2	5	4	4	24	36	54	40	58	TCRBV24,TCRBV28													X+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTATGCGCCCAGGCGGCAAGAGACCCAGTACTTCGGGCCA	CSARDYAPRRQETQYF	In	VDJ	1	42	7.334194810184054E-4	8.902265838614638E-4	48	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	4	4	2	9	3	26	40	53	49	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDYAPRRQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGAGGAGGCCCGCGCGGGAGATGAGCAGTTCTTCGGGCCA	CASSEEARAGDEQFF	In	VDJ	1	42	7.334194810184054E-4	8.902265838614638E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	2	8	12	0	22	34	-1	46	53		TCRBV12-03,TCRBV12-04												CASSEEARAGDEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCGCTATTTATAGGGACCCCAATGAGCAGTTCTTCGGGCCA	CASAIYRDPNEQFF	In	VDJ	1	42	7.334194810184054E-4	8.902265838614638E-4	42	unresolved						TCRBJ02	TCRBJ02-01	01	8	0	7	6	10	2	22	31	46	41	48	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASAIYRDPNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTACATCTGCAGTGCTAGAATCGAGGGGACAGGTCTTTCAACAGGAGCGGGTTTAAGTGAAAAACTGTTTTTTGGCAGT	CSARIEGTGLSTGAGLSEKLFF	In	VDJ	1	42	7.334194810184054E-4	8.902265838614638E-4	66	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	4	7	6	24	7	19	33	25	57		TCRBV20-01,TCRBV20-or09_02												CSARIEGTGLSTGAGLSEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGACCCGGACTAGCGGGAGGAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSARPGLAGGGSYNEQFF	In	VDJ	1	43	7.508818496140817E-4	9.114224549057843E-4	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	1	1	1	3	4	26	38	55	41	59		TCRBV20-01,TCRBV20-or09_02												CSARPGLAGGGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCTACTGGAACAATGAGCAGTTCTTCGGGCCA	CSAAYWNNEQFF	In	VDJ	1	43	7.508818496140817E-4	9.114224549057843E-4	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	1	8	5	7	0	26	35	-1	42	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAAYWNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTGGGGATTGGGGAGTCGCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	43	7.508818496140817E-4		49	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	2	2	9	3	24	36	50	45	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTAAGGGACTAGCAGTCAATGAGCAGTTCTTCGGGCCA	CSARDLKGLAVNEQFF	In	VDJ	1	44	7.68344218209758E-4	9.326183259501049E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	7	6	6	3	26	40	55	46	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLKGLAVNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCAAGACAGGGGGCTAATGGCTACACCTTCGGTTCG	CATSDPRQGANGYTF	In	VDJ	1	44	7.68344218209758E-4	9.326183259501049E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	0	6	5	2	24	38	53	43	55		TCRBV24-01,TCRBV24-or09_02												CATSDPRQGANGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGGACCCGCGGATACACTGAAGCTTTCTTTGGACAA	CATSDRTRGYTEAFF	In	VDJ	1	44	7.68344218209758E-4	9.326183259501049E-4	45	TCRBV24						TCRBJ01	TCRBJ01-01	01	4	1	7	3	2	8	24	38	44	40	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDRTRGYTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGTGGGGGGCGCTGGGCCGGGGAGCTGTTTTTTGGAGAA	CATGGGRWAGELFF	In	VDJ	1	44	7.68344218209758E-4	9.326183259501049E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	6	0	6	0	6	24	-1	43	37	49		TCRBV24-01,TCRBV24-or09_02												CATGGGRWAGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGGGGGGGACTAGCCTAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	44	7.68344218209758E-4		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	7	0	3	4	18	29	41	32	45	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCAAGGGGGACTAAGCACAGATACGCAGTATTTTGGCCCA	CASSQGGLSTDTQYF	In	VDJ	1	44	7.68344218209758E-4	9.326183259501049E-4	45	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	9	0	5	0	19	31	-1	36	43		TCRBV05-06,TCRBV05-07				01,02								CASSQGGLSTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCACCTACCAAGACAGGGCCAGGGGCAACGTCCTGACTTTCGGGGCC	CATYQDRARGNVLTF	In	VDJ	1	44	7.68344218209758E-4	9.326183259501049E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	9	2	3	9	8	7	23	30	45	38	52	TCRBV09,TCRBV12													CATYQDRARGNVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGCGAGGGTGTAAGAGCAGTTCTTCGGGCCA		Out	VDJ	1	45	7.858065868054343E-4		44	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	0	10	5	5	26	43	53	48	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCAGGGGGGCTAGCGGGAGGAACCCAAGAGACCCAGTACTTCGGGCCA	CASSHPGGLAGGTQETQYF	In	VDJ	1	45	7.858065868054343E-4	9.538141969944255E-4	57	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	4	1	1	10	3	24	38	59	48	62		TCRBV03-01,TCRBV03-02												CASSHPGGLAGGTQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTAGACAAGGTTCAAGCACCGGGGAGCTGTTTTTTGGAGAA	CSAPRQGSSTGELFF	In	VDJ	1	46	8.032689554011106E-4	9.750100680387461E-4	45	TCRBV20						TCRBJ02	TCRBJ02-02	01	5	2	6	4	4	9	26	35	43	39	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPRQGSSTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCGTCTAGCGGGAGGGCCGCTTGGCGGGGAGACCCAGTACTTCGGGCCA	CASSRLAGGPLGGETQYF	In	VDJ	1	46	8.032689554011106E-4	9.750100680387461E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	4	0	5	3	12	18	30	45	33	57	TCRBV07,TCRBV11													CASSRLAGGPLGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACAGGGGATCACCTATGGCTACACCTTCGGTTCG	CASSQQGITYGYTF	In	VDJ	1	47	8.20731323996787E-4	9.962059390830665E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	2	4	0	5	26	-1	47	41	52		TCRBV03-01,TCRBV03-02												CASSQQGITYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGCACAGCGGGAGCCCCTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	47	8.20731323996787E-4		52	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	6	2	3	5	5	26	42	55	47	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCAGAGAACTAGGCGCCCAGTACTTCGGGCCA		Out	VDJ	1	47	8.20731323996787E-4		38	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	3	8	9	7	3	26	38	50	45	53		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTTCTGGTGGCGGCTAAAAGTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	47	8.20731323996787E-4		56	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	7	5	0	10	7	25	38	52	48	59		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGAACAGGGGGCCGCGAGCAGTACTTCGGGCCG	CASRTGGREQYF	In	VDJ	1	48	8.381936925924632E-4	0.0010174018101273873	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	0	6	1	2	26	37	47	38	49	TCRBV12,TCRBV21													CASRTGGREQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGCCCTAGCGGGAGGGCTTTACCTAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	48	8.381936925924632E-4		55	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	4	0	5	4	8	26	41	57	45	65		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCARCCAGACMKMTCTKTACYWCTGTGCCAGCAGCGCTTCCACCCAAGTGGGAGAAAAACTGTTTTTTGGCAGT	CASSASTQVGEKLFF	In	VDJ	1	48	8.381936925924632E-4	0.0010174018101273873	45	unresolved						TCRBJ01	TCRBJ01-04	01	4	0	8	8	16	0	22	32	-1	48	52	TCRBV08,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSASTQVGEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGTCGGGGGACGCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	48	8.381936925924632E-4		43	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	8	2	4	3	4	24	38	47	41	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCGCGGACTAGCGGGAGCCGTGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	48	8.381936925924632E-4		55	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	1	2	5	3	7	24	41	57	44	64		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTCCTCCAGGGGACGAGCAGTACTTCGGGCCG	CSAPPPGDEQYF	In	VDJ	1	49	8.556560611881395E-4	0.0010385976811717078	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	2	5	8	0	26	34	-1	42	48		TCRBV20-01,TCRBV20-or09_02												CSAPPPGDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAACCCTCTTGTCGCGGGAGACATCTACGAGCAGTACTTCGGGCCG	CSANPLVAGDIYEQYF	In	VDJ	2	50	8.731184297838158E-4	0.0010597935522160284	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	7	2	3	13	4	26	34	54	47	58		TCRBV20-01,TCRBV20-or09_02												CSANPLVAGDIYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAAAGGATCTGGGACAGGGGTAACTATGGCTACACCTTCGGTTCG	CSARERIWDRGNYGYTF	In	VDJ	2	50	8.731184297838158E-4	0.0010597935522160284	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	1	11	0	26	37	-1	48	58		TCRBV20-01,TCRBV20-or09_02												CSARERIWDRGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACGGGGGATGGCTGGAAACACCATATATTTTGGAGAG	CASSLRGMAGNTIYF	In	VDJ	2	51	8.905807983794922E-4	0.001080989423260349	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	2	8	2	2	0	4	26	-1	47	41	51		TCRBV12-03,TCRBV12-04												CASSLRGMAGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGACAGGGGAAAGGGAAAAACTGTTTTTTGGCAGT	CASSQVTGEREKLFF	In	VDJ	2	51	8.905807983794922E-4	0.001080989423260349	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	2	2	8	1	5	26	42	51	43	56		TCRBV03-01,TCRBV03-02												CASSQVTGEREKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCGACAGGGGAACTATGGCTACACCTTCGGTTCG	CASSRQGNYGYTF	In	VDJ	2	52	9.080431669751685E-4	0.0011021852943046695	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	2	2	2	0	26	37	-1	39	47		TCRBV03-01,TCRBV03-02												CASSRQGNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGGCATGTTCATTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT	CASSRHVHFWHHQPQHF	In	VDJ	2	53	9.255055355708448E-4	0.00112338116534899	51	TCRBV03						TCRBJ01	TCRBJ01-05	01	5	5	4	5	0	19	26	-1	41	38	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRHVHFWHHQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTAACTACAGGGGAACTCGGAACATTCAGTACTTCGGCGCC	CSATNYRGTRNIQYF	In	VDJ	2	53	9.255055355708448E-4	0.00112338116534899	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	3	2	7	6	7	26	36	49	42	56		TCRBV20-01,TCRBV20-or09_02												CSATNYRGTRNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTGAAGGCCGGGCTGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	53	9.255055355708448E-4		41	TCRBV20						TCRBJ01	TCRBJ01-05	01	8	8	0	2	8	3	26	32	44	40	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCATGGGGGGACTTCAAACCTACGAGCAGTACTTCGGGCCG	CASSMGGLQTYEQYF	In	VDJ	2	53	9.255055355708448E-4	0.00112338116534899	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	10	2	6	5	24	35	47	41	52		TCRBV24-01,TCRBV24-or09_02				01,02								CASSMGGLQTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAAGGGGCGCGGCGGTTCCAGCCGGCGAGCAGTACTTCGGGCCG	CASSQERGAAVPAGEQYF	In	VDJ	2	53	9.255055355708448E-4	0.00112338116534899	54				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	2	6	1	18	18	35	41	36	59	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQERGAAVPAGEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCRGGRGACWCAGCWSKGTATYTCTGTGCCAGCAGCTTAACTACAGGACTAGATACGCAGTATTTTGGCCCA	CASSLTTGLDTQYF	In	VDJ	2	53	9.255055355708448E-4	0.00112338116534899	42	unresolved						TCRBJ02	TCRBJ02-03	01	2	3	4	5	3	3	22	37	45	40	48	TCRBV07,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTTGLDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTACCCCTCCGTGGGGTGAGCAGTTCTTCGGGCCA	CASSTPPWGEQFF	In	VDJ	2	54	9.429679041665211E-4	0.0011445770363933106	39	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	6	2	9	10	0	24	36	-1	46	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTPPWGEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGAGGGGACTAGCAAACTATGGCTACACCTTCGGTTCG	CSARRGLANYGYTF	In	VDJ	2	55	9.604302727621974E-4	0.0011657729074376311	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	0	7	2	6	1	26	34	49	40	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRGLANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGAGGAGACAGGGGGCTCTGGCTACACCTTCGGTTCG	CASSLEETGGSGYTF	In	VDJ	2	55	9.604302727621974E-4	0.0011657729074376311	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	0	7	4	2	18	34	48	38	50	TCRBV07,TCRBV11													CASSLEETGGSGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTTCGGGAGGGCAGAGCAGATACGCAGTATTTTGGCCCA	CSAFREGRADTQYF	In	VDJ	2	56	9.778926413578739E-4	0.0011869687784819517	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	0	4	3	5	26	35	46	38	51		TCRBV20-01,TCRBV20-or09_02												CSAFREGRADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCCCAGGGTAAACTATGGCTACACCTTCGGTTCG	CASSQGPRVNYGYTF	In	VDJ	2	57	9.953550099535502E-4	0.0012081646495262722	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	3	2	4	2	26	42	51	46	53		TCRBV03-01,TCRBV03-02												CASSQGPRVNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTCCTGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLAPGATNEKLFF	In	VDJ	2	58	0.0010128173785492263	0.0012293605205705928	48							TCRBJ01	TCRBJ01-04	01	0	6	2	0	4	0	18	35	-1	39	43	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAPGATNEKLFF+X+TCRBJ01-04			TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTGGTTCGGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	59	0.0010302797471449026		46	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	8	4	5	7	0	26	43	-1	50	54		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCGGCCCCTCCGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	59	0.0010302797471449026		46	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	7	5	4	1	7	26	42	47	43	54		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGCCTAGCGGGAGGGCCGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSQGLAGGPSYNEQFF	In	VDJ	2	59	0.0010302797471449026	0.0012505563916149133	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	0	3	4	5	26	40	56	44	61		TCRBV03-01,TCRBV03-02												CASSQGLAGGPSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGGACCCAGGGGGAGGCTTTCTTTGGACAA	CATSDRTQGEAFF	In	VDJ	2	59	0.0010302797471449026	0.0012505563916149133	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	1	11	7	2	24	38	52	45	54		TCRBV24-01,TCRBV24-or09_02												CATSDRTQGEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGCACCGACAGGGAAGCTACGAACAATGAGCAGTTCTTCGGGCCA	CASSTDREATNNEQFF	In	VDJ	2	59	0.0010302797471449026	0.0012505563916149133	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	5	4	9	26	37	48	41	57	TCRBV06,TCRBV10													CASSTDREATNNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGAAGCTTGGTTCAGGAGGGGAAGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	60	0.001047742115740579		47	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	10	0	6	4	4	18	34	44	38	48	TCRBV05,TCRBV07													X+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTAGCCCGAGCCCCCACTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	61	0.0010652044843362553		46				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	10	3	12	0	35	50	-1	62	65	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01				01,02								X+X+TCRBJ02-07		TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTGGGGGGATTATCTGATATGAAGCTTTCTTTGGACAA		Out	VDJ	2	61	0.0010652044843362553		43	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	1	7	2	11	26	37	45	39	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTTCGGGACCGCAATTGGGAGCAGTACTTCGGGCCR	CASSFRDRNWEQYF	In	VDJ	2	61	0.0010652044843362553	0.0012929481337035544	42	unresolved						TCRBJ02	unresolved		3	0	7	11	2	12	18	32	39	34	51	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-05,TCRBJ02-07						CASSFRDRNWEQYF+X+TCRBJ02-X	unresolved		unresolved	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCGACTAGCGGCAGCACAGATACGCAGTATTTTGGCCCA	CASSPTSGSTDTQYF	In	VDJ	2	65	0.0011350539587189606	0.0013777316178808369	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	5	0	3	1	26	37	49	40	50		TCRBV03-01,TCRBV03-02				01,02								CASSPTSGSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGCGGATGAGGGACTCCTACGAGCAGTACTTCGGGCCG	CSARRMRDSYEQYF	In	VDJ	2	67	0.0011699786959103132	0.001420123359969478	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	0	0	9	1	26	34	48	43	49		TCRBV20-01,TCRBV20-or09_02												CSARRMRDSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTAAGACCCGGGGTAGCGGGAGATATATACGAGCAGTACTTCGGGCCG	CSVRPGVAGDIYEQYF	In	VDJ	2	67	0.0011699786959103132	0.001420123359969478	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	5	2	4	12	5	26	33	54	45	59		TCRBV20-01,TCRBV20-or09_02												CSVRPGVAGDIYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGGCGTCCGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARAASVSYNEQFF	In	VDJ	2	69	0.0012049034331016659	0.001462515102058119	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	1	9	0	0	1	6	26	39	43	40	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARAASVSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGGTTAGGGGACTCGAACACTAAAGCTTTCTTTGGACAA		Out	VDJ	2	72	0.0012572905388886948		50	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	0	10	9	8	9	26	42	56	50	65		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGAGGGAGGGCGCCGGGGAGCTGTTTTTTGGAGAA	CSAGREGAGELFF	In	VDJ	2	72	0.0012572905388886948	0.0015261027151910807	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	0	6	0	6	26	-1	42	35	48		TCRBV20-01,TCRBV20-or09_02												CSAGREGAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGACCGGACAGGGTTGTATGGCTACACCTTCGGTTCG	XASSQDRTGLYGYTF	In	VDJ	2	74	0.0012922152760800475	0.0015684944572797218	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	5	2	3	23	40	50	42	53	TCRBV01,TCRBV04													XASSQDRTGLYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGACTAGCGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSRLAAYNEQFF	In	VDJ	2	75	0.0013096776446757238	0.0015896903283240424	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	5	2	0	0	26	-1	-1	39	48		TCRBV03-01,TCRBV03-02				01,02								CASSRLAAYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGTCAGTATCCATTTCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	75	0.0013096776446757238		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	5	5	3	17	26	38	44	41	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGCGGACAGGGGGCAGGAGCAATCAGCCCCAGCATTTTGGTGAT	CSAKRTGGRSNQPQHF	In	VDJ	2	76	0.0013271400132714001	0.0016108861993683631	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	0	1	5	3	26	34	50	39	53		TCRBV20-01,TCRBV20-or09_02												CSAKRTGGRSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGCGGGAGGGCCGTTGGTTATGACAGATACGCAGTATTTTGGCCCA	CASSAGGPLVMTDTQYF	In	VDJ	2	76	0.0013271400132714001	0.0016108861993683631	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	8	0	3	0	12	23	-1	44	36	56	TCRBV02,TCRBV09													CASSAGGPLVMTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGAACGTCCAACACACCACCTACGAGCAGTACTTCGGGCCG	CASRNVQHTTYEQYF	In	VDJ	2	77	0.0013446023818670765	0.0016320820704126837	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	6	2	9	5	23	34	46	43	51	TCRBV02,TCRBV12													CASRNVQHTTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACATCAGGGATTTTGGAGGCGAGCAGTACTTCGGGCCG	CSARDIRDFGGEQYF	In	VDJ	2	78	0.0013620647504627528	0.0016532779414570042	45	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	4	3	6	3	10	26	40	48	43	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDIRDFGGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGAGCAGGGTGGGGAGCTGTTTTTTGGAGAA	CASEQGGELFF	In	VDJ	2	80	0.0013969894876541054	0.0016956696835456453	33	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	4	3	8	3	1	26	35	43	38	44		TCRBV03-01,TCRBV03-02												CASEQGGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCCAACAGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CATSAQQGAYNEQFF	In	VDJ	2	80	0.0013969894876541054	0.0016956696835456453	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	1	2	4	0	24	37	-1	41	49		TCRBV24-01,TCRBV24-or09_02												CATSAQQGAYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCAACCGGGTCAGGCAGGGGAGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSQANRVRQGRDYNEQFF	In	VDJ	3	83	0.0014493765934411344	0.001759257296678607	60	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	9	0	3	17	1	15	31	55	48	56		TCRBV03-01,TCRBV03-02												CASSQANRVRQGRDYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGATACTTCCCATCTTTCTCTGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	88	0.001536688436419516		49	TCRBV03						TCRBJ02	TCRBJ02-05	01	4	1	8	5	0	18	26	-1	42	39	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCAAAGAGTGGCAGCGCGGGGACAAAAACATTCAGTACTTCGGCGCC	CASTKEWQRGDKNIQYF	In	VDJ	3	90	0.0015716131736108687	0.001907628393988851	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	0	7	3	3	8	1	26	43	57	51	58		TCRBV03-01,TCRBV03-02												CASTKEWQRGDKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01*01	TCRBJ02-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCACCCTTGCGGTAGCGGGAGAGTACAATGAGCAGTTCTTCGGGCCA	CASTLAVAGEYNEQFF	In	VDJ	3	90	0.0015716131736108687	0.001907628393988851	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	5	2	4	9	2	23	33	51	42	53	TCRBV02,TCRBV21													CASTLAVAGEYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCCTTAGCGGGACCGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	93	0.0016240002793978976		47	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	3	1	6	2	26	37	51	43	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTCCGTAAGGGACAGGGCGAACGAGCAGTACTTCGGGCCG	CATSVRDRANEQYF	In	VDJ	3	94	0.001641462647993574	0.001992411878166133	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	0	3	5	7	3	24	33	49	40	52		TCRBV24-01,TCRBV24-or09_02												CATSVRDRANEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCACGTGGACAGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSTWTASTDTQYF	In	VDJ	3	94	0.001641462647993574	0.001992411878166133	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	5	0	3	2	24	37	46	40	48	TCRBV12,TCRBV21													CASSTWTASTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCATCCTTCGGGGTAGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	97	0.0016938497537806027		41	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	8	3	3	5	5	23	33	43	38	48	TCRBV01,TCRBV17													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCCCTTGACAGGGGAGGTTTTTACGAGCAGTACTTCGGGCCG	CSAPLDRGGFYEQYF	In	VDJ	3	99	0.0017287744909719553	0.002098391233387736	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	4	7	7	26	34	49	41	56		TCRBV20-01,TCRBV20-or09_02												CSAPLDRGGFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGACAGGACAGGGGCGGCTACACCTTCGGTTCG		Out	VDJ	3	100	0.0017462368595676317		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	2	8	5	1	24	38	52	43	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTCCCAAGGGAGACTATGGCTACACCTTCGGTTCG	CSVPKGDYGYTF	In	VDJ	3	104	0.001816086333950337	0.002204370588609339	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	9	2	3	7	0	26	33	-1	40	45		TCRBV20-01,TCRBV20-or09_02												CSVPKGDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAACAACTAGCCAAAATGAACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	112	0.0019557852827157478		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	3	7	0	3	8	23	33	42	36	50	TCRBV09,TCRBV21					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTGTCTAATGACTCCACGAGCAGTACTTCGGGCCG		Out	VDJ	3	114	0.0019907100199071004		41	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	10	5	9	2	24	36	49	45	51	TCRBV06,TCRBV24					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGTTCACAGGGTCCCGTGGCTAGCGGACGATACAATGAGCAGTTCTTCGGGCCA	CSASSQGPVASGRYNEQFF	In	VDJ	4	118	0.0020605594942898053	0.0025011127832298267	57	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	5	4	20	4	24	32	59	52	63		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSQGPVASGRYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCTCCGGGGGGGTATACTATGGCTACACCTTCGGTTCG	CASSSSGGVYYGYTF	In	VDJ	4	119	0.0020780218628854816	0.0025223086542741475	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	0	3	4	3	18	31	43	35	46	TCRBV07,TCRBV11													CASSSSGGVYYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTCGTATTCGATAGCGGGAGAGGCGAGCAGTACTTCGGGCCG	CASSFVFDSGRGEQYF	In	VDJ	4	124	0.002165333705863863	0.0026282880094957504	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	5	2	6	9	3	18	32	50	41	53	TCRBV05,TCRBV11													CASSFVFDSGRGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGCGCCCCCGGGGGCTACATATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	128	0.0022351831802465685		47	TCRBV24						TCRBJ02	TCRBJ02-01	01	5	6	0	8	9	5	24	37	52	46	57		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTGGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSWGANTEAFF	In	VDJ	4	130	0.002270107917437921	0.0027554632357616737	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	6	0	1	2	0	24	36	-1	38	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGANTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGGAGAGACAGGGGGCAGGCCTACGAGCAGTACTTCGGGCCG	CATGRDRGQAYEQYF	In	VDJ	4	146	0.0025495058149687423	0.0030945971724708025	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	2	0	2	6	3	24	33	49	39	52		TCRBV24-01,TCRBV24-or09_02												CATGRDRGQAYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACACAGACAGGGGGCGTCACTGAAGCTTTCTTTGGACAA	CATQTGGVTEAFF	In	VDJ	5	153	0.0026717423951384766	0.0032429682697810466	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	2	0	4	4	2	23	30	44	34	46	TCRBV06,TCRBV10													CATQTGGVTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCGGAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDRRNTGELFF	In	VDJ	5	154	0.002689204763734153	0.0032641641408253674	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	10	2	1	2	0	23	40	-1	42	46	TCRBV01,TCRBV04													CASSQDRRNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTTCCGAGCCCTACGAGCAGTACTTCGGGCCG	CASSFSEPYEQYF	In	VDJ	5	165	0.0028812908182865925	0.0034973187223128937	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	6	7	2	7	0	24	36	-1	43	46		TCRBV24-01,TCRBV24-or09_02				01,02								CASSFSEPYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGCGGGAGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGGTGELFF	In	VDJ	5	168	0.0029336779240736214	0.003560906335445855	42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	9	1	5	0	1	18	-1	41	35	42	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGGTGELFF+X+TCRBJ02-02		TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCGGGGACCTCGAGAAATGGCTACACCTTCGGTTCG	CASSPGTSRNGYTF	In	VDJ	5	177	0.0030908392414347083	0.0037516691748447403	42	TCRBV24						TCRBJ01	TCRBJ01-02	01	6	0	7	6	3	8	24	36	44	39	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGTSRNGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGCATCAGGGTAAGAGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	179	0.003125763978626061		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	3	1	5	6	26	40	50	45	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATACAGGAGATACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	182	0.00317815108441309		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	4	2	1	6	26	43	49	44	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACAGGGGGTCCCAAGAGACCCAGTACTTCGGGCCA	CASSQDRGSQETQYF	In	VDJ	6	193	0.003370237138965529	0.004090803111553869	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	1	1	0	2	23	-1	47	40	49	TCRBV01,TCRBV04													CASSQDRGSQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGGCCCACTATGGCTACACCTTCGGTTCG	CASSSAHYGYTF	In	VDJ	7	227	0.003963957671218524	0.004811462727060768	36	TCRBV12						TCRBJ01	TCRBJ01-02	01	4	9	0	3	1	2	26	39	43	40	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSAHYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAATCTAACTATGGCTACACCTTCGGTTCG	CASSQESNYGYTF	In	VJ	7	237	0.004138581357175287	0.005023421437503974	39	unresolved						TCRBJ01	TCRBJ01-02	01	0	0	0	0	0	2	23	-1	40	-1	42	TCRBV01,TCRBV04													CASSQESNYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCGCCGGACTTGACACAGATACGCAGTATTTTGGCCCA	CASAGLDTDTQYF	In	VDJ	8	262	0.004575140572067195	0.005553318213611988	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	1	10	2	3	3	23	32	40	35	43	TCRBV09,TCRBV12					01,02								CASAGLDTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCGTGGAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSSRGGGTEAFF	In	VDJ	9	286	0.004994237418363427	0.006062019118675682	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	4	5	1	4	7	0	26	39	-1	46	52		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRGGGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCACTCGGCACAGATACGCAGTATTTTGGCCCA	CASSLALGTDTQYF	In	VDJ	11	363	0.006338839800230503	0.007694101189088366	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	10	1	0	2	18	-1	38	35	40	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLALGTDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGGGACAGGGAATGGCTACACCTTCGGTTCG	CSARDGTGNGYTF	In	VDJ	16	538	0.00939475430447386	0.011403378621844465	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	3	6	1	1	26	40	50	41	51		TCRBV20-01,TCRBV20-or09_02												CSARDGTGNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTTCTCGGACAGGGGCAGCAGTACTTCGGGCCG	CASSLLGQGQQYF	In	VDJ	24	778	0.013585722767436175	0.0164903876724814	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	8	6	1	24	36	51	42	52		TCRBV24-01,TCRBV24-or09_02												CASSLLGQGQQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGACAGGGGCATGAACACTGAAGCTTTCTTTGGACAA	CSADRGMNTEAFF	In	VDJ	25	830	0.014493765934411344	0.01759257296678607	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	2	0	0	2	26	-1	43	34	45		TCRBV20-01,TCRBV20-or09_02												CSADRGMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCCCGAGCCCCCACTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	54	1754	0.03062899451681626		46	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	5	7	3	1	13	24	36	41	37	54		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGTCCGGGACTAGCGGGAGGGCCCCCCCAGAGACCCAGTACTTCGGGCCA	CSAESGTSGRAPPETQYF	In	VDJ	59	1927	0.03364998428386826	0.04084444350240573	54	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	0	0	4	6	7	26	35	57	41	64		TCRBV20-01,TCRBV20-or09_02												CSAESGTSGRAPPETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGGTGGCGTAATGAGCAGTTCTTCGGGCCA	CATSRDRWRNEQFF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	0	9	0	7	5	2	18	35	43	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRWRNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGGGGGACTCCTTCCATGTACTTCGGGCCG	CATSRDRGTPSMYF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	0	5	1	12	1	11	18	35	42	36	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRGTPSMYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCCCGGGCAAATCGGGGAGCTGTTTTTTGGAGAA	CATSRDPGQIGELFF	In	VDJ	1	41	7.15957112422729E-4	8.690307128171432E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-02	01	0	8	0	7	4	4	18	35	43	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDPGQIGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTCAAGGCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CATSSQGYSNQPQHF	In	VDJ	1	42	7.334194810184054E-4	8.902265838614638E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-05	01	3	5	4	0	3	3	18	32	38	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSSQGYSNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACCTAGGACAGTCATATGGCTACACCTTCGGTTCG	CATSRDLGQSYGYTF	In	VDJ	2	51	8.905807983794922E-4	0.001080989423260349	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	5	5	4	3	18	35	45	39	48														CATSRDLGQSYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCACCCGTACGGGGTTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATSRDHPYGVSGANVLTF	In	VDJ	2	59	0.0010302797471449026	0.0012505563916149133	57	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	0	8	3	1	9	2	18	35	49	44	51														CATSRDHPYGVSGANVLTF+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTTGGGCGGCTTCACAGATACGCAGTATTTTGGCCCA	CATSRDLGGFTDTQYF	In	VDJ	2	68	0.0011874410645059895	0.0014413192310137985	48	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	0	8	0	2	3	5	18	35	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDLGGFTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCTCGAACCAGGGGGGAGGCTACGAGCAGTACTTCGGGCCG	CATSSNQGGGYEQYF	In	VDJ	2	68	0.0011874410645059895	0.0014413192310137985	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	1	3	6	4	18	30	43	36	47														CATSSNQGGGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTTGAGGGTCTCTGGAAACACCATATATTTTGGAGAG	CATSRDLRVSGNTIYF	In	VDJ	4	120	0.002095484231481158	0.002543504525318468	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	11	0	0	3	1	18	35	43	38	44														CATSRDLRVSGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAACAGGGGGCGGCTAATGAAAAACTGTTTTTTGGCAGT	CATSREQGAANEKLFF	In	VDJ	4	124	0.002165333705863863	0.0026282880094957504	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	0	3	0	2	18	-1	44	35	46														CATSREQGAANEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAAGGGGACTAATGAAAAACTGTTTTTTGGCAGT	CATSRDKGTNEKLFF	In	VDJ	10	312	0.005448259001851011	0.006613111765828017	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	2	2	2	0	18	35	-1	37	42														CATSRDKGTNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTACGAGGAGAATGAAAAACTGTTTTTTGGCAGT	CATSRDYEENEKLFF	In	VDJ	22	709	0.01238081933433451	0.015027872570423281	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	10	2	5	6	0	18	35	-1	41	45														CATSRDYEENEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCCTCGACAGTGAGCACAGATACGCAGTATTTTGGCCCA	CATSPSTVSTDTQYF	In	VDJ	75	2470	0.043132050431320505	0.0523538014794718	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	5	0	5	2	18	30	40	35	42														CATSPSTVSTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTCTTCCATAGCGGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	2.095484231481158E-4		43	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	4	5	6	0	22	35	-1	41	48						01,02								X+TCRBV12-01+TCRBJ02-01	TCRBV12-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGGTTCCGCCCACAGGACGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	23	4.016344777005553E-4		46	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	4	1	9	2	22	33	47	42	49														X+TCRBV12-01+TCRBJ01-01	TCRBV12-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCCTATCGACAGCGAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	4.889463206789369E-4		43	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	3	6	4	22	34	45	40	49														X+TCRBV12-01+TCRBJ02-07	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTAGCGGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	44	7.68344218209758E-4		41	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	5	0	0	0	22	-1	-1	36	41						01,02								X+TCRBV12-01+TCRBJ02-01	TCRBV12-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTACGGCTAGCGGGATCCACAGATACGCAGTATTTTGGCCCA	CASSLRLAGSTDTQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	48	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	4	3	2	3	2	18	33	45	36	47														CASSLRLAGSTDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGACAGGGCACTGAAGCTTTCTTTGGACAA	CASSLGQGTEAFF	In	VDJ	3	112	0.0019557852827157478	0.0023739375569639034	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	3	4	0	0	18	-1	-1	34	41														CASSLGQGTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGGGGCAGGGGCTCACTATGGCTACACCTTCGGTTCG	CASSLGAGAHYGYTF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	2	3	3	3	18	34	43	37	46														CASSLGAGAHYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTATTCAGCCCCCCGGGCGAGCAGTACTTCGGGCCG	CASSLVFSPPGEQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	8	4	6	12	0	18	34	-1	46	50						01,02								CASSLVFSPPGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGTGTCCAGCGGCCAAGAGACCCAGTACTTCGGGCCA	CASSLVSSGQETQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	6	5	1	5	0	18	34	-1	39	44						01,02								CASSLVSSGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTCTGACTTGGGAGATACGCAGTATTTTGGCCCA	CASSFSDLGDTQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	2	10	5	4	4	18	32	40	36	44						01,02								CASSFSDLGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACAGGCCCGATCAGCCCCAGCATTTTGGTGAT	CASSLDRPDQPQHF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	4	5	0	4	18	-1	39	32	43														CASSLDRPDQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCGAAGGCAAGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	11	1.920860545524395E-4		41	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	5	4	2	5	4	18	30	38	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAAGCGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGSGPYNEQFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	4	2	4	1	18	32	42	36	43						01,02								CASSLGSGPYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACGCGGACCCTACGAGCAGTACTTCGGGCCG	CASSLGRGPYEQYF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	0	7	2	0	6	18	-1	37	32	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRGPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAAGCGACCAGGTCTCACTATGGCTACACCTTCGGTTCG	CASSQATRSHYGYTF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	4	4	3	8	4	18	30	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQATRSHYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAGGGACTATTTACAATGAGCAGTTCTTCGGGCCA	CASSRGTIYNEQFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	9	4	3	2	18	30	40	33	42						01,02								CASSRGTIYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAGCGGCTCCCACAGATACGCAGTATTTTGGCCCA	CASSLVAAPTDTQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	5	5	2	0	4	18	-1	40	34	44						01,02								CASSLVAAPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATCCGACTAGCGGGAGGAGGGGATACGCAGTATTTTGGCCCA	CASIRLAGGGDTQYF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	2	1	6	3	4	18	28	44	31	48														CASIRLAGGGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGGGGTACTCCGAATGGCTACACCTTCGGTTCG	CASSLEGGTPNGYTF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	9	1	6	0	8	18	-1	41	35	49														CASSLEGGTPNGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCGCGGGACGACTACGAGCAGTACTTCGGGCCG	CASSLSRDDYEQYF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	7	3	3	2	3	18	33	41	35	44														CASSLSRDDYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGGCGACAGCGACTCGTCCTACGAGCAGTACTTCGGGCCG	CASSRGDSDSSYEQYF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	2	5	1	6	7	18	30	41	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGDSDSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCCGGACTAGCGGGATTACCTACGAGCAGTACTTCGGGCCG	CASSLRTSGITYEQYF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	1	3	2	4	3	18	30	46	34	49														CASSLRTSGITYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACTGCGGGAGGCGCCCACGAGCAGTACTTCGGGCCG	CASSLTAGGAHEQYF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	7	1	5	3	5	18	33	44	36	49														CASSLTAGGAHEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCATGGACAGGGACAAACTACGAGCAGTACTTCGGGCCG	CASSSWTGTNYEQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	3	3	5	18	31	42	34	47														CASSSWTGTNYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGTCGGAGAGGGACTATGGCTACACCTTCGGTTCG	CASSWSERDYGYTF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	0	3	7	0	18	31	-1	38	43														CASSWSERDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGTCCGGGGGCCGGGAAGCTTTCTTTGGACAA	CASSFGSGGREAFF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	6	0	8	7	3	18	32	45	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGSGGREAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCTCTCGGACTCAGGGATCTATGGCTACACCTTCGGTTCG	CASSLSDSGIYGYTF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	5	4	3	4	10	2	18	30	45	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSDSGIYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCGGGGGACCCGGGGGGTTGATCGAGCAGTACTTCGGGCCG	CASSGGPGGLIEQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	1	6	8	5	18	30	45	38	50														CASSGGPGGLIEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGGTCAGCAGCCTCTCTTAGGGGGGCTACACCTTCGGTTCG		Out	VDJ	1	16	2.7939789753082106E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	2	8	16	0	18	29	-1	45	50														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGCAGGAGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSRSSSYNEQFF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	4	4	0	2	5	18	30	36	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRSSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGAGGCAAATAGAGATGAAGCTTTCTTTGGACAA	CASSLEANRDEAFF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	0	9	0	7	0	9	18	-1	38	35	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEANRDEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGTACGACCCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSYDPGANVLTF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	4	2	7	2	5	1	18	31	39	36	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSYDPGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAGGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSLQGATDTQYF	In	VDJ	1	17	2.968602661264974E-4	3.6032980775344963E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	0	2	0	0	18	-1	-1	33	41														CASSLQGATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTGGGGAGCGGGAAGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPWGAGRNTGELFF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	6	3	2	8	3	18	30	45	38	48														CASSPWGAGRNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTAACAGGGGGCTGGATGAAAAACTGTTTTTTGGCAGT	CASSSNRGLDEKLFF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	0	6	3	3	18	31	43	34	46														CASSSNRGLDEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCTCGGGGGACTAGCGGGAGGCCTCGCACAGATACGCAGTATTTTGGCCCA	CASSLARGTSGRPRTDTQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	0	1	1	7	4	18	32	54	39	58														CASSLARGTSGRPRTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATGGCTCACCAGAAGGAAGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	19	3.3178500331785003E-4		49	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	2	1	8	4	13	2	18	33	49	46	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCTTGGGGCCAGATACGCAGTATTTTGGCCCA	CASSLGLGPDTQYF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	7	0	4	6	0	18	32	-1	38	43														CASSLGLGPDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCAACTGGACACCGCGCTCTGAAGCTTTCTTTGGACAA	CASSANWTPRSEAFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	6	6	7	7	18	30	42	37	49														CASSANWTPRSEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATTACCCTGGAGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLDYPGGSYEQYF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	1	0	7	0	18	35	-1	42	47														CASSLDYPGGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGGAGGGACTGGAAAACTGTTTTTTGGCAGT	CASSLGGGTGKLFF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	0	10	10	5	2	18	34	45	39	47						01,02								CASSLGGGTGKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCACCAATCGGGGGCTAAATGAAAAACTGTTTTTTGGCAGT	CASSTNRGLNEKLFF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	5	6	0	5	7	2	18	30	43	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTNRGLNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTGGGGGAAACACTGAAGCTTTCTTTGGACAA	CASSLVGGNTEAFF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	1	6	1	2	2	1	18	34	41	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAGTCTGGGGCGGGAGAGACCCAGTACTTCGGGCCA	CASSLQSGAGETQYF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	2	7	0	4	6	3	18	33	44	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQSGAGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCACCAGGGGAGGGACTGAAGCTTTCTTTGGACAA	CASSFTRGGTEAFF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	0	5	6	0	18	32	-1	38	45														CASSFTRGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGGCCACAGGGCAAGAGACCCAGTACTTCGGGCCA	CASSLATGQETQYF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	3	2	4	0	18	32	-1	36	42														CASSLATGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACACCCAGTGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	28	4.889463206789369E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	6	4	0	8	18	-1	39	34	47														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGACTTACCTACGAGCAGTACTTCGGGCCG	CASSLEGLTYEQYF	In	VDJ	1	30	5.238710578702895E-4	6.35876131329617E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	10	2	0	2	18	-1	41	35	43						01,02								CASSLEGLTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCTAGCGGGAGGTAGTGAGCAGTTCTTCGGGCCA	CASSFLAGGSEQFF	In	VDJ	1	31	5.413334264659658E-4	6.570720023739376E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	1	9	1	3	18	32	44	33	47														CASSFLAGGSEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGATCAGGCAGCCACAGATACGCAGTATTTTGGCCCA	CASSLDQAATDTQYF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	4	2	4	4	18	32	40	36	44														CASSLDQAATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTTAGGTCTCAGCGGGAGGGTAGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	32	5.587957950616421E-4		56	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	6	0	4	10	4	18	32	52	42	56														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGCGTTGAACCCCTACGAGCAGTACTTCGGGCCG	CASSSALNPYEQYF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	7	6	2	2	7	18	31	36	33	43						01,02								CASSSALNPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGACTCCCGGGTCTCCTACGAGCAGTACTTCGGGCCG	CASSFDSRVSYEQYF	In	VDJ	1	38	6.635700066357001E-4	8.054430996841816E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	2	10	0	1	7	18	32	37	33	44						01,02								CASSFDSRVSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCCAGCAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSFPAGGTEAFF	In	VDJ	1	42	7.334194810184054E-4	8.902265838614638E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	4	5	0	18	32	-1	37	44														CASSFPAGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGGACAGGGTACTACGAGCAGTACTTCGGGCCG	CASSPGTGYYEQYF	In	VDJ	1	45	7.858065868054343E-4	9.538141969944255E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	3	3	2	18	30	42	33	44														CASSPGTGYYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACAGGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPGQVSGANVLTF	In	VDJ	2	51	8.905807983794922E-4	0.001080989423260349	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	4	0	2	1	18	30	40	32	41														CASSPGQVSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGACTCTCTCTGAACTACAATGAGCAGTTCTTCGGGCCA	CASSSGLSLNYNEQFF	In	VDJ	2	51	8.905807983794922E-4	0.001080989423260349	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	10	3	1	9	18	31	38	32	47						01,02								CASSSGLSLNYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGGGACGGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSAGRPNTGELFF	In	VDJ	2	52	9.080431669751685E-4	0.0011021852943046695	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	7	3	0	0	4	18	-1	36	30	40														CASSAGRPNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCATGAGACTAGCGGGATACACAGATACGCAGTATTTTGGCCCA	CASSFMRLAGYTDTQYF	In	VDJ	2	53	9.255055355708448E-4	0.00112338116534899	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	2	3	2	5	2	18	32	48	37	50														CASSFMRLAGYTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGGACAGGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGDRGYTGELFF	In	VDJ	2	64	0.0011175915901232843	0.0013565357468365163	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	1	3	3	1	18	31	45	34	46														CASSSGDRGYTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACCCACCTGGACTAGTCGGAAGTGAGCAGTTCTTCGGGCCA	CASSLDPPGLVGSEQFF	In	VDJ	2	79	0.001379527119058429	0.0016744738125013248	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	1	8	9	7	7	18	35	49	42	56						01,02								CASSLDPPGLVGSEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGTCGGTCCGGGGTGGGAGATACGCAGTATTTTGGCCCA	CASSPRRSGVGDTQYF	In	VDJ	3	84	0.0014668389620368107	0.0017804531677229275	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	3	5	11	4	18	30	46	41	50														CASSPRRSGVGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACAGGTATACCTACGAGCAGTACTTCGGGCCG	CASSLDRYTYEQYF	In	VDJ	4	126	0.002200258443055216	0.0026706797515843915	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	4	2	0	4	18	-1	39	35	43														CASSLDRYTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACTTGTTTGGCGGCGCCAATCAGCCCCAGCATTTTGGTGAT	CASNLFGGANQPQHF	In	VDJ	4	142	0.002479656340586037	0.0030098136882935203	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	7	5	3	5	3	18	32	41	37	44						01,02								CASNLFGGANQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACTAACCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSTNPNTGELFF	In	VDJ	5	158	0.002759054238116858	0.0033489476250026496	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	3	9	0	0	3	18	-1	34	30	37						01,02								CASSTNPNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCTGCGTGTTGGGACTAGTTGGAATACGCAGTATTTTGGCCCA	CASTLRVGTSWNTQYF	In	VDJ	6	190	0.0033178500331785005	0.004027215498420908	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	0	8	7	11	5	18	28	47	39	52						01,02								CASTLRVGTSWNTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGACAGCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLGDSSSYEQYF	In	VDJ	7	225	0.003929032934027171	0.0047690709849721276	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	0	0	3	18	-1	41	34	44														CASSLGDSSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAATTCAGGATCTCCCTCGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLNSGSPSGANVLTF	In	VDJ	11	356	0.006216603220060769	0.007545730091778122	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	4	4	4	5	10	18	32	41	37	51														CASSLNSGSPSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTACTGGGCGGGAGGACGAGCAGTACTTCGGGCCG	CATGREDEQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	33	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	7	1	5	0	0	26	-1	-1	37	45														CATGREDEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCAGAGGGGGTCTATTAATGAAAAACTGTTTTTTGGCAGT	CASQRGSINEKLFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	12	5	1	4	7	5	26	31	44	38	49														CASQRGSINEKLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCGAAACCATATTAGCGGAAGAGACCCAGTACTTCGGGCCA	CASAETILAEETQYF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	5	5	3	12	0	26	36	-1	48	54						01,02								CASAETILAEETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGGCTCGGACGTGAAGCTTTCTTTGGACAA	CASGLGREAFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	33	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-01	01	6	1	7	7	4	1	26	37	45	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLGREAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAACCTTGGCGGGGGGACTTACAATGAGCAGTTCTTCGGGCCA	CASNLGGGTYNEQFF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	7	1	4	11	3	26	31	50	42	53														CASNLGGGTYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCTACCGGACTGGGGATGACCGGGGAGCTGTTTTTTGGAGAA	CASATGLGMTGELFF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	1	10	5	5	7	26	36	46	41	53						01,02								CASATGLGMTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTGTGGCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	30	5.238710578702895E-4		40	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	9	0	1	3	0	26	41	-1	44	47														X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACTCGTCCGAGGGGCGCAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASGLVLVRGAQNTGELFF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	57	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	0	5	2	1	9	4	24	41	55	50	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLVLVRGAQNTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGCACTCGGGCGACAGGGCCCCAAGAGACCCAGTACTTCGGGCCA	CASTRATGPQETQYF	In	VDJ	1	38	6.635700066357001E-4	8.054430996841816E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	9	2	3	1	9	2	26	34	50	43	52														CASTRATGPQETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCTCACACCTCCAAGAGACCCAGTACTTCGGGCCA	CASASHLQETQYF	In	VDJ	1	40	6.984947438270527E-4	8.478348417728227E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	3	6	1	4	3	26	36	43	40	46														CASASHLQETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTCGGCGGGACTAGCGGGAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRRD*REGNTGELFF	Stop	VDJ	2	60	0.001047742115740579		51	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	0	0	1	4	0	26	35	-1	39	55														CASRRD*REGNTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGAGGGGACTAACCTCCCCAAATCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	61	0.0010652044843362553		49	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	0	9	1	2	11	26	34	43	36	54						01,02								X+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCTGGGACTAGCTCCTGAGACCCAGTACTTCGGGCCA	CASGLGLAPETQYF	In	VDJ	2	74	0.0012922152760800475	0.0015684944572797218	42	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	7	5	3	4	26	37	49	40	53						01,02								CASGLGLAPETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTAGGACTTCCGGGACTAGCGGGAGCCAATGAGCAGTTCTTCGGGCCA	CASGLGLPGLAGANEQFF	In	VDJ	2	80	0.0013969894876541054	0.0016956696835456453	54	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	0	2	6	9	1	26	40	63	49	64														CASGLGLPGLAGANEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTAGCCGGGTACCTAGGCCTCAATGAGCAGTTCTTCGGGCCA	CASSLAGYLGLNEQFF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	8	6	13	4	20	31	48	44	52						01,02								CASSLAGYLGLNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCACTCAAGCGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	14	2.4447316033946847E-4		41	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	6	6	5	5	0	20	37	-1	42	46						01,02								X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATTGGGGGACTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDWGTSSYNEQFF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	8	0	6	0	20	35	-1	41	49						01,02								CASSQDWGTSSYNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGGACAGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSQGQSSGNTIYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	5	0	0	2	20	-1	41	35	43														CASSQGQSSGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCCCAGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	17	2.968602661264974E-4		40	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	5	4	1	1	20	37	41	38	42														X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCACTTTGCGGGAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSHFAGGTGELFF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	7	1	4	7	0	20	31	-1	38	46														CASSHFAGGTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGGGGTCGGCGGTGGGTACCAAGAGACTCAGTACTTCGGGCCA	CASSQGVGGGYQETQYF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	51	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	2	6	2	11	0	23	20	-1	39	35	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVGGGYQETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGGAGGGACAGGGGGGACCAAGAGACCCAGTACTTCGGGCCA	CASRRDRGDQETQYF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	1	0	2	1	20	31	44	33	45														CASRRDRGDQETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACCCCCATCCTGGGGGAGGGCCTTCTGAGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	35	6.111829008486711E-4		56	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	9	0	4	12	9	20	30	49	42	58														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGACACGGCACTGTATCTCTGCGCCACCAAACCGGGACAGACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	66	0.001152516327314637		40	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	0	5	2	7	1	20	27	41	34	42														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCTACAGGAGACCCCACTATGGCTACACCTTCGGTTCG		Out	VDJ	3	95	0.0016589250165892503		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	4	3	1	7	20	37	43	38	50														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAAGGGCGGACTAGCGGGATTACAATGAGCAGTTCTTCGGGCCA	CASSQRAD*RDYNEQFF	Stop	VDJ	3	112	0.0019557852827157478		51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	1	3	4	5	1	20	35	52	40	53														CASSQRAD*RDYNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACAGGGGGATATCTAACTATGGCTACACCTTCGGTTCG	CASNRGISNYGYTF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	1	0	0	4	23	-1	41	33	45														CASNRGISNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACGGGATCAGCCTACGAGCAGTACTTCGGGCCG	CASSTGSAYEQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	3	2	1	4	23	35	41	36	45														CASSTGSAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACTAGCTTTGGCGAGCAGTACTTCGGGCCG	CASSYGTSFGEQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	7	6	0	5	23	-1	47	38	52						01,02								CASSYGTSFGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACAAGGGACGGTCAACAGATGACAGATACGCAGTATTTTGGCCCA	CATRDGQQMTDTQYF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	10	0	7	3	3	12	23	30	38	33	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRDGQQMTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGCCACCGGGACAGGGCAGAATCAGCCCCAGCATTTTGGTGAT	CASRATGTGQNQPQHF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	3	4	7	3	23	34	50	41	53														CASRATGTGQNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCCCCAGGGGGTATGGCTACACCTTCGGTTCG	CASSYSPRGYGYTF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	1	5	3	0	23	40	-1	43	50														CASSYSPRGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACCGGGACAGGGTTTGGGCGGCTACACCTTCGGTTCG	CASSLPGQGLGGYTF	In	VDJ	1	11	1.920860545524395E-4	2.3315458148752622E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	8	4	7	23	36	49	40	56														CASSLPGQGLGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCATCGCCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	2.095484231481158E-4		41	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	4	6	3	2	6	23	38	42	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGTGGGCCCTACCTACAATGAGCAGTTCTTCGGGCCA	CASSLVGPTYNEQFF	In	VDJ	1	12	2.095484231481158E-4	2.543504525318468E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	8	0	2	4	4	23	36	44	40	48														CASSLVGPTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAGGGACACCACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRRDTTNTGELFF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	6	0	2	3	23	34	42	36	45														CASRRDTTNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGTCGGCAATCAAGAGACCCAGTACTTCGGGCCA	CASRVGNQETQYF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	6	9	0	2	4	3	23	34	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVGNQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGTCCGGGACCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYSPGPGANVLTF	In	VDJ	1	13	2.2701079174379212E-4	2.755463235761674E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	2	0	7	2	5	0	23	38	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSPGPGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTGGGGCTGCCCCAGCCCCAGCATTTTGGTGAT	CASSLGLPQPQHF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	7	0	7	3	5	23	34	42	37	47														CASSLGLPQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGACCTAGCTTAGGCGAGCAGTACTTCGGGCCG	CASSYGPSLGEQYF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	7	6	4	5	23	38	47	42	52						01,02								CASSYGPSLGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGAACCCCGGGGCAGCCCTTGAACACTGAAGCTTTCTTTGGACAA	CASSYSRTPGQPLNTEAFF	In	VDJ	1	14	2.4447316033946847E-4	2.967421946204879E-4	57	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	7	0	0	9	6	23	40	54	49	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSRTPGQPLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTCAACAGGATAAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	2.4447316033946847E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	4	0	2	5	23	36	43	38	48														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATGGGACAGGGCAATATACGAGCGGGGTCAGGGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	14	2.4447316033946847E-4		56	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	3	6	1	22	23	30	40	31	62														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCAAAGCGGGACATCTGAACACTGAAGCTTTCTTTGGACAA	CATKAGHLNTEAFF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	10	6	3	0	4	4	23	30	41	34	45														CATKAGHLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCTCGGGGGCCCTGGGGATACGCAGTATTTTGGCCCA	CASRLGGPGDTQYF	In	VDJ	1	15	2.6193552893514474E-4	3.179380656648085E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	6	0	6	4	6	23	34	44	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLGGPGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGGACCAACAATGGGGGCCGGCGGAGAGCAGTTCTTCGGGCCA	CASSGPTMGAGGEQFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	6	0	10	12	7	23	34	52	46	59														CASSGPTMGAGGEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCGTTAGCGGGTACACGAACTATGGCTACACCTTCGGTTCG	CASSVVSGYTNYGYTF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	5	4	2	5	6	23	35	47	40	53						01,02								CASSVVSGYTNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGACCGGGACTGGGAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	16	2.7939789753082106E-4		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	10	0	6	4	23	38	50	44	54						01,02								X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGGTCGGGGGAGCAGTACTTCGGGCCG	CASSYGSGEQYF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	3	7	5	0	23	37	-1	42	47														CASSYGSGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACAAATGGACTAGATAGGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	3.143226347221737E-4		38	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	1	8	9	5	6	23	30	42	35	48						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAAAACGACTAGCGGGAGGAAAGAGACCCAGTACTTCGGGCCA	CASRKTTSGRKETQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	2	1	3	6	1	23	34	53	40	54														CASRKTTSGRKETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCGGGACAGGGGTTACTACGAGCAGTACTTCGGGCCG	CASRRDRGYYEQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	3	2	3	23	34	46	36	49														CASRRDRGYYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTCCGGGAGGGCCCCTAGCACAGATACGCAGTATTTTGGCCCA	CASRSGRAPSTDTQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	8	0	0	3	5	23	34	45	37	50														CASRSGRAPSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAAACAGGGAATACTGAAGCTTTCTTTGGACAA	CASSQTGNTEAFF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	5	3	3	23	35	44	38	47														CASSQTGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTCAGCCCCATTCTCTCTGGAAACACCATATATTTTGGAGAG	CASSYLSPILSGNTIYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	2	4	5	0	2	9	23	38	43	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLSPILSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTCGGCACGTTCGAGCAGTACTTCGGGCCG	CASSYLGTFEQYF	In	VDJ	1	18	3.143226347221737E-4	3.815256787977702E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	9	0	6	3	5	23	38	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLGTFEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAGGGACTAGCGGGTATCTGGGAGCAGTTCTTCGGGCCA	CASSEGLAGIWEQFF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	4	10	3	7	23	34	49	37	56						01,02								CASSEGLAGIWEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACGACTAGCGGGGCAACAGATACGCAGTATTTTGGCCCA	CASSYTTSGATDTQYF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	2	3	3	2	2	23	38	51	40	53														CASSYTTSGATDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCCTCGGACTAGCGGGAGTCAGACCCAGTACTTCGGGCCA	CASSFPRTSGSQTQYF	In	VDJ	1	19	3.3178500331785003E-4	4.027215498420908E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	1	2	6	6	2	23	36	55	42	57														CASSFPRTSGSQTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGACAGGCGAGTATCAGCCCCAGCATTTTGGTGAT	CASSETGEYQPQHF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	4	5	2	5	23	35	43	37	48														CASSETGEYQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGATCCGGAGGGCTATGGCTACACCTTCGGTTCG	CASSYDPEGYGYTF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	10	0	4	5	0	23	38	-1	43	49														CASSYDPEGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGACTAGCGGGAGGGGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	21	3.667097405092027E-4		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	1	0	6	0	3	23	-1	47	32	50														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAACCTCCAGGGGACAGACCCCTATGGCTACACCTTCGGTTCG	CASSNLQGTDPYGYTF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	4	9	4	23	35	51	44	55														CASSNLQGTDPYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACACGCGGGGTTCAGGTTATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	4.016344777005553E-4		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	10	7	3	5	3	8	23	30	39	33	47														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCACACAAGGTGGAGCAGATCCCTATGGCTACACCTTCGGTTCG	CASTTQGGADPYGYTF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	10	2	4	11	7	23	33	48	44	55														CASTTQGGADPYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACAGGGGGGTGGGCGAGCAGTACTTCGGGCCG	CASSYDRGVGEQYF	In	VDJ	1	23	4.016344777005553E-4	4.8750503401937304E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	1	6	0	5	23	-1	47	38	52														CASSYDRGVGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGAAATGAACACTGAAGCTTTCTTTGGACAA	CASSYSEMNTEAFF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	2	8	0	1	2	23	40	43	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSEMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGCCGGGGGGCGAGCGAGCAGTACTTCGGGCCG	CASRRGASEQYF	In	VDJ	1	24	4.190968462962316E-4	5.087009050636936E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	8	1	6	3	4	23	32	42	35	46														CASRRGASEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCGAGAAACTTAGATACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	24	4.190968462962316E-4		55	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	15	5	23	35	53	50	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGCTACCCGGGACCCTATACAATGAGCAGTTCTTCGGGCCA	CASSELPGTLYNEQFF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	0	7	4	9	4	23	35	49	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSELPGTLYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGAGGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	25	4.365592148919079E-4		40	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	0	0	0	0	23	-1	-1	38	44														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTGGAACAGGGGGCGCGGTGTATGGCTACACCTTCGGTTCG	CASGTGGAVYGYTF	In	VDJ	1	25	4.365592148919079E-4	5.298967761080142E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	3	0	5	4	6	23	31	44	35	50														CASGTGGAVYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGGGGCTCGAACCAGGGAGCTGTTTTTTGGAGAA	CASSYSGARTRELFF	In	VDJ	1	26	4.5402158348758424E-4	5.510926471523347E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	5	2	9	0	9	23	-1	45	40	54														CASSYSGARTRELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGAGCAGGGATCCCTTAACAATGAGCAGTTCTTCGGGCCA	CASREQGSLNNEQFF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	5	4	8	23	34	43	38	51														CASREQGSLNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTAAGGAGGGACTCCTCTCCTACGAGCAGTACTTCGGGCCG	CASIKEGLLSYEQYF	In	VDJ	1	27	4.7148395208326056E-4	5.722885181966553E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	10	0	7	3	23	33	46	40	49						01,02								CASIKEGLLSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCGCGGCCAGGACGCACAGATACGCAGTATTTTGGCCCA	CASSARPGRTDTQYF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	1	7	1	10	0	23	34	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSARPGRTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGTCGGGACAGGGGAGACTACGAGCAGTACTTCGGGCCG	CASGRDRGDYEQYF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	2	3	4	3	23	32	46	36	49														CASGRDRGDYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGACAGGGGGCGCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	29	5.064086892746132E-4		47	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	0	1	0	3	23	-1	47	37	50														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACCCTACCCCCTCTGCCTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	29	5.064086892746132E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	4	9	2	5	13	23	30	38	35	51						01,02								X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCATCTAGCGGGAGGAAGGATGAGCAGTTCTTCGGGCCA	CASSPSSGRKDEQFF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	1	8	5	4	23	34	50	39	54														CASSPSSGRKDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCTTTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSAFSGGTDTQYF	In	VDJ	1	32	5.587957950616421E-4	6.782678734182582E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	3	1	5	0	23	35	-1	40	48														CASSAFSGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTCCGGGACATCCCGGGGGACTAGCGGGAGTCGAGCAGTACTTCGGGCCG	CASTPGHPGGLAGVEQYF	In	VDJ	1	33	5.762581636573184E-4	6.994637444625787E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	0	2	6	16	1	23	33	63	49	64														CASTPGHPGGLAGVEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGTTCACCTAACTATGGCTACACCTTCGGTTCG	CASSYGSPNYGYTF	In	VDJ	1	33	5.762581636573184E-4	6.994637444625787E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	0	10	0	0	5	23	-1	40	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGSPNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGACCACGAGGGGCGGGTTACCTACGAGCAGTACTTCGGGCCG	CAISDHEGRVTYEQYF	In	VDJ	1	33	5.762581636573184E-4	6.994637444625787E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	5	2	2	8	7	23	34	47	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISDHEGRVTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACATATCGGCTAGCGGGAGCTACGAGCAGTACTTCGGGCCG	CASSYISASGSYEQYF	In	VDJ	1	36	6.286452694443474E-4	7.630513575955404E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	4	2	3	7	0	23	38	-1	45	55														CASSYISASGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGACTGGGGGGAGTCACTGAAGCTTTCTTTGGACAA	CASGLGGVTEAFF	In	VDJ	1	36	6.286452694443474E-4	7.630513575955404E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	9	1	4	5	3	23	32	43	37	46														CASGLGGVTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTGAACGGCGATGAGCAGTTCTTCGGGCCA	CASSYVNGDEQFF	In	VDJ	1	40	6.984947438270527E-4	8.478348417728227E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	2	9	0	8	6	1	23	38	47	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYVNGDEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATTACAGGGAAGTGGCGGCTACACCTTCGGTTCG	CASRLQGSGGYTF	In	VDJ	1	42	7.334194810184054E-4	8.902265838614638E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	8	3	7	23	34	43	37	50														CASRLQGSGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGAGGGACCTATCCTCCTACGAGCAGTACTTCGGGCCG	CASSYRRDLSSYEQYF	In	VDJ	1	43	7.508818496140817E-4	9.114224549057843E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	0	0	1	7	23	38	45	39	52														CASSYRRDLSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTGGCCGGGACTAGCGGGAGGCGGCAGTACTTCGGGCCA	CASSLAGTSGRRQYF	In	VDJ	1	45	7.858065868054343E-4	9.538141969944255E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	0	1	11	7	3	23	34	56	41	59														CASSLAGTSGRRQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTATACCGACCACCGGGCGGCGTCTGGACAA	CASSYTDHRAAS	In	VDJ	1	45	7.858065868054343E-4	9.538141969944255E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	8	0	19	14	6	23	34	52	48	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTDHRAAS+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTGCGGACACTGAAGCTTTCTTTGGACAA	CASSVADTEAFF	In	VDJ	1	45	7.858065868054343E-4	9.538141969944255E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	5	3	3	0	23	35	-1	38	42						01,02								CASSVADTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGGCGGGACAGGTTTATGCTTTCTTTGGACAA	CASSYLAGQVYAFF	In	VDJ	1	49	8.556560611881395E-4	0.0010385976811717078	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	4	11	5	5	23	38	51	43	56														CASSYLAGQVYAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGTATTCGGGACAGCTTGAACACTGAAGCTTTCTTTGGACAA	CASSYGGIRDSLNTEAFF	In	VDJ	2	50	8.731184297838158E-4	0.0010597935522160284	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	5	0	10	2	23	38	55	48	57														CASSYGGIRDSLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGCGGACTAGCGGGAAGTGAGCAGTTCTTCGGGCCA	CASSRGLAGSEQFF	In	VDJ	2	51	8.905807983794922E-4	0.001080989423260349	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	1	3	9	4	2	23	34	50	38	52														CASSRGLAGSEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGAGGGCGGGTATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	53	9.255055355708448E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	8	0	4	2	6	23	35	45	37	51														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGATGGACTAGCGGGAGTGAAGGTATTCATAAATGAGCAGTTCTTCGGGCCA	CASRDGLAGVKVFINEQFF	In	VDJ	2	62	0.0010826668529319316	0.0013141440047478752	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	1	2	7	4	14	23	34	51	38	65														CASRDGLAGVKVFINEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAACAAGGACAGGCCCCTGGAAACACCATATATTTTGGAGAG	CASKQGQAPGNTIYF	In	VDJ	2	69	0.0012049034331016659	0.001462515102058119	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	1	4	2	5	3	23	33	45	38	48														CASKQGQAPGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTTAGCGGGAAACACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	69	0.0012049034331016659		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	3	2	2	4	23	35	45	37	49														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGAATCCGGGGCGAGAAATGAGCAGTTCTTCGGGCCA	CASSSESGARNEQFF	In	VDJ	2	69	0.0012049034331016659	0.001462515102058119	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	4	7	0	7	8	4	23	36	49	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSESGARNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGGGGCCCTTTGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	75	0.0013096776446757238		52	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	5	1	0	0	8	23	-1	44	38	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGGGATCCTCCTACGAGCAGTACTTCGGGCCG	CASSVGSSYEQYF	In	VDJ	3	104	0.001816086333950337	0.002204370588609339	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	0	8	0	2	2	23	35	41	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGGGACCTGGCAATGAGCAGTTCTTCGGGCCA	CASSYRGPGNEQFF	In	VDJ	4	115	0.0020081723885027767	0.0024375251700968653	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	2	0	7	6	2	4	23	38	45	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRGPGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGACTATACCGGGACGCACGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	120	0.002095484231481158		47	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	0	7	1	8	5	23	34	47	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTACAGGGGCTCCGGTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	5	148	0.002584430552160095		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	5	2	6	0	7	23	-1	43	38	50														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAGGGGGCCGCCTACGAGCAGTACTTCGGGCCG	CASSQGAAYEQYF	In	VDJ	6	182	0.00317815108441309	0.0038576485300663432	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	0	2	1	2	23	34	43	35	45														CASSQGAAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGACGCCCTCGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	7	214	0.003736946879474732		41	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	6	0	7	3	0	8	23	-1	39	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTTACAGGGGGCGCTTGGTCCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLQGALGPGANVLTF	In	VDJ	7	231	0.004033807145601229	0.00489624621123805	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	3	0	2	3	8	23	34	46	37	54														CASSLQGALGPGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACAAGCGGTAGCGGGAGATCTTATGTTGAGCAGTTCTTCGGGCCA	CASTSGSGRSYVEQFF	In	VDJ	7	233	0.004068731882792582	0.004938637953326692	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	5	2	9	7	9	23	33	49	40	58														CASTSGSGRSYVEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATAGCAGGTGCGATGGGCTACACCTTCGGTTCG	CASSIAGAMGYTF	In	VDJ	7	241	0.004208430831557993	0.005108204921681256	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	4	4	8	5	7	23	34	43	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIAGAMGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGCAAACTGGGCCTACGAGCAGTACTTCGGGCCG	CASSGANWAYEQYF	In	VDJ	8	272	0.004749764258023958	0.005765276924055194	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	7	0	2	0	8	23	-1	40	35	48														CASSGANWAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCCAAGCTGTGGACCCCTTGCAGTTCTTCGGGCCA	CATQAVDPLQFF	In	VDJ	44	1445	0.02523312262075228	0.030628033659043218	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	10	1	7	12	10	5	23	30	44	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATQAVDPLQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCTAGGACAGGGGATGTACGAGCAGTACTTTGGGCCG	CASSLGQGMYEQYF	In	VDJ	1	10	1.7462368595676318E-4	2.1195871044320567E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	19	4	18	24	35	48	39	66													Vb 18	CASSLGQGMYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTCCAGGGGGGGATGACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	2.095484231481158E-4		46	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	1	4	1	7	2	6	24	40	49	42	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGGCAGCCGGGGAGCTGTTTTTTGGAGAA	CASSPQAAGELFF	In	VDJ	1	16	2.7939789753082106E-4	3.391339367091291E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	1	4	5	6	3	0	24	40	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPQAAGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTGGGCGGCACCATGAACACTGAAGCTTTCTTTGGACAA	CASSLGGTMNTEAFF	In	VDJ	1	20	3.4924737191352636E-4	4.2391742088641134E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	5	8	0	0	2	7	24	36	42	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLGGTMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCGGGCAGCATGAAGCTTTCTTTGGACAA	CASSPPGQHEAFF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	8	0	7	4	4	24	38	46	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPGQHEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTGCACGGGATTCCTCCGGGACAGGGGGCGGCTATGGCTACACCTTCGGTTCG	CASSARDSSGTGGGYGYTF	In	VDJ	1	21	3.667097405092027E-4	4.451132919307319E-4	57	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	0	4	16	2	24	35	63	51	65													Vb 18	CASSARDSSGTGGGYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACTGGCGGGAGTGGCACAGATACGCAGTATTTTGGCCCA	CASSPTGGSGTDTQYF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	7	2	1	4	2	24	39	50	43	52													Vb 18	CASSPTGGSGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAGGAACATCCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPTGTSNTGELFF	In	VDJ	1	22	3.84172109104879E-4	4.6630916297505244E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	4	2	0	7	24	-1	44	38	51													Vb 18	CASSPTGTSNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTCTGGGCAGGGGGCGTAAGCACAGATACGCAGTATTTTGGCCCA	CASSLWAGGVSTDTQYF	In	VDJ	1	28	4.889463206789369E-4	5.934843892409758E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	0	0	8	3	24	35	51	43	54													Vb 18	CASSLWAGGVSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCCATTCCCGGGACTAGTATCGGGAGCTGGAGAGACCCAGTACTTCGGGCCA	CASSPFPGLVSGAGETQYF	In	VDJ	1	30	5.238710578702895E-4	6.35876131329617E-4	57	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	0	8	4	5	13	24	39	52	44	65						01,02							Vb 18	CASSPFPGLVSGAGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGACAGTCGCAGGTGAAAAACTGTTTTTTGGCAGT	CASSLTVAGEKLFF	In	VDJ	1	33	5.762581636573184E-4	6.994637444625787E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	5	7	1	7	24	37	43	38	50													Vb 18	CASSLTVAGEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGACTAGCGGGAGACTACAATGAGCAGTTCTTCGGGCCA	CASSPRLAGDYNEQFF	In	VDJ	1	35	6.111829008486711E-4	7.418554865512198E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	2	2	3	0	1	24	-1	52	40	53													Vb 18	CASSPRLAGDYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCCAACGGACAGGGGTTTTGGCTACACCTTCGGTTCG	CASSPPTDRGFGYTF	In	VDJ	1	37	6.461076380400237E-4	7.842472286398609E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	2	7	6	3	24	38	53	44	56													Vb 18	CASSPPTDRGFGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
AGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCTCAGGAGGAACCGGGTCTAGCGGGAGTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	40	6.984947438270527E-4		59	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	4	2	4	18	1	22	33	61	51	62													Vb 18	X+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGAAGGCTGTGGGACACTGAAGCTTTCTTTGGACAA	CASSPRRLWDTEAFF	In	VDJ	1	43	7.508818496140817E-4	9.114224549057843E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	0	9	3	10	0	24	39	-1	49	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRRLWDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTCAGGGACAGGGCCCTACGAGCAGTACTTCGGGCCG	CASSPSGTGPYEQYF	In	VDJ	1	43	7.508818496140817E-4	9.114224549057843E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	2	4	1	24	38	51	42	52													Vb 18	CASSPSGTGPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAAAGGGGTAACGAGGACCGGGGAGCTGTTTTTTGGAGAA	CASSKGVTRTGELFF	In	VDJ	1	46	8.032689554011106E-4	9.750100680387461E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	5	2	5	2	8	24	36	43	38	51													Vb 18	CASSKGVTRTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCCGTCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSVSSYNEQFF	In	VDJ	1	47	8.20731323996787E-4	9.962059390830665E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	5	0	5	0	24	36	-1	41	44													Vb 18	CASSSVSSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCTGGACAGGTTAACTATGGCTACACCTTCGGTTCG	CASSPPGQVNYGYTF	In	VDJ	1	48	8.381936925924632E-4	0.0010174018101273873	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	4	1	4	1	24	38	49	42	50													Vb 18	CASSPPGQVNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGNTGELFF	In	VDJ	1	49	8.556560611881395E-4	0.0010385976811717078	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	8	0	2	0	0	24	-1	-1	38	42													Vb 18	CASSPGNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTAGCGGGAGTATCTACGAGCAGTACTTCGGGCCG	CASSPPSGSIYEQYF	In	VDJ	2	56	9.778926413578739E-4	0.0011869687784819517	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	5	2	3	0	3	24	-1	50	41	53													Vb 18	CASSPPSGSIYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCTAGCTCACCCTACTTGCCGGGCACAGAAGGAGAATTTGGCTACACCTTCGGTTCG	CASSPYLPGTEGEFGYTF	In	VDJ	2	60	0.001047742115740579	0.001271752262659234	54	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	3	3	5	7	13	10	24	38	55	51	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPYLPGTEGEFGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGGCGGATGAACACTGAAGCTTTCTTTGGACAA	CASSPPGRMNTEAFF	In	VDJ	2	70	0.0012223658016973422	0.0014837109731024396	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	7	0	0	0	3	24	-1	46	41	49													Vb 18	CASSPPGRMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGTACAGGGAGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSYREGSYEQYF	In	VDJ	2	70	0.0012223658016973422	0.0014837109731024396	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	0	1	5	1	24	35	47	40	48													Vb 18	CASSYREGSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-07*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGAGACAGGAACACTGAAGCTTTCTTTGGACAA	CASSRDRNTEAFF	In	VDJ	2	72	0.0012572905388886948	0.0015261027151910807	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	1	2	0	24	37	-1	39	44													Vb 18	CASSRDRNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACCGGACTACATGAGCAGTTCTTCGGGCCA	CASSTGLHEQFF	In	VDJ	3	99	0.0017287744909719553	0.002098391233387736	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	9	8	3	1	24	36	45	39	46						01,02							Vb 18	CASSTGLHEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	5244B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2027	1669	332	24	0	1113	900	193	20	0	57266	47179	9383	704	0	0.139094025	8.44874287	0.130423516	8.80032063				86944	0.0187319014	0.0523538031	0.0431320518	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:05	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1192,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 321,type of chemo:carbo/taxol	0.8233842893483138	MSKCC- Snyder- P01-02		1629.0	
